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This thesis discusses four endogenous retroviruses. The first one is an 
endogenous Lentivirus detected in the genome of Galeopterus variegatus. The 
second is (rather a remnant of) an endogenous Deltaretrovirus described in the 
genomes of Miniopteridae bats. The third one is an endogenous Gammaretrovirus in 
the genome of Odocoileus hemionus; and the fourth is the presumed 
Gammaretrovirus present in the Cricetulus griseus genome (or rather in the cells 
obtained from this species and widely used in biotechnology). 
These animals come from only remotely related taxa and the studied retroviruses 
come from several groups. Therefore, in the introduction, I try to discuss the general 
phenomenon of endogenization, the individual groups of retroviruses, and the host 
restriction towards retroviral infection. The overview of the possible outcomes of the 
presence of an endogenous retrovirus for the host, and other aspects of the presence 
of an endogenous retrovirus in the animal genome are discussed not so elaborately.  
The Methods section is divided into sub-chapters, each discussing methods used 
in an individual project connected to a particular retrovirus. This is so that the reader 
has an easier job following this thesis. If a particular method is used in various 
projects, it is described only once and a cross-reference is included to it in the other 
project section. 
The results and discussion sections normally occurring in two individual chapters 
are merged, for with so many different projects, I found it easier to follow for the 
reader. In many cases, the methods, results or discussion texts might highly resemble 
the ones occurring in the published papers. Several figures are the ones included in 
the attached manuscripts, for several results discussed in this thesis or closely 
connected to it have been already published. All of these manuscripts are in the 
Supplement to this thesis. I tried to include the data I feel I contributed with to the 
presented papers (if not stated otherwise further on in the text), even though it is 
complicated in some cases (due to the facts stated in the declaration).  
VII 
 
I also tried to discuss the data not published in the papers (for they are either 
preliminary or were proven to be a dead end analyzes) more in detail than the ones 
that could be found in the attached manuscripts. These data and figures from them 
are generally rather preliminary, yet already informative. 
Taken together, I believe the experiments reported in this thesis would add to 
our understanding of the assorted diversity of interactions between endogenous 
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Endogenous retroviruses (ERVs) originate by germline infection and subsequent 
mendelian inheritance of their exogenous counterparts. With notable exceptions, all 
mammalian ERVs are evolutionarily old and fixed in the population of its host species.  
Some groups of retroviruses were believed not to be able to form endogenous 
copies. We discovered an additional endogenous Lentivirus and a first endogenous 
Deltaretrovirus. Both of these groups were previously considered unable to form 
endogenous copies. Endogenous lentiviruses were discovered only recently and are still 
quite rare. These are still just small pieces of evidence insufficient to give a broader 
picture about the history of virus endogenization. We described a novel endogenous 
Lentivirus in the genome of Malayan colugo (Galeopterus variegatus) denoted ELVgv 
(endogenous Lentivirus of G. variegatus). Based on several analyzes we proved that this 
is the oldest Lentivirus discovered up to date and confirmed its presence in the only 
other extant species of Dermoptera - Cynocephalus volans. 
Endogenous deltaretroviruses were the last group without a single endogenous 
member. We detected the remnants of endogenous Deltaretrovirus in the genome of 
Natal Long-fingered bat (Miniopterus natalensis). However, this sequence was present in 
the genome only in one copy. We subsequently amplified and sequenced the provirus 
remnants from other related Miniopteridae bats. 
Besides filling in the gaps of missing types of endogenous retroviral copies in 
genomes, we tried to add to current knowledge about the process of endogenization. 
The processes accompanying endogenization and the features of viruses capable of 
endogenization are still not well elucidated. 
This might be owed to absence of a suitable model of endogenization. We 
propose such a model. Besides endogenous retrovirus in koalas, ERV in mule deer 
(Odocoileus hemionus) forms new germ line insertions in the natural host population in 
the present evolutionary time and might serve as an important model of the retrovirus 
endogenization process. We have determined complete genome sequence of the deer 
ERV, denoted cervid endogenous retrovirus (CrERV). In the previous studies, thousands 
of highly polymorphic CrERV integrations in approximately 50 animals were 
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characterized. Notable polymorphism within the population of mule deer with CrERV 
integration sites allocated to specific area verify the predicted young age of the virus as 
well as the current process of endogenization. 
We performed experiments to characterize CrERV from virological perspective 
and explain the inefficiencies in virus replication cycle, for CrERV exhibits xenotropic 
behavior despite being efficient in creating new germ line copies. Experiments tackling 
this question were only partially successful and several questions remained unanswered. 
Besides these experiments, we tried to assemble retrovirus restriction factors from 
Cervidae species' genomes and perform analyzes to estimate possible presence of their 
positive selection.  
We also came across of concept, which could elucidate the occurrence of a 
replication block of viruses with amphotropic envelope in Chinese hamster ovary cells 
(CHOK1). We propose that these cells (widely used in biotechnology applications) bear 
an endogenous retrovirus unable to produce infectious particles, but able to produce 
defective Env protein. This protein might inhibit infection by exogenous retrovirus by 





Endogenní retroviry  (ERV) vznikají retrovirovou infekcí zárodečné linie a 
následným přenosem do dalších generací podle pravidel Mendelovy dědičnosti. Až na 
pár výjimek jsou všechny druhy savčích ERV evolučně staré a fixované v populaci svých 
hostitelských druhů. 
O některých skupinách retrovirů se předpokládálo, že nejsou schopny vytvářet 
endogenní kopie. Objevili jsme další příklad endogenního Lentiviru a první endogenní 
Deltaretrovirus. Obě tyto skupiny byly dříve považovány za neschopny vytvářet 
endogenní kopie. Endogenní lentiviry byly objeveny pouze nedávno a stale se považují za 
velmi vzácné. Toto jsou stále jen minoritní důkazy z kterých nemůžeme získat celkový 
obraz o průběhu virové endogenizace. Popsali jsme nový endogenní Lentivirus v genomu 
letuchy malajské (Galeopterus variegatus) a nazvali ho ELVgv (endogenous Lentivirus of 
G. variegatus). Na základě několika analýz jsme dokázali, že se jedná o nejstarší dosud 
objevený Lentivirus, a potvrdili jsme jeho přítomnost v jediném jiném současném druhu 
Dermopter - Cynocephalus volans.  
Endogenní deltaretroviry byly poslední retrovirovou skupinou bez nalezeného 
endogenního člena. Našli jsme zbytky endogenního Deltaretroviru v genomu netopýra 
létavce natalského (Miniopterus natalensis). Tato retrovirová sekvence byla přítomna v 
genomu pouze v jedné kopii. Následně jsme tento provirus amplifikovali pomocí PCR a 
osekvenovali také z jiných příbuzných druhů čeledi Miniopteridae.  
Kromě vyplnění mezery v typech endogenních retrovirových kopií nalezených v 
hostitelských genomech jsme se dále snažili rozšířit současné poznatky o vlatním 
procesu retrovirové endogenizace. Procesy doprovázející endogenizaci a vlastnosti virů 
schopných endogenizace nejsou stále dostatečně objasněny.  
To je částečně zapříčiněno chybějícím vhodným modelovým systémem pro 
endogenizaci. Jako vhodný model navrhujeme ERV jelence ušatého (Odocoileus 
hemionus), který vytváří nové inzerce v zárodečných buňkách v populaci svého hostitele 
v nedávne evoluci, a může sloužit jako důležitý model pro studium procesu retrovirové 
endogenizace. Popsali  jsme kompletní sekvenci genomu jelenčího ERV, nazvaného 
cervid endogenous retrovirus (CrERV). V předchozích studiích byly charakterizovány 
4 
 
tisíce vysoce polymorfních integrací CrERV v přibližne 50 zvířatech. Tento pozoruhodný 
inzerční polymorfismus v populaci severoamerických jelenců, s jednotlivými integracemi 
CrERV typickými pro konkrétní geografické lokality, naznačuje předpokládaný mladý 
evoluční věk viru a také současně probíhající proces endogenizace.  
Provedli jsme experimenty zaměřené na charakterizaci CrERV z virologického 
hlediska a na vysvětlení bloků retrovirového replikačního cyklu, protože CrERV vykazuje 
xenotropismus navzdory efektnímu vytváření nových zárodečných kopií. Tyto 
experimenty byly úspěšné jemom zčásti a mnohé otázky zůstaly stále otevřené. Kromě 
těchto experimentů jsme se dále snažili sestavit sekvence retrovirových restrikčních 
faktorů z genomů jelenovitých druhů a provést analýzy na možnou přítomnost 
pozitivního selekčního tlaku 
Dále jsme se pokusili objasnit přítomnost replikačního bloku virů s amfotropní 
retrovirovou obálkou na linii ovarialních buněk čínského křečka (Chinese hamster ovary 
cells - CHOK1). Předpokládame, že tyto buňky (hojně využívané v biotechnologii) v sobě 
nesou endogenní retrovirus neschopný produkce infekčních částic, ale schopný 
produkce a sekrece defektního obalového glykoproteinu (Env). Tento glykoprotein může 
působit inhibičně na infekci exogenním retrovirem, mechanismem kompetitivní inhibice 
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1 HYPOTHESES AND AIMS 
1) The first aim of this thesis is to characterize the findings of the computational 
screening of all publicly available genomes. This screen was aimed at the 
discovery of novel or unusual endogenous retroviruses. We chose two hits from 
this screen to be characterized in this work. 
 Discovery of an endogenous Lentivirus in Galeopterus variegatus 
(Malayan colugo) denoted ELVgv (Endogenous Lentivirus in Galeopterus 
variegatus). 
o Characterize the orthologous and paralogous sequences found in 
Galeopterus variegatus and the only other extant species from 
Dermoptera - Cynocephalus volans. 
o Characterize the relationship of ELVgv and its host. 
 Discovery of the first endogenous Deltaretrovirus found in the genomes 
of Miniopteridae bats denoted MINERVa (Miniopterus endogenous 
retrovirus). 
2) The second aim of this thesis was to induce Cervid endogenous retrovirus 
(CrERV) from mule deer cells by cocultivation with susceptible human cells to 
characterize virus by virological methods. 
3) The third aim was to describe the host-virus interactions of CrERV. The original 
idea was to use gammaretroviral pseudotypes to identify the replication block of 
the virus in mule deer cells. This approached was later complemented with 
marker rescue assay. 
4) The fourth aim is the further description of host-virus interactions of CrERV by 
assembling the host retrovirus restriction factors in silico and estimating the 
magnitude of the positive selection towards them. 
5) The fifth aim of the study was to analyze whether the infection block of Chinese 
hamster ovary (CHOK1) cells occurs due to the presence of endogenous 
retrovirus fragments secreted by CHOK1 cells. 
Figure 1 schematically shows the planned pseudotype constructs (MLV core and CrERV 
envelope and vice versa) and what would the infectivity outcomes on mule deer or 




Figure 1: Possible outcomes of the pseudotyping experiment. The parts used from MLV virus are 
depicted in red and parts of CrERV virus are depicted in blue. Hexagon indicates gag-pol and 




2.1 Retroviruses  
 Retroviruses are the causative agents of various pathologies (e.g. tumors, 
immunodeficiency, and neurological disorders). Retroviruses compose roughly 10% of 
mammalian genomes, composing approximately 50% of genomes together with the 
other retroelements. Retroviruses are enveloped single-stranded RNA viruses containing 
reverse transcriptase enzyme. Reverse transcriptase enables retroviruses to be an 
exception in the central dogma of molecular biology, being a key player in transcribing 
their RNA genome to DNA (hence the name retro-viruses). They are used as a molecular 
biology tool and their close examination brought several important discoveries 
(carcinogenesis, cellular growth control, oncogenes, signal cascades and various other 
issues in molecular biology). Therefore, the continuous interest in them and close 
examination of their possible exploitation is still an issue. This is also exemplified by the 
fact that retroviral vectors have been used in more than 300 clinical trials.  
2.1.1 Retroviral structure 
 
Figure 2: Schematic structure of a retrovirus (Gammaretrovirus). The pictures depict schematic 
structure of an immature and mature virion. The Env is depicted as a trimer of a surface (SU) and 
transmembrane (TM) subunit. Pictures are adapted from webpages of Swiss institute of 
Bioinformatics (http://viralzone.expasy.org/). 
 
The three major genes in the retroviral genomes are gag (group antigen), pol 
(polymerase) and env (envelope glycoprotein). Proteins coded by gag are MA (matrix), 
CA (capsid), NC (nucleocapsid); proteins coded by pol are PR (protease), RT (reverse 
11 
 
transcriptase), IN (integrase); and the env gene codes for the SU (surface) and TM 
(transmembrane) subunits of the retroviral envelope. Retroviruses have a pseudodiploid 
RNA genome encapsulated in the viral core. Schematic structure of a retrovirus is 
depicted in Figure 2. The structure of the cores and genomes varies among retroviral 
genera.  
2.1.2 Retroviral life cycle 
Retroviral life cycle consists of early phase (from entry into the cell up to 
integration into the host genome) and late phase (expression of the integrated 
retrovirus, assembly, and release of the retroviral particles). During several steps of this 
process retroviruses hijack the host molecular machinery for their replication. Starting 
from entry, which is enabled via host surface proteins (virus receptors), then continuing 
with exploitation of host transcription and translation complexes to acquiring lipid 
bilayer from host cells.  
 Entry into the cell is the first step in the retroviral life cycle. The viral Env 
interacts with the cellular receptor and this induces conformational changes in the 
transmembrane Env subunit (TM). Many examples demonstrate that the interaction of 
cellular receptor and retroviral Env might not be sufficient for the retroviral entry into 
the cells (e.g. presence of co-receptors is needed). However, cellular receptor and Env 
interaction is still believed to be the most crucial aspect of the cellular entry.  
 Reverse transcription occurs right after the viral particle enters the cytoplasm. 
The process of reverse transcription was discovered while studying Rous sarcoma virus 
(RSV) (reviewed in (Baltimore, 1995). It is dependent on the two activities of reverse 
transcriptase: DNA polymerase (able to utilize both, DNA and RNA as template) and a 
nuclease (ribonuclease H). The product of the process is a double stranded DNA 
genome. 
Reverse transcription starts with one RNA of the pseudodiploid genome, utilizing 
as a primer a cellular tRNA bound to PBS (primer binding site). The elongation continues 
towards the 3‘end (left RNA LTR-long terminal repeat) synthetizing the left DNA LTR. 
When the RNA template for the elongation ends, the original RNA LTR is digested and 
the newly synthesized DNA part of the LTR binds to the right (downstream) RNA LTR. 
12 
 
Subsequently elongation continues until the newly synthesized first DNA strand reaches 
the PBS used for the first binding of the primer. The remaining RNA is digested except 
for PPT (polypurine tract) located right next to the downstream LTR. The remaining RNA 
serves as a primer for the synthesis of the second DNA strand. When the synthesis 
reaches right LTR, the DNA double strand disassociates and the newest shorter strand 
(already without PPT) serves as a primer for a full length double strand viral DNA 
synthesis. This results in the fact that after the process of reverse transcription is over, 
the dsDNA has a complete LTR (consisting of U3-R-U5 sequences) on both sides. 
Retroviruses can recombine during reverse transcription by template switching during 
DNA synthesis. After mixed infection, half of the produced retroviruses are 
recombinants (Goodrich & Duesberg, 1990). 
 Some retroviruses are known to be able to actively enter the nucleus. They are 
heavily disassembled in the host cell cytoplasm and are subsequently able to exploit the 
host nuclear transport machinery (e.g. HIV). Other retroviruses have to wait for the 
division of the cell nucleus in the cell cycle when the nuclear envelope is temporarily 
disassembled (e.g. MLV). These processes were reviewed recently (Cohen, Au, & Pante, 
2011). 
 Prior to integration, a pre-integration complex is formed. It is a complex of host 
and viral proteins which can be isolated from infected cells (Farnet & Haseltine, 1990). 
This complex enables performance of three steps of the integration: processing, joining, 
and repair. Processing of the retroviral DNA ends (cleavage of two nucleotides from both 
ends) and joining of viral and host DNA is mediated by viral protein integrase. The 
integration is finalized in the last step when occurring gaps in DNA strands are filled by 
host polymerases. The result of the retroviral life cycles up to this step is integrated viral 
DNA (called provirus) with identical LTRs on both ends ready for transcription. Upon 
integration, short target site duplication (TSD) of host DNA is formed. 
 Transcription produces RNA templates for subsequent translations of retroviral 
genes as well as full RNA genomes to be later packed into the newly released viral 
particles. Transcription is performed by the host transcriptional machinery (RNA 
polymerase II). The organization of the genomes of particular retroviral genera with 
weak and strong stop codons enables translation of particular genes to occur in desired 
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orders and amounts. For example, lentiviruses have a weak stop codon ending the pol 
sequence which enables the read-through transcription of gag or gag-pol. The env is 
transcribed after a read-through and a frameshift, for Env is needed in lesser amount for 
retroviral assembly. Splicing occurs abundantly and is present also in simple retroviruses, 
generally for env (see Figure 2 for reference), and in complex retroviruses for additional 
accessory genes. The following translation must occur in the right moment in order to 
produce sufficient amount of particular gene product, the last being the products of gag 
and env to prepare enough protein for the retroviral particle assembly. 
 The process of retrovirus assembly occurs in the cellular cytoplasm close to the 
cytoplasmic membrane. The site of assembly varies for different retroviruses. When the 
retrovirus assembly is complete, the virus buds from the cell and finally is released. 
These processes are determined mainly by the products of the gag gene. Encapsidation 
signals on the unspliced RNAs are recognized by nucleocapsid proteins and the 
encapsidated RNA is then not to serve as a transcription template. 
 When the retrovirus is released from the cell, the particles undergo so-called 
maturation. This step enables the particles to become infectious for further processing 
of Gag and Gag-pro-pol is required. Mutants in the retroviral PR (protease) domain or 
particles assembled in the presence of PR inhibitor are not able to undergo this step. For 
example, gammaretroviral R-peptide (prevents fusion with host cell membranes before 





2.1.3 Retrovirus classification 
 
 
Figure 3: Phylogenetic relationship of retroviral groups (adapted from (Ruboyianes & Worobey, 
2016). 
 
The retroviral family is composed of seven genera (see Figure 3). 
Alpharetroviruses, betaretroviruses, and gammaretroviruses are simple retroviruses 
encoding only basic retroviral genes and mostly lack accessory genes. Deltaretroviruses, 
epsilonretroviruses, and lentiviruses are complex retroviruses coding for several 
accessory genes. Spumaviruses (Foamy viruses) are a special clade of retroviruses that 
generally do not cause pathologies.  
2.2 Genomics state of art as a defining factor in discovering 
endogenous retroviruses 
 The current state of the overall sequenced genomes is the major factor in 
determining the advances in the endogenous retroviruses research. The number of 
currently sequenced animal genomes available at NCBI (National Center for 
Biotechnology Information) is 4 amphibians, 73 birds, 80 fishes, 32 flatworms, 82 
roundworms, 222 insects, 127 mammals, 16 reptiles, and 83 other unclassified genomes 
(data from January 2017). Importantly, the assemblies of these genomes are of a 
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variable quality. ERVs, which are mostly present in many highly similar copies, are often 
either missing or assembled and annotated incorrectly in the genomes. 
 The cost of sequencing has been decreasing rapidly during the past few years and 
this might have been a factor in new initiatives such as Genome 10K project. This project 
aims to sequence ten thousand vertebrate genomes (Genome, 2009). One of the first 
groups of sequenced animals is 48 avian species (SJ, Haussler, & Ryder, 2014). In two 
years since the project was launched, the number of sequenced genomes increased 
from 26 to 277 (Koepfli, Paten, Genome, & O'Brien, 2015). The project was enlarged and 
gave rise to an initiative by Avian phylogenomics consortium to sequence ten thousand 
bird genomes (Birds10K) by the year 2020 (Zhang et al., 2015). Other large-scale projects 
such as Bat1K (Skibba, 2016), which aims to analyze bat communication via sequencing 
thousand bat genomes, provide set of sequencing data which can be further utilized to 
screen for endogenous retroviruses.  
 The rapid accumulation and development of Next generation sequencing (NGS) 
data sets available for public use from various species enables everyone with required 
skills to screen for sequences of their interest. Besides all possibilities, it potentially 
provides data to deepen our understanding of evolution of retroviruses. Evolutionary 
events in extant and recently infecting retroviruses combined with population genetics 
might elucidate the biology of retroviruses from various aspects, including 
endogenization (Johnson, 2015). Other areas of biology could benefit from sequencing 
and assembling various animals’ genomes as well. The technology designed for 
sequencing human genome and other large scale projects (such as 10,000 human 
genomes (Genomes Project et al., 2010) and ENCODE (http://www.encodeproject.org)) 
might be further utilized in this aspect to fill in the gaps of understanding major biology 
questions in various fields (Richards, 2015). 
2.3 Retrovirus endogenization 
Endogenous virus is a virus which infected and integrated into the germline cells 
and is further inherited vertically in mendelian fashion. The process of establishing the 
presence of a virus in the host cell is called endogenization. The term ‘endogenous 
retrovirus’ can be used to denote both, the integrated DNA sequence, and the infectious 
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particles produced by this sequence. The fate of the endogenous retrovirus in the 
infected population might vary. Generally, three possible outcomes are present. First, 
the virus might become fixed in the population; second, it might remain in a 
polymorphic state; and third, it might get washed out from the population completely 
(Katzourakis, Rambaut, & Pybus, 2005). 
The presence of the endogenous retrovirus might provide an advantage to the 
infected host. This might result in an enhanced spreading of the endogenous retrovirus 
element and a higher probability of its fixation in the host population. This scenario is 
probably rare, with best example provided by the presence of Syncytin gene originating 
from a retrovirus infection among placental animals. Syncytin produces fusogenic 
protein utilized in placentation (discussed in the chapter 2.6.3 Endogenous retroviruses 
with a role in the host physiology ). 
The presence of the endogenous retrovirus might not have an impact on the host 
whatsoever. Such neutrality is presumably the most common case. These proviruses 
might as well get fixated or vanish from the population, as well as they might be present 
in the genome in the polymorphic integration in the host genomes. While there is 
neither positive nor negative selection towards the fixation of an endogenous retrovirus 
in the host genome is rather random (Rouzine, Rodrigo, & Coffin, 2001). Such a situation 
is desired in the model used to study processes accompanying endogenization on a 
population scale.  
The presence of the endogenous retrovirus might be a burden for the host. The 
product of the virus might be toxic or even lethal for the host. The major disadvantage 
of the presence of the provirus for the host occurs if the provirus integrates into a gene 
exon or into intron in the plus orientation and therefore disrupts it or causes aberrant 
splicing. Such a provirus will be usually lost from the population early after integration 
(van de Lagemaat, Medstrand, & Mager, 2006).  
All of the three possible scenarios of retroviral spread in the population are 




Figure 4: The possible fate of endogenous retrovirus integration in the population. The virus 
might have no remarkable impact on the host, so the spread of the virus in the population is 
affected by other non-evolution related events (e.g. geographic barrierrs, bottleneck); leading to 
different integration patterns in different sub-populations. 
 
Despite the fact that retroviruses were believed to be the only viruses capable of 
endogenization, further examination of sequences suggested that this process is not 
exclusive to them (see Table 1 for reference). This illustrates that retroviruses might not 




Table 1: List of remnants of non-retroviral viruses among animal genomes. 
Positive sense single strand RNA viruses 
Flaviviruses Yellow fever mosquito (Katzourakis & Gifford, 2010) 
Negative sense single strand RNA viruses 
Bornaviridae Ground squirrel 
Snakes 
Thirteen-lined ground squirrels  
Bats 
(Horie et al., 2010)  
(Gilbert et al., 2014) 
(Suzuki, Kobayashi, Horie, & 
Tomonaga, 2014) 
(Cui & Wang, 2015) 
Double strand RNA viruses 
- - - 
Viruses utilizing reverse transcriptase in their life cycle 
Hepadnaviruses Passerine birds (Katzourakis & Gifford, 2010) 
Single strand DNA viruses 
Dependoviruses Domestic dog, Guinea pig, Nine-
banded armadillo, Horse, Tammar 
wallaby, African elephant, Mouse, 
Little brown bat, Pika, Duckbilled 
platypus, European rabbit, 
Hamadyras baboon, Cape hyrax, 
Malayan flying fox, Brown rat, 
Bottlenose dolphin, Alpaca 
(Feschotte & Gilbert, 2012) 
Parvoviruses Guinea pig, Tenrec, Rat, Tammar 
wallaby, Opossum 
Amdoviruses Cape hyrax 
Circoviruses Domestic dog, Cat, Giant panda, 
and Opossum 
Double strand DNA viruses 
Herpesviruses Human, Aye-aye, Bonobo, 
Philippine tarsier 
(Aswad & Katzourakis, 2014) 
Pappillomaviruses Platypus (Cui & Holmes, 2012b) 
 
2.3.1 Estimating the age of integrated ERV elements 
Endogenized viruses are a valuable tool in studying deeper evolutionary history 
of viruses. Upon endogenization the virus genome starts to mutate at a much slower 
rate (being the mutation rate of the host mammalian genome) than exogenous 
retrovirus, this difference can be up to 106-fold. Thanks to this fact, we are able to 
connect events in recent and ancient viral evolution (Aiewsakun & Katzourakis, 2015).  
The time of the integration of ERV elements into the host genome might be 
estimated by several approaches. The most straightforward way is to determine the 
presence or absence of ERV in the genomes of phylogenetically related species 
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(Johnson, 2015). In general, any ERV infiltration should have occurred in the most recent 
common ancestor of all the species bearing the ERV studied. This method is very robust, 
but yields usually a quite broad time interval for the ERV age estimated.  
A second method is dubbed ‘LTR aging’. This approach exploits the fact that both 
LTRs are identical at the time of integration, and uses the number of sequence 
differences that occurred since that time until present. The calculation of the time (T) 
needed to accumulate a given number of sequence differences (N) in the combined LTR 
length (L), assuming e.g. a neutral genomic substitution rate (R) of 2.3 × 10−9 to 5 × 10−9 
per site per year, following formula: T = N/(R × L) can be used for the age estimation of 
the ERV integration (Johnson & Coffin, 1999). This provides additional data about dating 
individual viral groups as well as it might serve as an additional marker in dating host 
species divergence. However, limitations of this method such as presence of a single 
LTR, recombination, gene conversion, and probable differences in the mutation rate at 
different sites must be taken into account. 
A third method uses the fact that genomic loci with ERV integration might 
duplicate in the evolutionary history of the host species. If the virus is present in both 
regions, then the duplication event must have occurred after virus integration and a 
minimal time estimate can be obtained (Hron, Fabryova, Paces, & Elleder, 2014; 
Katzourakis, Tristem, Pybus, & Gifford, 2007).  
The fourth approach is the time-calibrated phylogenetic analysis of orthologous 
proviral sequences from multiple species (using molecular clock). This is the most 
sophisticated method and provides information about the whole ERV lineage, not just 
about specific ERV integrations (Jha et al., 2009; Kamath et al., 2014; Tonjes & Niebert, 
2003). 
All of the methods used in estimating the age of integration of the endogenous 
retrovirus have limitations. Statistically speaking, the used method to estimate the time 
of the integration must ‘fit the data’ (Shapiro et al., 2011). For example, analyzes of 
extremely old retroviruses (pushing their origin to more 450 MYA) must often consider 
the accuracy of the methods when it comes to such old retroviruses (Aiewsakun & 
Katzourakis, 2017).  
20 
 
2.3.2 Proposed models for studying endogenization of retroviruses 
The process of endogenization and the events accompanying it are still poorly 
elucidated. As reviewed previously, endogenization might occur among virus families 
other than retroviruses, but rather rarely. Endogenous retroviruses (with emphasis on 
the rare ones) and some of their exogenous analogues are described in the next chapter. 
Here, the viruses perceived to have a potential to elucidate the events accompanying 
endogenization are described.  
2.3.2.1 Koala retrovirus (KoRV) 
One of the possible models for studying the process of endogenization is a 
recently discovered virus in Australian koalas, Koala endogenous retrovirus (KoRV). Its 
integration polymorphism (the presence of a proviral DNA at a particular integration site 
only in some individuals and a complete presumed lack in others) is a reason to consider 
it a young endogenous retrovirus (Tarlinton, Meers, & Young, 2006). Despite the fact, 
that insertional polymorphism was described already in other species (e.g. mice 
(Frankel, Stoye, Taylor, & Coffin, 1990), cats (Banerji, Kapur, & Kanjilal, 2007), sheep 
(Chessa et al., 2009)), so far it was always only a small number of integrations. The 
process of endogenization and subsequent adaptation in the host genome is still not 
elucidated. 
KoRV particles were first described in the tissues of leukemic koalas (Canfield, 
Sabine, & Love, 1988). The virus was sequenced and detected in stimulated peripheral 
blood cells as well as in three leukemia-positive koalas. The virus displayed sequence 
similarity (78% sequence identity) to Gibbon ape leukemia virus (GaLV) (Hanger, 
Bromham, McKee, O'Brien, & Robinson, 2000). The elevated level of KoRV transcripts in 
leukemic koalas is suggestive to the fact that KoRV causes neoplastic diseases in koalas 
(Tarlinton, Meers, Hanger, & Young, 2005). However, no causative studies have been 
performed yet.  
The sequence similarity of GaLV and KoRV remained an issue to resolve. An 
endogenous virus in Melomys burtoni might be the link between these two viruses 
(Simmons, Clarke, McKee, Young, & Meers, 2014). An insight into this problem was given 
by comparison of GaLV, KoRV, and Murine leukemia virus (MLV with Amphotropic 
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envelope 4070A) infectivity and receptors. These studies indicate that the host range of 
GaLV and KoRV do overlap, but their envelopes alter. Both GaLV and KoRV are capable 
of infecting a wide species range (Oliveira, Farrell, & Eiden, 2006). 
There was another possible mode of transmission of KoRV described. The 
possible vertical transmission of the retrovirus combined with the fact that KoRV copy 
number varies among individuals suggests that the virus is probably invading the 
genome of koalas. The prevalence of KoRV varies based on the geographic region. None 
of the samples obtained from Kangaroo Island (Australia) were positive. This enabled us 
to witness the initial entry of the endogenizing retrovirus into the wildlife species 
population (Tarlinton et al., 2006). 
The phenomenon of varying KoRV presence was also observed when koalas kept 
in ZOOs were analyzed (reviewed in (Denner & Young, 2013)). This fact combined with 
the presence of currently active exogenous variants of KoRV suggested to cause 
pathologies in koalas makes it an interesting platform to study the process of 
endogenization. The significance of the virus is emphasized by the veterinary importance 
(reviewed in (Kinney & Pye, 2016)). 
However, the usage of KoRV as a model to study endogenization has its pitfalls. 
Attempt to characterize its integration sites occurred only recently. The results indicate 
that the koala genome might have been invaded by KoRV at least seven times with the 
most recent integrations up to 50,000 years ago (Ishida, Zhao, Greenwood, & Roca, 
2015) The samples obtained from living koalas were compared to the historic museum 
samples (Avila-Arcos et al., 2013). The results indicate that only a small number of KoRV 
integrations sites recognized as recently integrated are shared by multiple animals. The 
regional differences in KoRV fixation were proposed, despite the fact that only small 
number of animals was analyzed. Beside that, the genome of koala is still not assembled 
and released, therefore the closest genome (Tammar wallaby - Macropus eugenii) is 
often used for KoRV analyzes (Cui et al., 2016). 
2.3.2.2 Cervid endogenous retrovirus (CrERV) 
 A situation similar as the one occurring in koala genome is also occurring in the 
genome of North American mule deer (Kamath et al., 2014). Despite the virus being 
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already described (Aaronson, Tronick, & Stephenson, 1976), only current methods 
enabled its thorough examination. 
 Initially, CrERV was described as the first endogenous retrovirus in the a species 
originating in the New World. It was described to possess distinct immunological 
properties. The endogenous retrovirus was induced by cocultivation with both, human 
and equine cells. The virus was described to exhibit xenotropic behavior. In most of the 
studies connecter to CrERV, the struggle with low virus titers was present (Aaronson et 
al., 1976). 
 At the time of the initial description of the virus, sequencing techniques were not 
widely avaliable. The tools available to use to determine the endogenous retrovirus 
sequence similarity to other endogenous retroviruses of other members of related phyla 
(such as Artiodactyla) were mainly hybridization techniques. The obtained CrERV 
sequence at the time hybridized strongly with the members of Cervidae (approximately 
85% similarity) clade, less effectively with the Bovidae clade (approximately 20% 
similarity) and did not hybridize with the related virus sequences obtained from more 
distant animal clades (Tronick, Golub, Stephenson, & Aaronson, 1977). 
 After more than 30 years, the CrERV caught the eye of researchers again. Its 
partial sequence was identified in a metagenomics screening of pathogens present in 
mule deer lymph nodes (Wittekindt et al., 2010). Eventually complete CrERV sequence 
was obtained and the endogenous nature of the virus was described (Elleder et al., 
2012). The presence of specific CrERV integrations in the mule deer and absence in the 
white-tailed deer suggested that the virus is rather evolutionary young for these two 
species split approximately 1 million years ago (MYA). Moreover, the provirus was 
proven to be transcriptionally active (Wittekindt et al., 2010). Using the adapted method 
based on PCR and next generation sequencing (NGS), hundreds of CrERV integrations 
were described in the genome of each and every mule deer individual examined (Le Bao, 
2014). The integrations were discovered to be highly polymorphic. This means that the 
germinal cells of mule deer must have been infiltrated by CrERV several times. All this 
evidence points to the fact that the virus is probably currently endogenizing, thus it 
seems to be a suitable model to study the processes accompanying endogenization 
(Elleder et al., 2012).  
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 Further studies of the provirus sequence consisted of sequencing 14 proviruses 
and following their presence/absence in various mule deer populations. The pattern of 
the presence of specific proviruses showed that individual CrERV integrations tend to 
cluster in localized geographic regions. This served as strong independent evidence that 
these integrations are extremely evolutionarily young, possibly only a few generations of 
the deer host. The polymorphic nature of CrERV integrations can also be utilized as a 
powerful genetic marker to study the population structure and history of the host 
species (Kamath et al., 2014). In general, endogenous retrovirus-derived genetic markers 
are very powerful, for the following reasons: (I) their ancestral state is known (absence 
of virus), (II) extremely high number of variants, because retroviruses can effectively 
target any position in mammalian genome, and in two orientations of integrated 
provirus, (III) once integrated, the provirus basically cannot be completely excised from 
the genome (Biek, Drummond, & Poss, 2006). 
 All of the aforementioned recent studies of CrERV were based on genetic analysis 
of its sequences, but did not study the virological aspects of the provirus. Replication of 
the original Aaronson cocultivation experiments was performed (Aaronson et al., 1976). 
The induced virus (originally named Deer Kidney Virus – DKV – by Aaronson) was shown 
to be sequentially identical to the sequences of CrERV used in the recent studies. The 
virus was proven to be xenotropic and its particles sediment in the area of the Iodixanol 
gradient typical for retroviruses. Replication-competent clone of the virus was 
constructed and the infection kinetics was described (Fabryova, Hron, Kabickova, Poss, 
& Elleder, 2015).  
2.3.2.3 Jaagsiekte sheep retrovirus (JSRV), Enzootic nasal tumor virus 
(ENTV), and endogenous retroviruses (enJSRVs) 
JSRV is a Betaretrovirus causing infectious lung cancer in sheep flocks. The JSRV, 
ENTV, and enJSRV have been studied due to their evolutionary interplay and also 
restriction effect of enJSRV Gag on exogenous JSRV (discussed later). However, presence 
of endogenous JSRV and currently infecting JSRV is highly suggestive of the fact that 
JSRV might be currently endogenizing. The oldest copy of enJSRV invaded the sheep 
genome approximately 7 MYA. The presence of orthologous copies not only in sheep 
genome, but also in the genome of goats, himalayan thar, and takin indicate, that the 
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invasion of the genome occured prior to the speciation of the Ovis genus. The presence 
of another provirus in takin and sheep, but not in goats and thar indicate that another 
invasion of the genome occured later on in the genus evolution. Positive selection 
pressure towards enJSRV is indicated, making it tempting to assume, that the presence 
of enJSRV in the selected ungulate genomes might be an asset for the animals (Arnaud 
et al., 2007a).  
2.3.3 Other evolutionary young endogenous retroviruses 
The aforementioned viruses are currently the best characterized models for 
studying the processes acompanying endogenization. However, they are not the only 
cases of evolutionary young endogenous retroviruses, and two other examples are 
presented below. 
2.3.3.1 Polar Bear (Ursus maritimus) Endogenous Retrovirus (UrsusERV) 
Polar bear genomes harbor retroviruses phylogenetically related to such 
evolutionary young viruses as PERV (porcine endogenous retrovirus) and KoRV. The 
provirus detected in the bear genome was overall intact. None of the integrations of the 
provirus in the genome were orthologous to integrations among bear species and 
analysis of the UrsusERV LTRs present in the genome indicates, that the bear genome 
was invaded by a virus forming an endogenous copy at least twice (Tsangaras, Mayer, 
Alquezar-Planas, & Greenwood, 2015). 
2.3.3.2 Unfixed Chimeric Endogenous Betaretrovirus in Armadillo (DnERV) 
Endogenous retrovirus with gammaretroviral env gene and otherwise 
Betaretrovirus features was discovered in the genome of armadillo (Dasypus 
novemcinctus). DnERV has not yet reached fixation in the armadillo genome, because 
insertional polymorphism was detected among Dasypus genus and only haploid copies 




2.4 Non-human endogenous retroviruses in vertebrates and their 
exogenous counterparts 
 Up to date there was no vertebrate genome described to lack retroelements or 
endogenous retroviruses. Recent massive sequencing of human and animal genomes led 
to the realization of the fact that almost 10% of mammalian genomes consist of ERVs. 
For a long time, it was thought that only simple retroviruses (alpha-, beta-, and 
gammaretroviruses) are able to create endogenous copies. This theory was proven 
wrong upon the discovery of the first endogenous Lentivirus - RELIK (Katzourakis et al., 
2007) and other endogenous complex retroviruses were subsequently described. These 
chapters summarize some of the endogenous retroviruses in the animal kingdom and 
their relationships to exogenous counterparts (if existing). With respect to the topics 
discussed in this thesis, lentiviruses are discussed in more detail.  
2.4.1 Alpharetroviruses 
 Alpharetroviruses as a model system helped to clarify quite a few phenomena of 
modern molecular biology. Despite playing a crucial role in elucidating many 
phenomena in the past, interest in them seems to be declining recently. Endogenous 
copies of retroviruses were first found in avian alpharetroviruses; hence they are 
included in this chapter. 
2.4.1.1 Avian sarcoma leukosis virus (ASLV) and Rous sarcoma virus (RSV) 
 The ASLV and RSV might be considered one the most important viruses forming 
the field of retrovirology in twentieth century. The discoveries based on studies of ASLV 
were awarded the Nobel Prize three times. First, it was discovered, that chicken 
leukemia can be transmitted from animal to animal by cell-free tissue filtrate (Ellermann 
and Bang) and cell-free tumor filtrate (Rous, 1910). Peyton Rous was then awarded the 
Nobel Prize in 1966. Proceeding in the studies of ASLV and RSV it was proven that these 
viruses contain RNA genomes. The elucidation of the process of reverse transcription 
and integration of produced viral DNA was discovered by Howard Temin and two years 
later H. Temin and David Baltimore independently discovered reverse transcriptase. 
They were both awarded the Nobel Prize for the discovery in 1975. 
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  ASLV and RSV are genetically very similar, but RSV contains a complete ORF for 
the src gene. The discovery of this gene was awarded the Nobel Prize to J. Michael 
Bishop and Harold E. Varmus for their discovery of "the cellular origin of retroviral 
oncogenes". Src is a tyrosine kinase, which triggers uncontrolled growth of cells. The 
virus acquired the src gene (denoted v-src) from the host cell (cell analogue denoted c-
src) during its replication. However, cellular and viral src genes differ. v-Src lacks tyrosine 
527 and is therefore constitutively active without possible inhibitory regulation whereas 
c-src is a strictly regulated proto-oncogene active only when required (Czernilofsky et al., 
1980; Smart et al., 1981). Similar cases of cellular proto-oncogenes present in other 
retroviruses are overviewed in the chapter Oncoretroviruses. 
 ASLV is still currently studied not only for its ability to trigger cancerogenesis, but 
also for the fact that its subtypes require different receptors for viral entry (see Table 2 
for reference). ASLV is also studied to elucidate the restriction processes resulting in 
avian retroviruses inability to infect mammalian cells (Lounkova et al., 2014). 
Endogenous copies of retroviruses were first found in avian alpharetroviruses. First, 
avian leukosis virus in the domestic fowl (Gallus gallus) was discovered, and murine 
leukemia virus and murine mammary tumor virus in the laboratory mouse (Mus 
musculus) followed (Weiss, 2006). Transcriptionally active ASLV promoters were found 
in pathogen free chickens (McNally, Wahlin, & Canto-Soler, 2010). 
2.4.2 Betaretroviruses 
 MMTV and JSRV might not be particularly rare retroviruses, but they are among 
the suitable models for studying the processes accompanying endogenization. The 
species present in this genus include JSRV - Jaagsierte sheep retrovirus, MPMV - Mason 
Pfizer monkey virus, MMTV - Mouse mammary tumour, HML1-10 - Human mouse 
mammary tumor virus like, Beta like retroviruses, Python-molurus. Selected examples of 
endogenous betaretroviral species are described in this chapter. 
2.4.2.1 Murine mammary tumour virus (MMTV and Mtv) 
 MMTV is a milk-transmitted retrovirus (Bittner, 1936). Despite the fact that 
several mice bear an endogenous copy (denoted Mtv), and the possible mode of 
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transmission is also via the maternal milk enables the virus to spread via two routes. The 
virus transmitted via the exogenous route is capable of creating tumors later in life.  
 Mtv is a simple retrovirus, but its genome encodes for additional gene sag. 
Endogenous copies are either able or not able to produce the functional viral particles 
due to several mutations, but in most cases the reading frame for sag remains intact 
(reviewed in (Holt, Shevach, & Punkosdy, 2013)). The sag probably has some beneficial 
features for the host with its ability to regulate the host immunity response by affecting 
the nature of the T-cell reservoir (Kang et al., 1994). This results in affecting the mode of 
other not exclusively viral infections as well. MMTV also encodes for a gene which is a 
self-regulatory RNA export gene rem (Mertz, Simper, Lozano, Payne, & Dudley, 2005). 
2.4.2.1.1 Pika-BERV 
 An endogenous analogue to MMTV was found in the genomes of pikas 
(Ochotona sp.) and denoted Pika-BERV (Pika-beta endogenous retrovirus). The invasion 
of the genome was dated to be 3-7 MYA and the proviral sequence was described in 
several Ochotona species (Lemos de Matos et al., 2015). 
2.4.2.2 Jaagsiekte sheep retrovirus (JSRV) and its endogenous counterpart 
(enJSRV) 
 The sheep genome is colonized with the endogenous copies of JSRV (the copies 
being denoted enJSRV). This virus was already discussed as a model used for studying 
the phenomenon of endogenization. Due to the presence of an interesting interplay 
between JSRV and enJSRV, this virus is discussed in more detail in the chapter 2.6.4. 
Endogenous retrovirus genes and exogenous virus infection. 
2.4.2.3 Python morulus endogenous retrovirus (PyERV) 
PyERV probably causes a fatal disease - boid inclusion body disease - in boid 
snakes. Despite the clame that this retrovirus is unclassifiable, some place the virus in 
the genus Betaretrovirus. An endogenous copy of PyERV was named PyT2RV (Huder et 
al., 2002). 
2.4.2.4 Pan troglotydes endogenous retroviruses (PtERVs) 
 PtERVs are a LTR retrotransposons present in three classes: CERV (Chimpanzee 
endogenous retrovirus) – gammaretroviruses, CERV II - betaretroviruses, CERV III - 
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spumaviruses. Majority of the chimpanzee-specific insertions belong to classes I and II. 
Frameshifts and substitutions damaged the ORFs of the proviruses so no functional gene 
could be expressed but eight copies could be retrotransposition-competent. Overall, 
PtERVs could drive genomic changes after the divergence of chimpanzees and humans 
(Mun, Lee, Kim, Kim, & Han, 2014). 
 Using viral constructs with MLV cores and reconstructed Envs of extinct CERV, 
the receptor of the virus was detected as the copper transporter (CTR1). The presence of 
the receptor on human germline cells does not support the fact that the presence 
enables endogenization, for no endogenous PtERVs or related sequences were detected 
in human genomes (Soll, Neil, & Bieniasz, 2010).  
2.4.3 Gammaretroviruses 
 The presence of a Gammaretrovirus in any genome mostly does not occur to one 
as a surprise. The proportion of endogenous gammaretroviruses in host genomes is 
illustrated in the Figure 5. Since endogenous gammaretroviruses are abundant, one 
could expect to be more likely to come across a Gammaretrovirus that might be 
currently endogenizing. Despite the expectations resulting in presence of polymorphic 
integration in some genomes, the opposite is true. To thoroughly examine the process of 
endogenization, one needs a population with the similar integration pattern within it as 
well as the pattern being different to a one described elsewhere. This situation was so 
far described in the population of Australian koalas and mule deer inhabiting Northern 
part of America (discussed in previous chapters). The species in the genus are: HERVs - 
Human endogenous retroviruses, PERV - Porcine endogenous retrovirus, GALV - Gibbon 
ape leukemia virus, FeLV - Feline leukemia virus, MLV - Murine leukemia virus, KoRV - 




Figure 5: Endogenous gammaretroviruses among vertebrate genomes. The number of ERVs is 
depicted by the size of the outter gray circle. The proportion Class I ERV (Gamma- and 
Epsilonretrovirus) is depicted by inner circle. The proportion of gammaretroviruses is depicted by 
red in the inner circle (pie chart). The figure is adapted from (Hayward, Grabherr, & Jern, 2013). 
 
2.4.3.1 Cervid endogenous retrovirus (CrERV) 
 The studies of CrERV dates back to the discovery of the first type C 
Gammaretrovirus discovered in the mammalian species of the New World origin 
(Aaronson et al., 1976). The discovered virus was denoted Deer kidney virus (DKV). The 
DKV virus was obtained by cocultivation with susceptible cells.  
 However, the virus became to be of higher interest when it was proved to be 
highly polymorphic and subsequently integration sites specific for a host population 
were described (Elleder et al., 2012; Kamath et al., 2014). Currently CrERV is a virus with 
one of the most polymorphic integration sites, whereas some patterns of integrations 
cluster geographically. This indicates that the endogenous copies of the retrovirus are 
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evolutionarily young and therefore the virus is a suitable model for studying the 
processes accompanying the early steps of endogenization. Despite the fact that the 
virus is efficient in creating new endogenous copies, it is inefficient as an exogenous 
virus in the original host species (discussed in this thesis). 
2.4.3.2 Gibbon ape leukemia virus (GALV) 
 GaLV together with WMV (Wooly monkey virus) were the first exogenous 
retroviruses associated with leukemia in primates (Kawakami, Kollias, & Holmberg, 
1980). Both of the viruses share a high sequence similarity together with KoRV (koala 
retrovirus). An endogenous copy of GaLV was detected in a rodent Melomys burtoni 
(Alfano et al., 2016). This finding might help explain the close relatedness of GaLV and 
KoRV for gibbons and koalas are not even geographically overlapping and the transfer of 
the retrovirus used to be rather a mystery. 
2.4.3.3 Feline endogenous leukemia virus (FELV)  
 FeLV is one of the most studied endogenous retroviruses due to being the main 
caus of leucosis occurring in domestic cats which is their most common form of 
malignancy (Priester & Mantel, 1971). However, FeLV is not a threat to several 
populations of domestic cats only, but it also occurred in captive Asian leopard (Rasheed 
& Gardner, 1981), wildcat (Felis silvestris) (Boid et al., 1991), captive bobcat (Felis rufus) 
(Sleeman, Keane, Johnson, Brown, & Woude, 2001), in captive cheetah (Acinonyx 
jubatus) (Marker, Munson, Basson, & Quackenbush, 2003), but not in free ranging 
(Munson et al., 2004), panthers (Nolen, 2004), Florida pumas (Puma concolor 
coryi)(Cunningham et al., 2008), Iberian lynx (Lynx pardinus)(Meli et al., 2009), Pallas' 
cats (Felis manul) (Naidenko, Pavlova, & Kirilyuk, 2014), and guignas (Leopardus guigna) 
(Mora, Napolitano, Ortega, Poulin, & Pizarro-Lucero, 2015).  
 Being a threat to domestic cats and endangered species, a broad research 
concerning this pathogen has been conducted. Four FeLV subgroups (FeLV-A, FeLV-B, 
FeLV-C, and FeLV-T) were described. Subgroup B (which presence is an indicator of a 
poorer prognosis of leukemia (Sheets, Pandey, Jen, & Roy-Burman, 1993)) and C (causing 
non-fatal anemia (Mackey, Jarrett, Jarrett, & Laird, 1975)) are generated from subgroup 
A. Subgroup T is associated with immunosuppressive disease (Donahue et al., 1991). 
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2.4.3.4 Koala retrovirus (KoRV) 
 Leukemic and lymphoid neoplasia was proven to be present in koalas a long time 
ago. Findings in the year 1988 of gammaretroviral particles in koalas indicated that the 
pathologies might have a retroviral etiology (Canfield et al., 1988). Later the virus 
sequence was discovered to be similar to the sequence of GALV. Despite the high 
sequence similarity, the geographical distribution of koalas and gibbons makes the direct 
transmission among the two species highly improbable. However, these two viruses 
might have a common ancestor (Melomys burtoni retrovirus- MbRV) (Simmons et al., 
2014).  
2.4.3.5 Melomys burtoni retrovirus (MbRV) 
 MbRV was discovered by screening 42 either native or introduced species to 
Australia for the presence of KoRV-like retrovirus. The viral genome was sequenced. The 
sequence of pol and env cluster with KoRV and GaLV in the phylogeny trees. The 
presence of the virus particles was proven by electron microscopy, but the virus 
probably does not cause any cytopathic effect (Simmons et al., 2014).  
2.4.3.6 Murine leukemia virus (MLV) 
 The MLV genome was the starting material in vector constructions in gene 
therapy. It is used as a model system in studies analyzing retroviral integration 
preferences. It may be due to the fact that it has a simple, well described genome 
(reviewed in (Rein, 2011)) and its subtypes are able to show different tropism: 
amphotropic - infecting all species, xenotropic - infecting only species different to the 
original host, and ecotropic - being able to infect only the original host. MLV is present in 
mice in endogenous form in many copies and some polymorphic integrations were 
described, but not in sufficient numbers to be utilized as a model for studying processes 
accompanying endogenization.  
2.4.3.7 Porcine endogenous retrovirus (PERV) 
 PERV is considered a threat when it comes to xenotransplantation. 
Xenotransplantation has been performed in the passing of the history of medicine, 
mainly due to the lack of knowledge about the immunological interspecies barrier. 
However, using organs of other species for transplantation is still a current topic and 
some success was reported transplanting pig liver at least for the prolonged waiting time 
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for the human donor organ (Makowka et al., 1994). Still, the presence of PERV in the pig 
genome and possible zoonotic infection is still a major obstacle to overcome when it 
comes to xenotransplantation (reviewed in (Mattiuzzo, Takeuchi, & Scobie, 2012)). One 
of the most promising approaches towards this problem is the use of CRISPR-Cas 
technology to eliminate the presence of PERV in the pig genome (Yang et al., 2015). Due 
to its clinical significance, PERV is one of the best described endogenous retroviruses. 
2.4.4 Deltaretroviruses 
 Deltaretroviruses are possibly the most mysterious group of retroviruses. An 
endogenous copy of Deltaretrovirus was not found for a long time. The belief that 
deltaretroviruses are not capable of creating endogenous copies was supported by the 
general belief that complex retroviruses are not efficient in infecting germline cells. 
However, we were successful in identifying the first presence of an endogenous 
deltaretroviral sequence. 
As mentioned before, deltaretroviruses possess complex genomes coding for 
gag-pol-env and the sequences of additional genes. The additional genes for 
deltaretroviruses are Tax, Rex, and HBZ. Tax is an activator of viral and cellular 
transcription; Rex binds and stabilizes viral RNA, and HBZ plays a role in leukemogenesis 
and has multiple other functions. HBZ has the ORF of the sequence in the opposite 
strand compared to the rest of the provirus sequence. The species in this genus are: 
HTLV-1,2,3,4 - Human T-lymphotropic virus 1-4; STLV-1,2,3,4 - Simian T-lymphotropic 
virus 1-4; and BLV- Bovine leukaemia virus. 
2.4.5 Epsilonretroviruses 
 Epsilonretroviruses are an exception for despite the fact they have complex 
genomes; they are able to form endogenous copies quite efficiently (see Figure 5 for 
reference). Epsilonretroviruses is the newest genus of Orthoretrovirinae. Endogenous 
copies of these viruses were found in fish and amphibians.  
Walleye dermal sarcoma virus (WDSV) causes dermal sarcomas in its piscine host 
- walleye (Stizostedion vitreum). The accessory genes regulate the host metabolism and 
induce cancerogenous changes. The most distinc feature of the cancerogenesity is its 
seasonal cycle (Bowser, Wolfe, Forney, & Wooster, 1988) and a complex life cycle with 
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varying gene expression pattern throughout the replication of the virus and stage of the 
disease (Quackenbush, Holzschu, Bowser, & Casey, 1997).  
Walleye epidermal hyperplasia virus (WEHV) was found in two subtypes: WEHV1 
and WEHV2. Both are probably causing hyperplasia in walleye. Similarly to WDSV, the 
occurrence of the pathology has seasonal cycles (LaPierre, Holzschu, Wooster, Bowser, 
& Casey, 1998).  
Xenopus laevis endogenous retrovirus (Xen1) with length over 10 kb is probably 
of the largest endogenous retrovirus known. It has only four frameshift mutations and 
no obvious stop codon. The 99% similarity of the provirus LTRs suggests that the virus 
integrated into the genome recently (Kambol, Kabat, & Tristem, 2003). 
2.4.6 Lentiviruses 
Lentiviruses were thought to be a young genus of retroviruses for their 
endogenous copy was not detected for a long time. Due to the quite recent HIV 
outbreak, lentiviruses might be currently the most studied retroviruses. They cause 
severe pathologies. The members of this group with the important notion are HIV 
(human immunodeficiency virus) and other immunodeficiency viruses such as of simian 
species (SIV) and felids (FIV). Lentiviruses possess complex genomes. Besides gag, pol, 
and env, they also bear additional accessory genes.  
Discoveries of their endogenous copies pushed the knowledge about their 
evolution several million years deeper. These discoveries also provide an interesting 
insight about host-interaction evolution via combining information about accessory 
genes and analysis of evolution of their counteracting restriction factors.  
2.4.6.1 Lentiviral regulatory and accessory genes 
Not all of the lentiviruses bear all of the regulatory and accessory genes. Based 
on the discoveries of their endogenous forms we are able to study the evolution of 
lentiviral accessory genes as well. The evolutionary tree indicating the evolutionary 
dynamics of presence/absence of some accessory genes is depicted in the Figure 7. 
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2.4.6.1.1 Regulatory genes 
2.4.6.1.1.1 Tat  
Tat acts as a trans-activator during transcription to enhance initiation and 
elongation. Tat binds nascent RNA with TAR (Tat-responsive element) in LTR. It works in 
cooperation with cellular protein pTEFb which binds Tat and TAR. pTEFb phosphorylates 
polymerase II and thus increases the processivity of the polymerase (reviewed in (Zou, 
Peng, Wang, & Zhou, 2016)). Tat is not present in feline lentiviruses, but many binding 
sites for enhancer proteins are present in LTRs of felid lentiviruses. However, their 
presence was not proven to be essential for replication of felid lentiviruses (Miyazawa, 
Tomonaga, Kawaguchi, & Mikami, 1994).  
2.4.6.1.1.2 Rev  
The abbreviation Rev stands for “regulation of expression of virion proteins”. Rev 
contains and arginine-rich RNA binding domain which binds to RRE (Rev responsive 
element). The Rev responsive element acts post-transcriptionally, regulating mRNA 
splicing and transport to the cytoplasm. It works with cellular proteins binding Rev (e.g. 
importin). Rev contains NLS (nuclear localization signal) which aids its return to the 
nucleus (reviewed in (Grewe & Uberla, 2010). Presence of Rev was not detected in 
endogenous Lentivirus of Malayan colugo (Han & Worobey, 2015; Hron et al., 2014). As 
discussed previously, the accessory gene might have been present in the circulating 
retrovirus at the time of infection, but due to being heavily mutated, we are not able to 
detect it, so our presumption of its absence might be biased. However, if Rev was 
lacking in the genome of the virus which integrated into the colugo genome, the virus 
might have been using different replication strategy than current lentiviruses. It was 
proven that viruses with impaired Rev exhibit faulty replication in various steps 
(Blissenbach, Grewe, Hoffmann, Brandt, & Uberla, 2010).  
2.4.6.1.1.3 P6 
P6 is technically not a regulatory gene, but is included here for if it is disrupted, 
the lentiviruses coding for P6 in its genome are budding only with difficulties and 
therefore its evolutionary study might give an additional insight on host-Lentivirus 
interactions. P6 is a proline-rich protein interacting with endosomal vesicles. However, 
besides studying it in HIV and primate lentiviruses (Bibollet-Ruche et al., 2004), not 
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much attention is paid to it. It was not described in any of the discovered endogenous 
lentiviruses.  
2.4.6.1.2 Other accessory genes 
When it comes to identification of accessory genes in endogenous retroviruses, 
two possible scenarios if the accessory gene is stated to be lacking might occur. Either 
the area bearing was already heavily mutated and hence the presence of an accessory 
gene cannot be determined properly or the accessory gene was lacking in the virus that 
endogenized. This leads to contradictions presented in the works studying lentiviral 
accessory genes. 
2.4.6.1.2.1 Vif 
The abbreviation Vif stands for virus infectivity factor. Vif aids virion maturation 
and infectivity. Vif is not present in equine lentiviruses and was not detected in the 
endogenous Lentivirus of colugo (Han & Worobey, 2015). Vif is stated to be present in 
RELIK by some (Han & Worobey, 2015) and stated to be lacking by others (Katzourakis et 
al., 2007). However Vif is detected in the genome of ELVmpf (endogenous Lentivirus of 
Mustela putorius furo) which happens to be dated as an older lentiviral lineage. 
Therefore the presence of Vif in the retrovirus endogenizing as RELIK occurs as more 
probable.  
2.4.6.1.2.2 Nef  
Nef is also known as a negative factor for originally it was described as a 
redundant accessory gene. However, it was proven to aid pathogenicity of the virus and 
if deleted from the SIV genome, it reduces pathogenicity in macaques (reviewed in 
(Laguette, Bregnard, Benichou, & Basmaciogullari, 2010). It was proposed that infection 
by Nef-lackig SIV might protect macaques from infection by more aggressive SIV forms. 
Nef was probably acquired only by simian and human immunodeficiency viruses.  
2.4.6.1.2.3 Vpu  
Vpu stands for “Viral protein-unknown”. Vpu downregulates CD4 in cells and 
increases virion release from the cells. The gene coding for Vpu was detected only in 
HIV-1 and HIV-1 related SIV isolates. HIV-2 and majority of the SIV isolates lack this 
accessory gene (Hussain, Wesley, Khalid, Chaudhry, & Jameel, 2008). It was proven to be 
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capable of counteracting the cellular restriction factor Tetherin. However, the HIV-1 
group O uses Nef to counteract the action of Tetherin (Bush & Tebit, 2015). This general 
absence of Vpu in the lentiviral group might indicate that this is rather a young accessory 
gene. 
2.4.6.1.2.4 Vpr (Vpx) 
Vpr stands for “Viral protein-regulatory”. Vpr induces G2 arrest of the cell cycle 
and induces apoptosis. Vpr is encoded by HIV-1. HIV-2, SIVsm, and SIVmac encode two 
proteins that are homologous to HIV-1 Vpr, namely Vpr and Vpx (reviewed in (Planelles 
& Barker, 2010). Vpx is encoded by HIV-2 and simian immunodeficiency viruses. Vpx 
counteracts the actions of SAMHD1 (Herrmann, Happel, & Gramberg, 2016). As with 
Vpu, the presence of this accessory gene only in human and simian immunodeficiency 
viruses indicates its rather recent acquisition by lentiviral genomes.  
2.4.6.1.2.5 dUTPase 
dUTPase is technically not an accessory gene. It is not a solitary gene, but is 
encoded by the pro gene or part of pol gene in some viruses. However, I discuss it here 
for its interesting evolutionary dynamics among lentiviruses. What comes as a surprise is 
the fact that dUTPase is encoded in various places in viral genomes (see Figure 6). This 
suggests that viruses might have acquired dUTPase during various evolutionary events 
(Hizi & Herzig, 2015). 
dUTPase is present in the genomes of EIAV (Equine infectious anemia virus), FIV 
(Feline immunodeficiency virus), and CAEV (Caprine arthritis encephalitis virus), but not 
in primate lentiviruses. The function of dUTPase in lentiviral genomes is still not clearly 
elucidated. EIAV and FIV with removed dUTPase replicate poorly in the cultured 
macrophages and viral load or severity of symptoms might be decreased in in vivo 
infections (Lerner et al., 1995; Lichtenstein et al., 1995). 
However, when it was removed from the CAEV, the virus was shown to replicate 
slowly in macrophages, but after some time it replicated at the same rate as wild-type 
CAEV. CAEV without dUTPase differs in pathogenesis compared to virus with intact 
dUTPase. The presence of dUTPase was also shown to increase genomic stability of 




Figure 6: Position of dUTPase in retroviral genomes. The schemes are not drawn to scale. The 
figure is adapted from (Hizi & Herzig, 2015). 
 
 




2.4.6.2 Endogenous lentiviruses 
Lentiviruses were believed not to form endogenous counterparts for quite a long 
time. Firstly, they were believed to be evolutionary young and secondly, they are 
complex retroviruses which were thought not to be able to form an endogenous copy at 
all. This was hypothesized to be either due to lack of receptor on germline cells or due to 
virus cytopathic effects. This belief was proven to be wrong. Endogenous Lentivirus was 
first discovered in the rabbit genome (Katzourakis et al., 2007). Subsequently, 
endogenous lentiviruses were discovered in lemurs (Keckesova, Ylinen, Towers, Gifford, 
& Katzourakis, 2009) and ferrets (Cui & Holmes, 2012a). 
2.4.6.2.1 Endogenous Lentivirus of Mustela putorius furo (ELVmpf) 
 ELVmpf was the third endogenous Lentivirus discovered. Besides lentiviral gag-
pol-env genes, Vif-like element was detected. The insertion into the ferret genome was 
estimated to occur 12 MYA (Cui & Holmes, 2012a). The further study of ELVmpf 
confirmed its presence in the species of Lutrinae and Mustelinae subfamilies but not the 
Martinae subfamily. This confirmed the estimated age of the provirus. An additional 
accessory gene was identified in endogenous lentiviruses- vif (Han & Worobey, 2012). It 
was proposed that ferrets could be used as a model to study lentiviral-host interactions 
for their cells can be productively infected by HIV-1 (Fadel et al., 2012) 
2.4.6.2.2 Endogenous simian immunodeficiency virus (pSIV) 
 An endogenous form of simian immunodeficiency virus was detected in the WGS 
(whole genome shotgun) data of Grey mouse lemur (Microcebus murinus) and denoted 
pSIVgml. The presence of pSIVgml was subsequently detected in samples from six 
additional species of lemur. The invasion of the genome was estimated to have occurred 
4 MYA. This estimation is still an object to be questioned, for pSIV is present both in 
lemurs inhabiting Madagascar and African landmass. These two areas are divided by a 
400 km wide and deep ocean for the last 130 million years, creating a geographical 
barrier hard to be crossed by lemurs. pSIV is the first and so far only evidence of an 
endogenous Lentivirus presence in a primate genome. Vpr and possibly nef sequences 




2.4.6.2.3 Rabbit endogenous Lentivirus type K (RELIK) 
 The first endogenous Lentivirus was discovered in the genome of European 
rabbit (Oryctolagus cuniculus). The provirus bears full-length gag, pol, and env genes, 
but highly mutated (frameshifts and stop codons included). The endogenous copy 
posseses an element resembling genes for tat and rev. The presence of relatively intact 
endogenous copies and several solo LTRs point out the established germline infection 
occuring approximately 5 MYA (Katzourakis et al., 2007). 
 The CA of RELIK was proven to interact with Trim5α. Trim5α was also proven to 
be under positive selection in Leporidae (Yap & Stoye, 2013). These facts might indicate 
the relationship between Trim5α and RELIK, but it is very hard to assign the presence of 
a positive selection towards a restriction factor to a specific virus. The CA of RELIK was 
also proven to interact with cyclophilinA (CypA). CypA was packaged into virions 
containing ancient lentiviral CA. The complex CA-CypA of ancient proviruses probably 
enabled the viruses to infect nondiving cells, protected them from restriction factors or 
play a role in the virion assembly or CA uncoating (Goldstone et al., 2010). 
2.4.7 Spumaviruses 
 Placed outside of the Orthoretroviral clade, spumaviruses make up a special 
retroviral group. Due to the fact they they do not cause severe pathologies, they were 
not of a deeper interest for a long time. This feature became lately an advantage for it 
makes them a great candidate to be used in gene therapy. As exogenous, they infect 
broad range of animals. Some of the species in the genus are: African green monkey 
simian foamy virus, Macaque simian foamy virus, Bovine foamy virus, Equine foamy 
virus,  Feline foamy virus.  
2.4.7.1 Sloth endogenous foamy virus (SloEFV) 
The presence of approximately 11,5 kb long SloEFV is the evidence that foamy 
viruses could be infecting ancestral mammals more than 100 MYA (Katzourakis, Gifford, 
Tristem, Gilbert, & Pybus, 2009). Despite the fact that SloEFV was described for some 
years, not much attention was paid to it nor was its more recent evolution studied. This 
might be partly owed to the fact that not many extant relative host species exist. The 
most recent work analyzes the ancient sequence found in modern sloths and 13,000 and 
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20,000 years old samples. Lineage-specific SloEFV copies were detected and the age of 
the repeated recent endogenization (10-20 MYA) was proposed (Slater et al., 2016).  
2.5 Retroviral life cycle and the host 
 When it comes to discussing any pathogen and the host relationship, the Red 
Queen Hypothesis proposed by Van Valen always comes to notice. Retroviruses are no 
exception. Since the hosts and retroviruses co-existed for millions of years, their 
relationship naturally evolved as well. 
2.5.1 Receptor block 
 The receptor is the virus’s gateway to the cell, making it the first line of defense 
against the virus for the cell. As mentioned before, retroviruses usually exploit cellular 
receptors used for physiologically occurring transport of various substances to the cell. 
However, the presence or absence of a particular receptor does not rule out nor indicate 
the potential of a retrovirus to endogenize. Some viruses utilize the same receptor, 
whereas some subtypes of a retrovirus utilize different receptors (see Table 2 for 
review). The occurrence of the replication block at a receptor lever might be determined 
by changed conformation of receptors or co-receptors. 
The other possible scenarios for the occurrence of receptor block are the changes 
in viral envelope. Of all the genes of retroviruses, env probably displays the most 
variable functionality and possess the most rapidly evolving sequence. The major 
function is the binding to the receptor. Some additional activities were detected in 
various retroviral Envs. For example, in MuLV, Env was proven to affect membrane 
fusion. JSRV Env transforms cells in vitro and work as an oncogene in vivo. The C-
terminal tail of Env in lentiviruses is uncommonly long and besides determining Env 
structutal and functional features, plays a role in the maturation of virions and 




Table 2: Retrovirus receptors 
Retrovirus Receptor Reference 
HIV, SIV CD4 helper T cell receptor, 
CXCR4, CCR5, and others 
(Dalgleish et al., 1984) 
(Klatzmann et al., 1984) 
(Maddon et al., 1986) 
MLV-E CAT-1 (SLC7A1) (Specific 
membrane receptor expressed 
on mouse cells) 
(Albritton, Tseng, Scadden, & 
Cunningham, 1989) 
MLV-A Ram-1 and GLVR-2 (Cellular 
receptor for amphotropic 
murine retroviruses)  
(Miller, Edwards, & Miller, 1994) 
(van Zeijl et al., 1994) 
GALV GLVR-1 (O'Hara et al., 1990) 
GALV, 10A1 MLV, 
FeLV-B, woolly 
monkey virus 
Pit1 (SLC20A1) (phosphate 
transport) 
Reviewed in (Overbaugh, Miller, 
& Eiden, 2001) 
A-MLV, 10A1 MLV, 
FeLV-B, BLV 
Pit2 (SLC20A2) (phosphate 
transport) 




XPR1 (G-protein coupled 
signaling) 
Reviewed in (Overbaugh et al., 
2001) 
MMTV Mtvr, Protein of unknown 
function 
(Stewart, 2002) 
FeLV-B The same receptor as GALV (Takeuchi et al., 1992) 
FeLV-C Flvcr (anion transporter) (Quigley et al., 2000) 
FeLV-T FeLIX and Pit1 (SLC20A1); Env 
like protein 
(Anderson, Lauring, Burns, & 
Overbaugh, 2000) 
ASLV-A tva-member of LDL receptor 
family 
(Gilbert, Bates, Varmus, & 
White, 1994) 
ASLV-C tvc (member of 
immunoglobulin superfamily) 
(Elleder, Plachy, Hejnar, Geryk, 
& Svoboda, 2004) 
ASLV-B Various alleles of tvb (member 
of TNF receptor superfamily) 
(Smith, Brojatsch, Naughton, & 
Young, 1998) 
ASLV-D (Smith et al., 1998) 
ASLV-E (Klucking, Adkins, & Young, 
2002) 
RD-114, type D SRV, 
BaEV, HERV-W 
RDR(SLC1A5) or RDR2(SLC1A4) 
(neutral amino acid transport) 
Reviewed in (Overbaugh et al., 
2001) 
BLV Blvr reported by (Ban et al., 
1993), was reported to be 
wrongly identified; the receptor 
is cationic amino acid 
transporter CAT1 
(SLC7A1) 
Reported at Cold Spring Harbor 
Retrovirusese meeting by Jean-
Luc Battini 
JSRV HYAL2 (hyaluronidase)  (Miller, 2008) 
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2.5.2 Later replication blocks 
 The block of the retrovirus replication might occur later in the retrovirus life 
cycle. After the entrance into the cell, the efficient disassembly of the viral particle, 
formation of pre-integration complex, reverse transcription or integration might be 
restricted (early blocks). The transcription of the integrated provirus as well as 
translation, efficient assembly, release or maturation of the viral particle might be 
restricted as well (late blocks). Cells usually possess mechanisms to block various step of 
the retroviral life cycle. Some of them might be mediated by intracellular host restriction 
factors.  
2.5.3 Intracellular restriction factors  
Restriction factors are a part of the innate immune system of the host cell. These 
intrinsic proteinaceous antiviral immune effectors are often induced by IFNα or antiviral 
activity. In complex viruses, viral antagonists for specific restriction factors are found. 
They do not share a specific trait, such as a sequence motif or specific structure. The list 
of restriction factors described deals with the most studied ones in relationship with 
retroviruses.  
2.5.3.1 APOBECs and AID family 
The abbreviation APOBEC stands for apolipoprotein B mRNA editing enzyme, 
catalytic polypeptide-like. AID encoded by aicda gene stands for Activation-induced 
cytidine deaminase. APOBECs are a family of evolutionary young proteins catalyzing 
cytidine deamination (C to U editing reaction). APOBECs are present in the vertebrate 
genomes in many subtypes (up to 11), whereas present in only one in sub-vertebrates. 
APOBECs 3 are supposed to be under positive selection (based on dN/dS ratio) and 
probably occurred as an APOBEC1/AID duplication (reviewed in (Harris & Dudley, 2015)). 
 APOBECs are widely studied in relationship with HIV. The sequences are 
assembled only in some ungulate species and well annotated only in Bos taurus and Ovis 




Table 3: The individual APOBEC and AID functions.  
 Function Reference 
APOBEC1 Cholesterol metabolism, oncogene, 
viral restriction 
(Rosenberg, Hamilton, Mwangi, 
Dewell, & Papavasiliou, 2011) 
APOBEC2 Muscle and heart specific APOBEC (Liao et al., 1999) 





RNA editing, cell cycle control (Jarmuz et al., 2002) 
APOBEC3F RNA editing, cell cycle control 
Could inhibit accumulation of HIV-1 RT 
products 
(Jarmuz et al., 2002) 
(Holmes, Koning, Bishop, & 
Malim, 2007) 
APOBEC3G Affects HIV replication in various steps: 
RT- Inhibits priming of tRNA and thus 
production of viral ssDNA 
Integration- APOBEC3 can cause 
aberrant LTRs formation, incapable of 
integration into the host genome 





and retrotransposition of endogenous 
murine gammaretroviruses, 
mainly by cytosine deamination of 
foreign DNA 
(Jarmuz et al., 2002) 
(Guo, Cen, Niu, Saadatmand, & 
Kleiman, 2006) 
(Mbisa et al., 2007) 
(Doehle, Schafer, Wiegand, 
Bogerd, & Cullen, 2005) 
(Sasada et al., 2005) 
(Lochelt et al., 2005) 
(Esnault et al., 2005) 
APOBEC3H Antiviral function in old world monkeys, 
but suppressed in humans 
(OhAinle, Kerns, Malik, & 
Emerman, 2006) 
APOBEC4 Lacks cytidine deaminase activity; 
boosts promoter activity and HIV 
replication. 
(Marino et al., 2016) 
AID Expressed in B-cells. Immunoglobulin 
gene class switches DNA recombination 
and somatic hypermutation. 
(Muramatsu et al., 2000) 
 
2.5.3.2 Mx 
Mx (Myxovirus resistance) is one of the interferon-inducible restriction factors. 
Mx1 codes Mx1 in mice and MxA in humans. Myxovirus A resistance protein (MxA) is 
elevated in the blood after the viral infection independent of the virus species, but is 
mostly studied in relationship with Orthomyxoviruses. Mx2 (also known as MxB) was 
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shown to inhibit HIV-1 and similar Lentivirus infections (Goujon et al., 2013; Kane et al., 
2013; Liu et al., 2013). 
Mx2 was shown to inhibit the HIV-1 nuclear entry (Goujon et al., 2013). Mx2 was 
also shown to interact with HIV-1 capsid and mediate the block of retroviral replication 
early after virus enters the cell. Cyclophilin might play a role in mediating the restriction 
in other HIV-1 life cycle stages as well (Bulli et al., 2016) 
2.5.3.3 SAMHD1 
 SAMHD1 (Sterile alpha motif and histidine-aspartate domain containing protein 
1) is a restriction factor that depletes the dNTP pool in the cell to block retroviral 
replication by restriction of reverse transcription. It is counteracted by the accessory HIV 
gene product Vpx. The mutations in the SAMHD1 gene cause Aicardi-Goutières 
syndrome which is a genetic encephalopathy mimicking congenital viral infection 
(Powell, Holland, Hollis, & Perrino, 2011).  
 This indicates that SAMHD1 probably plays a role in regulating innate immune 
response. The counteracting viral gene product Vpx is present only in HIV-2 and some 
SIV strains making these viruses more resistant to SAMHD1 restriction via unique clade 
specific SAMHD1-Vpx interactions (Wu et al., 2015). 
 SAMHD1 has enzymatic activities such as acting as a dNTPase and nuclease as 
well as being able to bind single-stranded DNA/RNA. The precise molecular action of 
SAMHD1 is still not completely elucidated despite thorough studies of the protein, 
including the structural ones (reviewed in (Ahn, 2016)). 
2.5.3.4 TREX1 
 Formerly known as DNaseIII, TREX1 (three prime repair exonuclease 1) is the 
major 3’ to 5’ DNA-specific exonuclease in mammalian cells (Hoss et al., 1999). The 
mutation in the TREX1 gene are associated with autoimmune diseases (reviewed in 
(Rice, Rodero, & Crow, 2015)). TREX1 plays a role in HIV infection via inhibiting cytosolic 
DNA sensing pathway and thus modifying the interferon response to infection as well 




 TRIM5α (Tripartite motif alpha) is a member of one of the eleven subgroups of 
TRIM proteins (see Figure 8 for reference). TRIMs are intrinsic immunity factors and 
have direct antiviral activity. Various TRIMs have been proven to act against different 
viruses (reviewed in (Nisole, Stoye, & Saib, 2005)). TRIM5 induces NFκB activation. 
TRIM5 recognizes the retroviral capsid by its PRY/SPRY domain. These facts indicate that 
TRIM5 as well as TRIM21 might be directly acting as pattern recognition receptors 
(Keeble, Khan, Forster, & James, 2008; Pertel et al., 2011). TRIM5α in macaques was 
proven to inhibit reverse transcription activity of HIV-1 as well as abort efficient 
disassembly of the viral particles (Campbell et al., 2015). 
 




 Viperin was not shown to play a role in fighting retroviral infections. 
2.5.3.7 Tetherin 
 Tetherin was discovered as a protein expressed on the surface of human 
plasmatic cells in cell lines (Goto et al., 1994). The function of Tetherin is to tether the 
viral particles inside the host cells and therefore preventing the further spreading of 
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infection. The HIV-1 codes an accessory gene product Vpu which counteracts this 
restriction. However, when the Vpu is lacking, virions are retained at the cell surface and 
consequently endocytosed (Perez-Caballero et al., 2009).  Despite the fact that Tetherin 
is known to be one corresponding gene present in one isoform in human, it is present in 
three isoforms in sheep (Arnaud et al., 2010) and in three isoforms in cattle (Takeda et 
al., 2012). Tetherins of various species were proven to inhibit PERV replication (Abe, 
Fukuma, Yoshikawa, Miyazawa, & Yasuda, 2014; Bae & Jung, 2014a, b; Mattiuzzo, Ivol, & 
Takeuchi, 2010; Mattiuzzo & Takeuchi, 2010). 
2.6 Endogenous retrovirus presence in the host genome 
 The presence of an endogenous retrovirus in the host genomes might have 
various impacts. Besides the fact, that the presence of a retrovirus might be a cause of 
pathology, it might be an asset for the host. The endogenous retrovirus might either 
work as a restriction factor preventing other infections or even play a part in the normal 
physiology or cellular functions. This phenomenon is reviewed in this chapter. However, 
there are other mechanisms how the retroviral integration at a specific integration site 
might affect the host.  
The insertion of the retrovirus into a gene may cause the gene disruption or gene 
up-regulation. Based on the site of integration, the virus can bring a promoter 
indefinitely inducing a transcription of a particular gene, leading to undesired pathology. 
The studies dealing with the integration site of a retrovirus (or a model construct 
representing one) often analyze not only the sequence of the integration site, but also 
the epigenetics of the chromosome area (e.g. methylation) of the site in order to 
estimate the probability of the retrovirus being transcribed.  
There is another mechanism by which a virus can cause deregulation in the 
signaling pathway. The virus might code a gene from the pathway leading to 
overexpression of the gene while the virus genes are expressed. Some genes coded by 
various retroviruses that might deregulate the signaling pathways. The first described 




2.6.1 Endogenous retrovirus and the immunity of the host 
 Besides triggering the action of restriction factors, a new concept of role of 
endogenous retroviruses in innate immunity response was recently proposed in T-cell 
independent B-cell response. Multivalent molecules with repetitive structures trigger 
antibody response through B cell receptor crosslinking with T-cell help absent. This 
causes upregulation of endogenous retrovirus RNAs in antigen-specific mouse B cells 
which may be detected by MAVS (mitochondrial antiviral signaling protein) triggering 
the MAVS-dependent RNA sensing pathway. The RNAs might be transcribed in the 
presence of reverse transcriptase and trigger the cGAS-cGAMP-STING [cGAS (Cyclic 
GMP-AMP synthase) –cGAMP (Cyclic guanosine monophosphate–adenosine 
monophosphate) –STING (Stimulator of interferon genes)] pathway promoting the 
immunoglobulin M production. Deficiency of MAVS, cGAS or reverse transcriptase in the 
cell dramatically decreases the immunological response suggesting that endogenous 
retroviruses might play a role in the B-cell response (Zeng et al., 2014) . 
2.6.2 Endogenous retrovirus genes and exogenous virus infection 
 The presence of retrovirus might have an impact on the host not only by 
affecting the genes surrounding its integration site or by delivering oncogenes to the 
host. It might be also utilized as a source of gene products included in the antiviral 
immunity. This concept was described as “Fighting fire with fire” by (Malfavon-Borja & 
Feschotte, 2015). On the contrary, products of endogenous retroviruses might be 
required for successful infection by an exogenous retrovirus. These cases are reviewed 
in the chapter 2.6.1.1.2 “Adding fuel to the fire”. 
2.6.2.1 “Fighting fire with fire”  
A longstanding concept that aberrant expression of retroviral genes might serve 
as a protection against further retroviral infection has been studied for several decades 
(Robinson, Astrin, Senior, & Salazar, 1981). Especially the proteins coded by the env 
(Malfavon-Borja & Feschotte, 2015) and gag (Mura et al., 2004) genes were shown to 




Fv1 was first described as a gene determining the susceptibility of mice to various 
strains of MLV. The precise mechanism of Fv1 action is not known, but it was proved 
that it restricts the infection after reverse transcription and prior to integration 
(Jolicoeur & Baltimore, 1976). Fv1 shares the general structural features with TRIM5. 
Both Fv1 and TRIM5 bind the retroviral capsid and restrict the virus in the similar 
manner. (Sanz-Ramos & Stoye, 2013). Fv1 gene is present in multiple alleles. The levels 
of expression from individual alleles vary. Different alleles show restriction specificity, 
which is not generally affected by their expression level (Li, Yap, Voss, & Stoye, 2016). 
Fv1 is sequentially homologous to gag gene of an endogenous retrovirus. Fv1 
was found to be under positive selection in all analyzed Mus subgenera, consistent with 
its role in antiviral defense (Yan, Buckler-White, Wollenberg, & Kozak, 2009). The 
evolutionary analysis revealed that mice have probably acquired endogenous retrovirus 
giving rise to Fv1 approximately 5 MYA (Yap, Colbeck, Ellis, & Stoye, 2014). 
2.6.2.1.2 Fv4/Akvr1 
Fv4 and Akvr1 are alternative names for the same gene, which is an expressed 
env gene of an endogenous ecotropic MLV (Kozak, 2014). Fv4 restricts the infection by 
binding to the receptor for exogenous ecotropic MLV, however the restriction is not 
absolute (Takeda & Matano, 2007). A mild restriction effect on amphotropic MLV was 
proven as well. 
2.6.2.1.3 Rmcf 
Resistance to mink cell focus-forming virus (Rmcf) is a product of an endogenous 
polytropic MLV and protects against polytropic MLV infection. Rmcf structure resembles 
the one of Fv4. Mus castaneus was proven to lack endogenous retrovirus producing 
Rmcf. The interference mechanism was characterized in receptor restriction mediated 
by Rmcf (Jung, Lyu, Buckler-White, & Kozak, 2002). 
2.6.2.1.4 Rmcf2 
Rmcf2 is a protein similar to Fv4, becuase it is an expressed env of a xenotropic 
provirus present in Mus castaneus genome, unable to produce infectious particles. It 
protects Mus castaneus against polytropic MLVs through interference. Rmcf2 is the third 
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described mouse gene of retroviral origin delivering protection against MLV infection 
(Wu, Yan, & Kozak, 2005).  
2.6.2.1.5 enJSRV gag and JSRV 
The Gag of enJSRV was the first endogenous retroviral Gag described as one with 
interfering properties to exogenous retrovirus infection by mediating late-stage 
replication block (Mura et al., 2004). This process is called JLR (JSRV late restriction), it 
became a model for studying late replication blocks in the retroviral life cycle. Because 
of the fact that JSRV is not able to grow in cell tissue culture (due to the lack of 
permissive cell line), the experiments performed after retroviral transfection studied the 
formation of the Gag aggregates and their disruptions (Arnaud, Murcia, & Palmarini, 
2007b). 
Still, there exists one exception to this restriction. An evolutionary young copy of 
JSRV (estimated as approximately 200 years old), denoted enJSRV26, is able to 
overcome the restriction mediated by endogenous gag. The counteraction of 
endogenous restriction is mediated by the env of enJSRV26. Amplification of the copies 
of enJSRV26 within the genome indicates that the sheep genome is still probably 
invaded by JSRV both endogenously and exogenously (Armezzani et al., 2011).  
2.6.2.1.6 Refrex-1 and FeLV 
Endogenous copies of FeLV were detected in the cat genomes. Exogenous feline 
retroviruses and feline ERVs have complicated genetic interactions: recombination 
between FeLV and ERV-DC (feline ERV) generated FeLV-D. Lately, a subgroup of FeLV-D 
was experimentally constructed combining an env of endogenous FeLV of domestic cats 
(ERV-DC) and exogenous FeLV. Close examination of the construct led to the discovery 
of the endogenous restriction factor Refrex-1 originating from env of ERV-DC (Ito et al., 
2013). By reverse mutation, functional env was reconstructed from ERV-DC. This 
“reverse evolution experiment” indicates, that env of FeLV was repeatedly inactivated 
(Ito, Baba, Kawasaki, & Nishigaki, 2015). 
2.6.2.1.7 CHOK1 cells and amphotropic retroviruses 
Chinese hamster ovary cells (CHOK1) harbor a variety of endogenous 
retroviruses. Chemical activation of CHOK1 cells with 5-Bromodexouridine induced 
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production of atypical retroviral C-type particles (Manly, Givens, Taber, & Zeigel, 1978). 
CHOK1 cells are not susceptible to infection by exogenous retroviruses or retroviral 
vectors with an amphotropic MLV envelope. CHOK1 cells are widely used for 
biotechnology applications and amphotropic viruses are commonly used as vectors. 
Introduction of human amphotropic or mouse ecotropic retrovirus receptor or 
tunicamycin treatment of the cells (deglycosylation of the receptor) was shown to 
rescue the aforementioned susceptibility (Miller & Miller, 1992). However, no detailed 
characterization and explanation of the resistance mechanism was available. 
2.6.2.2  “Adding fuel to the fire” 
As reviewed in the previous chapter, products of the endogenous retroviruses 
can serve as endogenous restriction factors, preventing infection by exogenous viruses. 
On the other hand, some remnants of endogenous retroviruses might act as enhancers 
of retroviral infection or can even be required for the infection to proceed. These 
products of endogenous retroviruses are reviewed in this chapter.  
2.6.2.2.1 FeLIX and FeLV 
Besides multiple membrane-spanning receptor molecules (e.g. Pit1), the 
subgroup T of FeLV (FeLV-T) requires a cellular cofactor FeLIX for productive infection. 
FeLIX is endogenously expressed and is sequentially similar to the env of FeLV (Anderson 
et al., 2000). Several sequences of endogenous FeLVs were detected in cats, but none of 
them was genetically fixed. However, FeLIX activity was detected in sufficient amounts 
in all of the tested cats from various domestic regions. This finding indicates that the 
FeLV capable of producing FeLIX entered the cat genome prior to the FeLVs recently 
isolated (Sakaguchi, Shojima, Fukui, & Miyazawa, 2015). 
2.6.3 Endogenous retroviruses with a role in the host physiology  
Besides all of the impacts of the presence of a retrovirus in the host genome 
listed above, one symbiotic relationship of the host and ERV stands out - endogenous 
retroviruses domesticated (also called exaptation) to play a role in a normal physiology.  
 Human endogenous retroviruses were first discovered in human placenta (Kalter 
et al., 1973). Human ERVW1 expresses its defective env Syncytin which was proven to 
play a role in formation of placenta. Syncytin is expressed mainly at placental 
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syncytiotrophoblasts where it causes the fusion of cells and formation of giant syncytia 
(Mi et al., 2000). Syncytin gene with its fusogenic function was also described in 
marsupials (Cornelis et al., 2015) and many other mammalian hosts. Multiple ERV 
variants are present in the reproductive system of Placentalia and have a fusogenic 
function. The presence in all of the major clades with placenta formation indicates that 
the presence of fusogenic ERV might be a requirement in order to increase success in 
reproduction (Imakawa, Nakagawa, & Miyazawa, 2015). 
 Digging deeper into the Env glycoprotein evolution, an ORF coding for abberant 
expression env with possible role for placentation was discovered in the spiny-rayed 
fishes. Spiny-rayed fishes are a unique clade, for they evolved placentation. The 
insertion of the gene is predicted to occur more that 110 MYA, making the detected ORF 
the oldest gene of retroviral origin (Henzy, Gifford, Kenaley, & Johnson, 2016). 
2.7 Expression of endogenous retroviruses 
 The expression of the integrated provirus is influenced by the environment of the 
integration site, including the genomic and epigenetic features of the site. No general 
preference of the integration site of the retroviral DNA was proven, however different 
groups of retroviruses prefer sites with distinct features (Derse et al., 2007; Elleder, 
Pavlicek, Paces, & Hejnar, 2002; Mitchell et al., 2004; Narezkina et al., 2004; Schroder et 
al., 2002; Wu, Li, Crise, & Burgess, 2003). 
 The transcription of the intgerated retroviruses is often suppressed (retrovirus is 
silenced). This might occur due to the CpG methylation of retroviral DNA and and is also 
influenced by various histone modifications (Blazkova et al., 2009; Poleshko et al., 2010). 
Transcriptional silencing is also one of the key mechanisms leading to the establishment 
of HIV latent reservoir (Bednarik, Cook, & Pitha, 1990; Blazkova et al., 2009). 
2.7.1 Endogenous retroviruses as promoters for mammalian genes 
The ERVs present in the host genome are often a source of alternative promoters. 
However, the presence of ERV does not usually affect the general expression pattern. 
LTR is rarely preferred as a source of a promoter hence it affects the expression of 
individual genes minorly, but provides an evolutionary opportunities for modifying the 
gene expression (Cohen, Lock, & Mager, 2009).  
52 
 
The CRISPR-Cas deletion of ancients ERVs from human genomes in three cell lines 
led to impaired pathways of IFN signaling. This might be owed to the missing promoters 
for the genes utilized in the pathway (Chuong, Elde, & Feschotte, 2016). 
2.8 Embryonic stem cells and endogenous retroviruses 
As mentioned previously, retroviruses need to infect germ line cells in order to 
endogenize. The analysis of transcription occurring in induced pluripotent murine stem 
cells revealed that majority of the transcripts originates in LTRs and contains fragments 
of murine endogenous retroviruses. It was also shown that murine embryonic stem cells 
and their pluripotency might be related to the presence of endogenous retroviruses and 
their expression, hence be shaping the early stages of mammalian development 
(Macfarlan et al., 2012).  
This phenomenon was also studied in human stem cells. The embryonic stem cells 
express HERV-H RNA abundantly. This transcription occurs in reduced amount in 
induced pluripotent stem cells, and is almost absent in differentiated cells. HERV-H is 
also regulated in early development and bears binding sites for pluripotency 
transcription factors. These facts indicate that endogenous retroviruses play a role in 
early stages of development and cell differentiation (Santoni, Guerra, & Luban, 2012).  
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3 MATERIALS AND METHODS 
3.1 Methods related to the screen of unusual endogenous 
retroviruses 
3.1.1 Endogenous Lentivirus in Malayan colugo 
3.1.1.1 Computational screen of vertebrate genomes 
The first step of the best bidirectional hit (BBH) strategy was performed by 
tBLASTn (Johnson et al., 2008) search in vertebrate genome database (including 104 
vertebrate genomes available at GenBank) to identify candidate endogenous Lentivirus 
fragments. In this step the following Pol amino acid sequences (employed for the screen 
because pol is the most conserved retroviral gene) were used as baits: human 
immunodeficiency virus type 1 (HIV-1), feline immunodeficiency virus (FIV), Visna/maedi 
virus, rabbit endogenous Lentivirus type K (RELIK), gray mouse lemur prosimian 
immunodeficiency virus (pSIVgml), and domestic ferret (Mustela putorius furo) 
endogenous Lentivirus (ELVmpf). The cutoff for the BLAST (Johnson et al., 2008) search 
was set at E-value < 10−5. To filter out non-lentiviral sequences, translated hits were 
used as a query for backward BLASTp (Johnson et al., 2008) search against database of 
retroviral Pol sequences belonging to all retroviral genera. Hits aligned with the best bit 
score to lentiviral sequences in the backward BLAST search were further analyzed. 
 
Figure 9: Screening strategy used for screening vertebrate genomes 
 
3.1.1.2 Source of the analyzed samples 
Three samples of genomic DNAs, covering both of the extant dermopteran 
genera, were kindly provided by W. Murphy (Texas A&M University). These included two 
G. variegatus subspecies (designed as GVA3, and GVA5) and Cynocephalus volans (CVO).  
The sample identity was confirmed by PCR amplification of FES and CHRNA1 loci, 
which were described for these specimens before (Janecka et al., 2008), using 
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Colugo1F/1R and Colugo2F/2R primer pairs, respectively (see Table 4). The CHRNA1 
locus was verified by sequencing of the PCR products in all specimens and comparison 
with previously described sequences. 
3.1.1.2.1 Whole genome amplification (WGA) of DNA samples 
Due to the low amounts available, dermopteran DNA samples were amplified by 
whole-genome amplification for majority of the applications using illustra GenomiPhi V2 
DNA Amplification Kit (GE Healthcare) according to the manufacturer's protocol. 
3.1.1.3 PCR amplification 
The ELVgv RT region was amplified using two primer pairs, ELVgvF1/R1 and 
ELVgvF2/R2, yielding PCR products of around 245 and 215bp. The short junctions 
between ELVgv 3'end and the host genomic DNA were amplified with one primer 
anchored in ELVgv 3'LTR (primer ColugoLTR) and the second primer anchored in the 3' 
flanking region of proviruses A, B and C (primers ColugoA1/B1/C1). The PCR products 
from proviruses A, B and C were 359, 337 and 268 bp long, respectively, and their 
identity was verified by sequencing. The empty pre-integrations sites were detected 
using primer pairs ColugoA1/A2, ColugoB1/B2 and ColugoC1/C2. To amplify the 3-kb 
regions from 5'parts the ELVgv proviruses, a semi-nested PCR approach was used: first 
amplification was performed with internal viral primer ELVgvR1 and a second primer 
anchored in the 5' flanking region of proviruses A, B and C (primers ColugoA2/B2/C2). 
Second PCR was then performed with viral primer ELVgvR2 and the same flanking primer 
as in the first PCR. In cases when this approach was not successful, variant viral primers 
ELVseq8 or ELVseq10, closer to the 5'flank, were used. The PCR products obtained were 
sequenced; in cases when heterozygosity was detected, the products were subcloned 
into pGEMTeasy vector (see 3.2.3 DNA cloning and vectors used) and multiple clones 
were re-sequenced. For the primer sequences see Table 4. 
The general PCR conditions for a typical 20 µl reactions were the following: 1x 
Phusion polymerase buffer, 200 µM d NTPs, 0,5 µM forward and reverse primer (each), 




The reactions were run according to the following protocol: initial denaturation 
at 98°C for 30 sec; 33 cycles of 98°C for 8 sec, 54°C for 25 sec, 72°C for 1 min (per 1kbp 
amplified); the final elongation at 72°C for 10min. 
Table 4: Primers used for ELVgv and control genes amplification and sequencing 
Primer Sequence (5’-3’) Description 
ELVgvF1 GAATAATGCAGGGCCAGGTA ELVgv virus PCR 
ELVgvR1 GGGTTTCAAATCCCCACTTT ELVgv virus PCR 
ELVgvF2 TCCTAAGATACAAACAGAAAACATTCA ELVgv virus PCR 
ELVgvR2 GCTTTTGATGGACAGCTCCT ELVgv virus PCR 
Colugo1F  GGGGAACTTTGGCGAAGTGTT control gene (FES) 
Colugo1R  TCCATGACGATGTAGATGGG control gene (FES) 
Colugo2F  GACCATGAAGTCAGACCAGGAG control gene (CHRNA) 
Colugo2R  GGAGTATGTGGTCCATCACCAT control gene (CHRNA) 
ColugoLTR  CCCAGAACTTTGTGTCTGGTTT ELVgv LTR for 3' junction 
ColugoA1  TGAGGCATCTCTTTCGGTATTC ELVgv integration A 
ColugoA2  CAGCACAGAATACAAGCAGTAGG ELVgv integration A 
ColugoB1 ACAGCAAATCTCACCCTCCA ELVgv integration B 
ColugoB2 GGGTTGTCCATAAAAACAGAACC ELVgv integration B 
ColugoC1 TCTTGATGTTGGCATCAGTTTG ELVgv integration C 
ColugoC2 CCAGCAAGAAGCTGGACATC ELVgv integration C 
ELVseq1 GCAACCAGAAACCAGACACA Sequencing the 5’ 3kb fragment 
of ELVgv 
ELVseq2 CAGCTGGCTAAAACATATATAAGACAT Sequencing the 5’ 3kb fragment 
of ELVgv 
ELVseq3 CAGGGAAGACAGCACACTGG Sequencing the 5’ 3kb fragment 
of ELVgv 
ELVseq4 GGATTTATGCCAGGTAGAAGTAAAAGG Sequencing the 5’ 3kb fragment 
of ELVgv 
ELVseq5 ACCATGATGGCAGAGGCTTT Sequencing the 5’ 3kb fragment 
of ELVgv 
ELVseq6 ATGATCAAGTTAAAATGACATGGAAT Sequencing the 5’ 3kb fragment 
of ELVgv 
ELVseq7 CATCCAGCAGGGTTTTCACA Sequencing the 5’ 3kb fragment 
of ELVgv 
ELVseq8 GCCTTTTACTTCTACCTGGCATAAA Sequencing the 5’ 3kb fragment 
of ELVgv 





3.1.1.4 Phylogenetic analyzes 
The alignment was generated in MEGA5 software (Tamura et al., 2011) using the 
MUSCLE algorithm (Edgar, 2004). The ML tree was constructed in MEGA5 software, 
using the rtREV amino acid substitution matrix (Dimmic, Rest, Mindell, & Goldstein, 
2002), Nearest-Neighbor-Interchange ML heuristic method and otherwise default 
parameters. Support for ML tree was assessed by 1,000 nonparametric bootstrap 
replicates. Bayesian analysis was run for 200,000 steps, sampling every 1,000 steps and 
discarding first 25% of the trees. Average standard deviation of split frequencies 
converged during 10,000 steps bellow 0.001. The amino acid model F81 in program 
MrBayes was used (Huelsenbeck & Ronquist, 2001).  
The analysis of phylogenetic relationship of ELVgv to other exogenous and 
endogenous lentiviruses was based on alignment including 2,350 most conserved 
nucleotides of gag-pol from 31 lentiviruses (Gilbert, Maxfield, Goodman, & Feschotte, 
2009), together with ELVmpf (Cui & Holmes, 2012a; Han & Worobey, 2012), and ELVgv 
sequence. The alignment was generated in MEGA5 program (Tamura et al., 2011) using 
the MUSCLE algorithm (Edgar, 2004). The ML analysis was performed using MEGA5 
program under Tamura-Nei model, Nearest-Neighbor-Interchange ML heuristic method 
and otherwise default parameters. Bootstrap supports were calculated as a percentage 
out of 1,000 replicates. To establish the phylogenetic placement of ELVgv within 
lentiviruses, we have aligned the amino acid sequence of the highly conserved reverse 
transcriptase (RT) region of pol with sequences from representatives of all retrovirus 
genera. In subsequent phylogenetic analysis maximum likelihood (ML) and Bayesian 
methods were combined.  
3.1.2 Endogenous Deltaretrovirus in the genome of Miniopteridae 
bats 
3.1.2.1 In silico sequence analysis 
Sequence datasets available at NCBI SRA from Miniopterid species genome or 
transcriptome (accession numbers PRJNA270665, PRJNA270639 and PRJNA218524) 
were queried by BLAST or downloaded and analyzed using CLC genomics workbench 9.5 
(http://www.clcbio.com) or DNASTAR Lasergene 10.0.0 (http://dnastar.com). This initial 
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analysis was mainly used to correct errors in the original MINERVa-containing contig 
from the M. natalensis genome assembly. 
3.1.2.2 Source of the analyzed samples and sample processing 
The bat tissue samples were obtained from museum specimens (National 
Museum Prague) as parts of the pectoral muscles and from released bats caught during 
various ecological studies as wing punch biopsies. The bat species were identified with 
respect to their external morphological traits and the identification was further 
confirmed by amplification and sequencing of cytochrome b or RAG2 loci. 
The DNA was isolated from the ethanol-preserved samples according to phenol-
chloroform extraction protocol (See section 3.2.13). 
Table 5: List of bat species analyzed 




Miniopterus schreibersii Schreibers' long-fingered 
bat 
Miniopteridae cytB 
Miniopterus fraterculus Lesser bent-winged bat Miniopteridae cytB 
Tadarida teniotis European free-tailed bat Molossidae RAG2 
Myotis myotis Greater mouse-eared bat Vespertilionidae RAG2 
Eptesicus serotinus Serotine bat Vespertilionidae RAG2 
Hypsugo savii Savi's pipistrelle Vespertilionidae RAG2 
Plecotus austriacus Grey long-eared bat Vespertilionidae RAG2 
Pipistrellus pipistrellus Common Pipistrelle Vespertilionidae RAG2 
Cistugo seabrae Angolan hairy bat Vespertilionidae RAG2 
Miniopterus natalensis Natal long-fingered bat Miniopteridae cytB 
Miniopterus africanus African long-fingered bat Miniopteridae cytB 
Miniopterus minor Least Long-fingered Bat Miniopteridae cytB 
Epomops dobsonii Dobson's fruit bat Epomophorini cytB 
Epomophorus 
gambianus 




3.1.2.3 PCR, sequencing, and further analysis of the genomic DNA 
The PCR amplifications were performed with a 1:200 mixture of Deep Vent and 
Taq polymerases and LongAmp Taq buffer (all from New England Biolabs) with the 
following conditions: 1 cycle of 4 minute 95°C; 3 pre-amplification cycles of 20 sec 95°C, 
2 min 52-55°C (according to primer used), and 1,5 min (per 1kb amplified) 65°C; 30 
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cycles of 20 sec at 95°C, 30 sec annealing at the temperature 4°C higher than in the pre-
amplification steps, 1,5 min (per 1kb amplified) 65°C. 
The full-length MINERVa provirus was amplified only from 2 samples (genomic 
DNA from M.schreibersii and M.fraterculus) using a nested PCR approach with primers 
DeltaGF6 and DeltaGR4 in the first PCR run; and DeltaGF5 and Delta GR5 in the second 
round. The product was sequenced using primers DeltaGR4, DeltaGF5, DeltaF3, DeltaR1, 
DeltaF1.  
The 5’ end of the provirus was amplified from the genomic DNA from all of the 
analyzed samples (M. schreibersii, M.fraterculus, M.natalensis, M.africanus, and 
M.arenarius) using primers DeltaR1+DeltaGF6. The 5’ end product was sequenced using 
primers DeltaR1, DeltaGF6, DeltaF1, DeltaR6. The 3’ end of the provirus was amplified 
using semi-nested PCR from all of the samples with primers GF6+GR4 in the first round 
and primers F1+GR4 in the second PCR reaction. The 3’ end product was sequenced 
using primers DeltaGR4, DeltaF1, DeltaF8, DeltaF3, DeltaR3, DeltaR6. 
The primers R3 and F1 were used for amplification from genomic DNA to check 
for the possible presence of a more complete pol and env gene elsewhere in the 
genome without yielding any longer product than the one predicted from the single 
deleted provirus described. The control gene cytB was amplified from genomic samples 
using primers cytBMVZ04 and cytBMVZ05 (Smith & Patton, 1991). The same primers 
were used for sequencing of this PCR product. Due to the fact that cytB amplification 
was not successful from some Chiroptera species (Tadarida, Myotis, Eptesicus, Hypsugo, 
Plecotus, Pipistrellus, and Cistugo), we amplified an additional control gene RAG2 using 
primers RAG2_968R and RAG2_428F (Smith & Patton, 1991). For the M. schreibersii, M. 
natalensis and M. fuliginosus we designed species-specific cytB primers denoted 
cytB_natalR and cytB_natalF. 
All of the used primers are listed in Table 6. Desired PCR products were 
sequenced directly after isolation from the agarose gel. We performed further PCR 
reactions to confirm the presence/absence of MINERVa proviruses in the examined 
species using primers which amplify the empty integration sites, LTRs, and gag regions 




Table 6: Primers used in experiments associated with endogenous Deltaretrovirus in 
Miniopteridae bats 
Primer  Sequence (5’-3’) Primer localization 
DeltaF1 GACAAGGGTCGAGTCACCTCCTAA MINERVa gag  
DeltaF2 AATCTCTCCTTCTGGCCTCTCACA MINERVa gag  
DeltaF6 ATTCATGAGGTGCACGTTTAAGCA 5’flanking region of MINERVa provirus 
DeltaF8 TATGTTTCCCCATACCTTGCCATCA MINERVa LTR 
DeltaR1 GAGGTCGCAGGGTTATATGGAGGT MINERVa gag  
DeltaR4 GGCATCAAAAGGTAAACAGAAGCA 3’flanking region of MINERVa provirus 
DeltaR5 CATGGTTCCACTGGTTATCATTTACA 3’flanking region of MINERVa provirus 
DeltaR6 CAATCGGCGGGGAGCTTAC MINERVa LTR 
DeltaF5 GGTGCACGTTTAAGCACATACTCG 5’flanking region of MINERVa provirus 
CytBnatalL GTTGCTCCTCAGAAAGATATTTGTCCTC  Miniopterus cytochrome B locus 
CytBnatalR ATGACCTGTGATATGAAAAACCACTGTTG  Miniopterus cytochrome B locus 
DeltaF4 GTTGGTTGCTCTCTTGCC TAGTCG MINERVa LTR 
DeltaF10 GGAATACCCGTTTCAGAGAGCAGA Miniopterus genomic locus 1 
DeltaR9 TGATCCCTGAGATGACAGAAGTCG Miniopterus genomic locus 1 
DeltaF9 TTCAGTATTGTGAAAGGGCTCTGC Miniopterus genomic locus 2 
DeltaR8 TCACTCTCTGGCTTTAGAGTCCTTCA Miniopterus genomic locus 2 
DeltaF7 TCATGTAAATGATAACCAGTGGAACC Miniopterus genomic locus 3 
DeltaR7 TGCAATGTGAGTTGTTGAAAGTGAAA Miniopterus genomic locus 3 
 
3.1.2.3.1 Sequence assembly 
The sequence chromatograms obtained were checked and sequences were 
edited and assembled using SeqMan software (Lasergene 10.0.0 (http://dnastar.com)). 
3.1.2.3.2 Sequence annotation and ORF detection 
For sequence annotation, the obtained sequence was aligned with other 
Deltaretrovirus sequences (HTLV-1 and BLV) annotated in NCBI Nucleotide database. 
The sequences were aligned using MAFFT algorithm included in the MegAlign software 
from LASERGENE package 10.0.0 (http://dnastar.com). Splice site acceptor and splice 
site donor sites were determined using the online prediction algorithm 
(http://www.fruitfly.org/seq_tools/splice.html). The ORFs were predicted using ExPASy 
translate tool from the ExPASy portal (http://web.expasy.org/translate/). 
3.1.2.3.3 Prediction of RNA secondary structures in LTR 
Secondary structure prediction of MINERVa putative Rex Response element was 
performed. Stem loop prediction in the 5’LTR in MINERVa was compared to other 
deltaretroviruses. The sequences used for secondary structure prediction in mfold 
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(http://unafold.rna.albany.edu/) were the following: MINERVa consensus sequence, 
HTLV-1 (GenBank accession number M37299), and BLV (K02120).  
3.2 Methods related to the CrERV project 
3.2.1 Tissue cultures 
3.2.1.1 Cells & media 
All cells were cultured in a humidified incubator at 37°C and 5% CO2. 
3.2.1.1.1 Human rhabdomyosarcoma cell line A-673 
Human rhabdomyosarcoma cell line A-673 (ATCC product number CRL-1598) was grown 
in Dulbecco’s modified Eagle’s medium (DMEM) (Sigma–Aldrich, St. Louis, MO) 
supplemented with 10% fetal calf serum, penicillin (100U/ml) and streptomycin (100 µg 
/ml).  
3.2.1.1.2 Human embryonal kidney 293T cells and their derivates 
Human embryonal kidney 293T cells (HEK293T) were grown in in DMEM, with 
serum supplements (4% fetal calf and 4% calf serum or 10% fetal calf), penicillin 
(100U/ml) and streptomycin (100 µg /ml). HEK293T cells expressing gag and pol genes 
derived from MLV virus were grown as unmodified HEK293T cells, but on tissue culture 
dishes covered with Poly-L-lysine (1mg/ml in H2O). HEK-293T cells producing PERV 
14/220 (Bartosch et al., 2004) were grown as regular HEK293T cells and used as a source 
of PERV particles. HEK293T cells stably transfected with molecular clone of CrERV were 
grown as regular HEK293T cells and denoted as Cr5. HEK293T cells producing molecular 
clone of CrERV and a GFP-encoding vector with two LTRs (denoted as C10 line) were 
used as a source of CrERV marked with GFP. HEK293T cells stably expressing a viral 
(MLV-based) construct with amphotropic envelope were maintained in the same 
medium as regular HEK293T cells.  
3.2.1.1.3 Primary cells of Cervidae species 
Primary mule deer (Odocoileus hemionus) kidney cells (OHK, ATCC product number CRL-
6193) were grown in DMEM supplemented with 10% fetal calf serum, penicillin 
(100U/ml) and streptomycin (100 µg /ml).  
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Primary red deer (Cervus elaphus) and fallow deer (Dama dama) cells were grown in 
DMEM supplemented with 10% fetal calf serum, penicillin (100U/ml) and streptomycin 
(100 µg /ml).  
3.2.1.2 Cryopreservation of the cells 
For cryopreservation, the cells were harvested and spun at 200 g for 5 min at 4°C. 
The cellular pellet was then resuspended in the cultivation medium containing 10% 
DMSO. The mixture was slowly cooled in the tubes in the freezing box with isopropanol 
(Nalgene) at -80°C for 24 hours and after that the tubes were stored in liquid nitrogen. 
3.2.1.3 Co-cultivation of human and primary deer cells 
The co-cultivation experiment was set by mixing equal amount of deer CRL-6193 
and human A-673 cells. The cells were kept in the co-culture for several weeks. Every 
week, fresh cells from both species were added to the coculture at a 1:1 ratio. At 
indicated time points, samples of the culture medium were harvested for the RT assay. 
The samples were centrifuged at 3,000 RPM for 5 min and filtered by a 0.22 m syringe 
filter in order to remove cellular debris. The samples were frozen at -80°C before further 
analysis. 
 
Figure 10: Schematic of the cocultivation experiment  
 
3.2.1.4 Ultracentrifugation methods -Iodixanol gradient 
Iodixanol (OptiPrepTM) was purchased from Axis Shield (Dundee). Thirty milliliters 
of cell-free supernatants from virus-producing cells were centrifuged to remove cell 
debris (3,000 RPM for 5 minutes at 4°C). Subsequently the supernatants were 
centrifuged through a 20% iodixanol cushion in a SW28 rotor (Beckman Coulter) for 2h 
at 23,000 RPM. The centrifuged pellet was resuspended in 1 ml of ice-cold PBS. Two-
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milliliter layers containing 50%, 40%, 30%, 20%, and 10% Iodixanol were layered in tubes 
for the SW41Ti rotor (Beckman Coulter) and the resuspended pellet in PBS was applied 
on top of the prepared gradient. The gradient was centrifuged for 17 h at 35,000 RPM at 
4°C. Twelve gradient fractions were collected from the top and their density was 
determined by refractometry. Aliquots from each fraction were used for the PERT assay. 
3.2.1.5 Electron microscopy 
Virus particles from the culture medium of infected cells were pelleted by 
ultracentrifugation as described above and fixed in 2% formaldehyde. Samples 
negatively stained with 3% phosphotungstic acid (PTA) were then viewed with Jeol JEM, 
2000 CX microscope (JEOL). 
3.2.2 PCR methods 
3.2.2.1 Conventional PCR 
Each PCR reaction mixture had a total volume of 20 μl, containing 1.5 μl of the 
DNA (up to 0.5 μg) solution and 300 nM (each) the forward and reverse primers, and 
160 μM of each dNTP. The PCR amplifications were performed with One Taq polymerase 
and its according buffer (all from New England Biolabs) with the following conditions: 1 
cycle of 4 min 95°C; and 25 cycles of 15 sec 94°C, 25 sec 55-60°C (according to the 
primer used), 1 min (per 1kb amplified) at 68°C; final elongation for 10 min at 68°C. 
 For determination of an integration pattern of CrERV, ExTaq polymerase 
(Takara) was used with the following PCR program: 1 cycle of 95°C for 2 min, and 31 
cycles of 94°C for 20 sec, 55°C for 30 sec, 68°C for 2 min, and final elongation for 10 min 




Table 7: Primers used for CrERV amplification, insertion pattern determination and sequencing. 


















3.2.2.2 Real-time quantitative PCR 
MESA GREEN qPCR mastermix (Eurogentec) was used for standard real-time 
quantitative PCR. Each reaction mixture had a total volume of 20 μl, containing 2 μl of 
the cell lysate and 300 nM (each) the forward and reverse primers. The samples were 
run on a Bio-Rad CFX96TM Real-Time System (Bio-Rad) with a two-step protocol (1 cycle 
of 5 min at 95°C and then 44 cycles consisting of 15 sec at 95°C and 60 sec at 60°C), 
followed by melting curve analysis in the CFX Manager software (Bio-Rad) to ensure the 
specificity of the amplification. An absolute standard curve for each assay was obtained 
by using as templates serial dilutions of a plasmid containing the corresponding 
amplicon. The results were normalized using the parallel amplification of a single-copy 
human genomic locus in porphobilinogen deaminase gene (Konig et al., 2008).  
Table 8: Primers used for qPCR to quantify the amount of CrERV env 







3.2.2.3 Digital droplet PCR 
For highly accurate absolute quantification of viral DNA, droplet digital PCR 
(ddPCR) system QX200 (Bio-Rad) was used. Each reaction mixture had a total volume of 
20 μl, containing 1x QX200 ddPCR Evagreen Supermix (Bio-Rad), 2 μl of the cell lysate (1-
5 ng DNA), and 250 nM (each) the forward and reverse primers. The reactions were 
treated for droplet generation according to the manufacturer's manual and then 
amplified with the following conditions: 1 cycle of 5 min at 95°C and then 40 cycles 
consisting of 15 sec at 95°C and 40 sec at 59°C followed by 1 cycle of 5 min at 72°C, 5 
min at 4°C and 5 min at 90°C. Samples were analyzed by droplet reader and QuantaSoft 
software (Bio-Rad) with thresholds set manually. 
*None of the data obtained by ddPCR are presented in this thesis, but can be found in the 
publications connected to this thesis. 
3.2.2.4 Product enhanced reverse transcriptase (PERT) assay  
The PERT assay was adapted from previously published protocols (Lovatt et al., 
1999; Pizzato et al., 2009; Sears & Khan, 2003). The samples (2 µl of culture supernatant 
or gradient fraction) were lysed in 8 μl of solution containing 1% TRITON X-100, 0.4 U/ μl 
RNasin (Promega), and 1x ProtoscriptII buffer (New England Biolabs) at room 
temperature for 30 minutes. Then, two master-mixes were prepared, with the following 
amounts per one reaction: Mix 1 contained 20 ng of the template RNA of MS2 phage 
(Roche), 0.5 μl of the reverse primer MS2b (5'- GCCTTAGCAGTGCCCTGTCT) and 10.1 μl 
water. Mix 2 contained 3.6 μl of 5x ProtoscriptII buffer, 2 μl of 100 mM DTT, 0.8 μl of 10 
mM dNTP2, and 6.4 μl water. Mix 1 was incubated at 65°C for 5 minutes and slowly 
cooled down to allow primer annealing. Next, the mixes were pooled and aliqoted by 18 
μl. To each aliquot, 2 μl of the lysates were added and incubated at 37°C for 30-60 
minutes (reverse transcription step), then inactivated at 70°C for 10 minutes. The newly 
generated MS2 cDNA was quantified by real-time PCR assay with forward MS2a (5'- 
AACATGCTCGAGGGCCTTA) and reverse MS2b primers and fluorescent probe (FAM-
TGGGATGCTCCTACATG-TAMRA). Each reaction contained 1.5 μl of the cDNA sample, 
1xqPCR master mix (Eurogentec), 7.5 pmol of each primer and 3.75 pmol of probe in a 
total volume of 15 μl. The samples were run on a Bio-Rad CFX96TM Real-Time instrument 
with a three-step protocol: 1 cycle of 10 min at 95°C and then 45 cycles consisting of 15 
sec at 95°C, 20 sec at 60°C and 20 sec at 72°C. Cycles of quantification (Cq) values were 
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generated by the CFX Manager software. With each run, one calibrator sample (MLV 
virions pseudotyped with VSV-G) was assayed and all values were expressed as relative 
values compared to the calibrator. 
3.2.3 DNA cloning and vectors used 
3.2.3.1   Preparation of DNA inserts 
3.2.3.1.1  Plasmids with env derived from CrERV 
CrERV env was amplified from OHK cell line genomic DNA using primers 
CrENVe1 (5'-cttaagcttccaccATGGAAGGCGAATGCTCATC) with ctt overhang (green), 
HindIII restriction site (underlined), Kozak sequence (blue) and proviral env (start codon 
red and other coding sequence yellow) and downstream primer CrENVe2 
acgttgaattcTTATGGGGAGGAATCTTCCTCT with overhang (green), EcoRI restriction site 
(underlined) and stop codon (red). 
CrENVFLAG was amplified from subcloned CrERVenv vector with primer 
CrEnvApa (5'-CTCCTGGGCCCACTTTTACT) with ApaI restriction site (underlined) and 
primer CrEnvFLAG, (5'-
AAgggcccTCACTTGTCATCGTCGTCCTTGTAGTCTCCTGGGGAGGAATCTTCCTCT) amplified 
from the genomic DNA sample 
AGAGGAAGATTCCTCCCCAGGAGACTACAAGGACGACGATGACAAGTGAgggcccTT where 
yellow is the env sequence, glycine is gray, FLAGtag is green (stop codon red) and ApaI 
restriction site is underlined 
CrERVnT was amplified from subcloned CrERVenv vector using CrEnvApa primer 
and primer CrENVnT (5'-AAGGGCCCTCAATTTAAAATACAAGGCCCAATTGTAA) targeting 
the sequence 
CTCCTGGGCCCACTTTTACTGTTAATACTAATACTTACAATTGGGCCTTGTATTTTAAATTGAgggc
ccTT introducing an early stop codon (red). 
3.2.3.1.2 Plasmids with env derived from amphotropic MLV  
Amphotropic env was amplified from commercial plasmid PCL Ampho 
(Addgene) using primer AmphoENV1 (5'-aatgGATCcACCATGGCGCGTTCAACGCT) with 
KpnI restriction site (underlined) and Kozak sequence (blue) and primer AmphoENV2 (5'-
gctctaGATCATGGCTCGTACTCTATGG) with XbaI restriction site (underlined). 
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AmphoenvFLAG was amplified from the subloned Amphotropic env vector 
using primer AmphoCla1 (5'-TGCATTCTCAATCGATTAGTCC) with ClaI restriction site 
(underlined) and primer AmphoenvFLAG (5'-
ATTCTAGATCACTTGTCATCGTCGTCCTTGTAGTCTCCTGGCTCGTACTCTATGG) generating a 
sense strand sequence 
CCATAGAGTACGAGCCAGGAGACTACAAGGACGACGATGACAAGTGATCTAGAAT with 
glycine (gray), FLAGtag (green, stop codon red) and XbaI restriction site (underlined).  
3.2.3.2 Plasmid vectors 
For DNA cloning procedures, the plasmid pGEM-T Easy (Promega) was used. For 
constructing expression vectors, expression plasmid pcDNA3 (Addgene) was used.  
3.2.3.3 Ligation 
All DNA inserts were first subcloned into the pGEM-T Easy vector according to 
the manufacturer's protocol using molecular ratio insert to vector 3:1; transformed to E. 
Coli (see chapter bacterial transformation), the colonies were screened by PCR and the 
products were sequenced. The constructs were then digested and re-cloned to 
expression vector pcDNA3. The constructs were again transformed to bacteria, colony 
screened and sequenced. Prior to ligation of the CrERVenvFLAG construct with pcDNA3 
plasmid, the plasmid was dephosphorylated using rAPiD alkaline Phosphatase (Sigma 
Aldrich) according to manufacturer’s protocol. 
3.2.3.4 Bacterial transformation 
The plasmids with cloned inserts were transformed to E.Coli strain XL1 blue (if 
restriction enzymes were sensitive to bacterial dam methylation, SCS110 strain was 
used). Aliquots of the ligation mixture were incubated with bacteria on ice for 40 
minutes. After that heat shock at 42°C was peformed for 1 minute. The mixture was 
immediately added to 0.5 ml of the LB media and recovered for 40-60 minutes at 37°C. 
The recovered bacterial culture was seeded to LB-agar plates with ampicilin (1 µg/ml, 
Sigma), IPTG (3mg/ml, Thermo Scientific), and S-gal or X-gal (both 30 mg/ml, Thermo 
Scientific), to enable blue/black-white colony screening. The plates were incubated 
overnight at 37°C. 
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3.2.3.5 Colony screen PCR 
 The white colonies were transferred to 20 μl of LB media with ampicillin. The 2 x 
OneTaq master mix (New England Biolabs) was used to mix reactions of 15 μl containing 
1.5 μl of bacterial mixture. Primers designed to anneal to the end of bacterial vectors 
were used: M13F and M13R for pGEMTeasy vector and pcDNA3F and pcDNA3R for 
pcDNA3 vector. 
3.2.4 Other used plasmid vectors 
 pVSV-G is a 6.5 kbp long plasmid bearing an envelope protein of VSV-G (vesicular 
stomatitis virus G) with cytomegalovirus (CMV) promoter. 
 pLG is a 5.658 kbp long plasmid bearing two MMLV and MMSV LTRs and EGFP 
with Ampicilin resistance and enhanced packaging singnal. 
 pBS-CMV-gagpol is a 9.333 kbp long plasmid bearing an MLV gag-pol available 
from Addgene (catalogue number 35614). 
3.2.5 Plasmid DNA isolation 
For the isolation of plasmids for sequencing or re-cloning, QIAprep Spin Miniprep 
Kit (Qiagen) was used according to manufacturer’s spin protocol. 
 The plasmids used for transfection were grown in bacteria in LB medium and 
isolated using GenElute HP Plasmid DNA Midiprep Kit (Sigma Aldrich) according to 
manufacturer’s protocol. The isolated plasmids were stored at 4°C. 
3.2.6 Storage of the transformed bacteria 
The bacteria bearing desired plasmids grown in LB medium overnight were mixed 
with 10% glycerol in 7:3 volume ratios and subsequently stored at -80°C. 
3.2.7 Transfection  
 For obtaining the retroviral constructs in sufficient amounts, calcium phosphate 
transfection was used. Cells were seeded to reach approximately 60% confluence on a 
100 mm plate. Up to 30 g of DNA was dissolved in 1080 l of water, mixed with 135 l 
2M CaCl2 and subsequently dripped stepwise to the mixture of 1120 l 2xHBS and 22 l 
100xPO4 while being lightly shaken to let the mixture form a precipitate; then the 
mixture was added to the cells (with medium changed at least one hour prior to the 
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procedure) in a dropwise manner. After 5 h incubation, cells were washed with warm 
(37°C) 15% glycerol in 1xHBS for 30 sec, washed with PBS and supplied with a fresh 
medium. The medium with the product of transfection was collected on day two and 
three after transfection. It was spun at 200 g for 10 min at 4°C to get rid of cell debris 
and immediately used or stored at -80°C. 
3.2.8 Infection 
 For infections, medium from virus-producing cells was harvested, spun for 10 min 
at 4°C at 200 g to remove cell debris and either used to infect the cells directly or was 
stored at -80°C. Medium harvested from cells expressing a reasonably high viral titer 
was filtered through 0.45 m filter. 
 If a virus was concentrated prior to use, it was spun at 23,000 RPM for 2 h in a 0-
micron environment at 4°C in a SW28 rotor (Beckman Coulter). 
 Virus vectors with an envelope not stable in ultracentrifugation procedures (e.g. 
Env of amphotropic viruses) were concentrated using RetroConcentin (System 
Biosciences) according to manufacturers’ protocol concentrating the viral stock 20x. 
 In case RetroNectin (Takara) was used to enhance the viral infectivity, the culture 
dishes were coated with RetroNectin according to manufacturer's spin protocol. 
RetroNectin reagent is a recombinant human fibronectin fragment that contains three 
functional domains. RetroNectin enhances retrovirus-mediated gene transduction by 
aiding the co-localization of target cells and viral particles. Specifically, virus particles 
bind RetroNectin via interaction with the H-domain, and target cells bind mainly through 
the interaction of cell surface integrin receptors VLA-5 and/or VLA-4 with the fibronectin 
C-domain and CS-1 sites, respectively. By facilitating close physical proximity, the 
RetroNectin reagent can enhance viral-mediated gene transfer to target cells expressing 
integrin receptors VLA-4 and/or VLA-5. 
In case polybrene was used to enhance retroviral infection, it was added directly 
to the viral stock to obtain a medium with a polybrene concentration of 4 µg/ml. 
Polybrene is presumed to enhance the retrovirus uptake in the cell in the assays for 
retrovirus gene transfer (Davis, Morgan, & Yarmush, 2002). 
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3.2.9 Retrovirus envelope pseudotypes 
 Retroviral pseudotypes were constructed by co-transfecting plasmids into 
HEK293T cells by calcium phosphate transfection. The constructs with concentration of 
individual plasmids are listed in Table 9. 
Table 9: Amounts of plasmid constructs used in the production retroviral pseudotypes 
Pseudotyope 
designation 




CrERVenv 5 µg 10.75 µg 12.5 µg 
CrERVenvFLAG 5 µg 10.75 µg 12.5 µg 
CrERVenvnT 5 µg 10.75 µg 12.5 µg 
Ampho 5 µg 10.75 µg 12.5 µg 
AmphoenvFLAG 5 µg 10.75 µg 12.5 µg 
Gag-pol 0 µg 25.75 µg 12.5 µg 
 
 The medium from the transfected cells was harvested two or three (or both) days 
after transfection and used for infection of cells.  
3.2.9.1 Western blot 
The cell lysates harvested from tissue culture plates were applied to a 8% (upper 
and 12% (lower) SDS polyacrylamide gel and transferred to PVDF membrane, which was 
subsequently blocked in 5% reduced milk. Membrane was subsequently incubated with 
an anti-FLAG antibody and a secondary anti-rabbit antibody with covalently bound 
horseradish peroxidase (Cell Signaling Technology). The luminescent reaction was 
performed using LumiGLO solution (Cell Signaling) and exposed on an X-ray film (Agfa). 




3.2.10 Retrovirus marker rescue assay 
 
Figure 11: Strategy used for the marker rescue assay. The cells bearing CrERV were transfected 
with an expression plasmid with VSV-G envelope. HEK293T cells stably transfected with GFP and 
infected with CrERV were transfected with a plasmid with a VSV-G envelope to produce a virus 
with CrERV core and Env, GFP marker, and VSV-G. 
 
 To perform the marker rescue, the HEK293T cell line bearing a molecular clone of 
CrERV and GFP was transfected with pVSV-G plasmid. The standard protocol for calcium 
phosphate transfection was used. The idea behind the strategy of marker rescue is 
depicted in the Figure 11. 
 2ml of fresh C10 cells (cells used to generate the rescued GFP-marked virus) 
medium was used for infection or 1ml of cells medium of CrERV positive cells 
transfected with VSV envelope. Three days after infection, cells were fixed and stained 
with DAPI (4′,6-Diamidine-2′-phenylindole dihydrochloride) to mark the nuclei. 
3.2.11 Flow cytometry (FACS) 
 Infected cells were harvested and centrifuged (200 x g, 5 min, 22°C), the cellular 
pelet was resuspended in Hoechst 33258 in PBS (1 μg/ml). Uninfected cells were treated 
the same way and used as a negative control to distinguish GFP+ and GFP- cells. The 
number of Hoechst-negative (live) and GFP-positive cells was measured using BD LSRII 
(BD Biosciences). The data were analyzed using FlowJo software 
(http://www.flowjo.com). 
 For fixation, the cells were resuspended in 1% paraformaldehyde (PFM) in PBS 
after harvesting and centrifugation. Prior to measurement, they were strained through 
50 µm strainer (Cell Trics, Sysmex) in order to remove the cell clumps.  
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3.2.12 Cell fixation for DAPI staining 
The cells were seeded on a cover slip in a 35 mm Petri dish and washed three 
times after 24 hours with PBS (heated to 37°C). The cell were fixed with 2 ml of 3% PFM 
in PBS (37°C) and incubated for 20 min at a room temperature. The slips were washed 
with PBS three times (with 15 min between washes), then washed in a demineralized 
water. A drop of Mowiol+DAPI was placed at the microscope slides. The cover slips were 
placed on the miscroscope slides so that no air bubbles would be introduced between 
the slides and slips and surplus fluid was removed. 
3.2.12.1 Preparation of 3% paraformaldehyde 
3 grams of PFM were dissolved in 70 ml PBS and mildly heated. The pH was 
adjusted to 6.9 using KOH. The PBS was added up to 100 ml, the solution was filtered 
and stored at -20°C in aliquots.  
3.2.13 Genomic DNA isolation by phenol-chloroform extraction 
The cellular pellet was resuspended in 800 μl of lysis buffer (containing water; 
0.5M EDTA-pH 8.0; and 10% SDS in the ratio 4:5:1). 40 μl of proteinase K (20 mg/ml) was 
added and the mixture was incubated at 55°C overnight in a rolling tube. The next 
morning, 2.5 μl of RNase A (100 mg/ml) was added and the mixture was incubated in the 
rolling tube at 37°C for 1 h. 800 μl of phenol:chloroform (1:1, pH 7.9) was added and 
thoroughly but not vigorously mixed. The mixture was subsequently centrifuged at room 
temperature at 16,000 g for 3 min. Aqueous phase-containing DNA was collected and 
mixed with an equal amount of cold (-20°C) 96% ethanol. The mixture was mixed and 
centrifuged (16,000 g, 15 min, 12°C) and the supernatant was removed. The pellet was 
washed with cold (-20°C) 80% ethanol and centifuged (16000 g, 15 min, 12°C). After 
removal of the supernatant, the pellet was air dried at 37°C and dissolved in 50 μl T10E0.1 
(10 mM TRIS, 0.1 mM EDTA) buffer.The samples were stored at 4°C. 
3.2.14 Alignments & construction of the phylogeny trees 
 Alignments of sequences were generated using the MUSCLE algorithm included 
in the MEGA6 (Tamura, Stecher, Peterson, Filipski, & Kumar, 2013) software package. 
The Neighbor-joining trees were constructed using algorithms in MEGA6 and visualized 
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in FigTree. The ProtTest analyzes trees were constructed using online ProtTest2.4 server 
(Abascal, Zardoya, & Posada, 2005).  
3.2.15 Assembly of the restriction factors sequences 
 Sequence datasets available from the Sequence Read Archive (SRA) at the 
National Center for Biotechnology Information (NCBI) from mule deer (BioSample 
PRJNA79789) were queried by BLAST (Johnson et al., 2008) using various ungulate 
restriction factor sequences as baits. The restriction factors with at least three hits to the 
mule deer SRA sequences were further processed. Sequencing data from lymph nodes 
of mule deer, sika deer, and European roe deer were used to assemble selected 
restriction factors using CLC genomics Workbench 9.5 (http://www.clcbio.com) or 
DNASTAR Lasergene 10.0.0 (http://dnastar.com). The assembled sequences and 
sequenced mined from the NCBI Nucleotide database were used for alignment 
construction, using MEGA6 software (Tamura et al., 2013) and further analyzed using 
DataMonkey algorithms (Delport, Poon, Frost, & Kosakovsky Pond, 2010) to detect the 
signatures of positive selection using the default parameters.   
3.3 Methods related to the CHOK1 cells project 
3.3.1 Tissue cultures 
All cells were cultured in a humidified incubator at 37°C and 5% CO2.  
3.3.1.1 The source of amphotropic virus 
S. Indik (University of Veterinary Medicine Vienna, Austria) provided HEK293T 
cells stably expressing a MLV-based retroviral construct with amphotropic envelope. The 
cells were maintained in the same medium as regular HEK293T cells. The virus-
containing cell culture medium was collected and spun to remove the cell debris (200 g, 
5 min, 4°C).  
3.3.1.2 Cultivation of CHOK1 cells 
The CHOK1 cells were maintained in NP medium (composition: 100 ml water; 104 
ml D-MEM/F12 2x; 4.5 ml 5% NaHCO3; 10.5 ml fetal calf serum; 10.5 ml calf serum; 
penicillin (100U/ml) and streptomycin (100 µg /ml); glutamine).  
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3.3.1.2.1 Tunicamycin treatment 
Cells were seeded at a 10% confluency. After four hours, tunicamycin was added 
to a final concentration of 0.4 µg per ml of medium. The infection was performed 19 h 
following the tunicamycin treatment. 
3.3.1.2.2 Harvesting of the conditioned medium 
In order to prepare sufficient amount of conditioned serum free medium we 
cultivated the CHOK1 cells grown to approximately 80% confluence in serum free NP 
medium for 24 hours. 
3.3.2 Infection 
 RetroNectin (Recombinant human fibronectin fragment, Takara) coating of the 
dishes was shown not to increase infectivity; hence it was not used in the experiment. 
Polybrene was used to enhance retroviral infection; it was added directly to the viral 
stock to obtain a medium with a polybrene concentration of 4 µg/ml. 
 To prove the inhibitory effect of the conditioned CHOK1 cells medium (or its 
fractions obtained by gel filtration), the conditioned medium (or the fractions) and 
prepared viral stock were added to the cells simultaneously in 1:1 volume ratio. As a 
control, fresh medium was added to the cells simultaneously in 1:1 volume ratio with 
prepared viral stock. 
3.3.3 Evaluation of the infection outcome 
To evaluate infection (and its inhibition) outcome, cells were either analyzed by 
flow cytometry or the number of foci of GFP-positive cells was manually counted under 
fluorescent microscope (both approaches discussed in the methods related to CrERV 
experiments).  
3.3.4 Medium concentration, fractionation, and mass spectrometry 
The Laboratory of Structural Biology (BIOCEV) performed medium concentration 
and fractionation. The mass spectrometry was performed by the core facility at BIOCEV.  
500 ml of CHOK1 conditioned media was concentrated to 12 ml using Amicon 
ultrafiltration device (MW cutoff = 10 kDa). 4 ml frozen aliquots of the concentrated 
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medium was stored at -20°C. 2x4 ml was separated on Superdex HR 75 16/60; fractions 
were collected by 3 ml.  
3.3.5 Evaluation of the mass spectrometry results 
The protein sequences obtained were used in BLAST searches against NCBI, TrEMBL, 
and SwissProt database and a personalized amino acid sequence database. The 
personalized database was created by predictions of endogenous retrovirus env 
sequences present in the CHOK1 genome. The best BLAST hits against hamster genome 













4 RESULTS AND DISCUSSION 
4.1 Screens for the unusual endogenous retroviruses in 
mammalian genomes 
4.1.1 Endogenous Lentivirus in Malayan colugo (Galeopterus 
variegatus) 
 We performed a computational screen of 104 mammalian genomes available at 
the time, aimed at detecting unusual cases of endogenous retroviruses, including 
endogenous lentiviruses (see Figure 12) and deltaretroviruses. We detected a novel 
endogenous Lentivirus in the Malayan colugo genome, denoting it ELVgv. We were able 
to assemble three endogenous copies of ELVgv. Construction of the phylogenetic trees 
confirmed that the provirus is sequentially most related to lentiviruses. However, ELVgv 
is evolutionary old and does not clearly cluster with any Lentivirus group, forming a 
separate group within lentiviruses.  
 
Figure 12: A. Schematic of the computational pipeline used for screening the vertebrate 
genomes. B. The outcome of the analysis. Every blast hit is denoted by 1 vertical line. The height 
of the line depicts the value of the bit score of the hit. The individual species are distinguished by 
various colors. Figure from (Hron et al., 2014). 
 
BLAST searches of the colugo genomic contigs revealed the presence of three 
complete ELVgv proviruses (provirus Ι at positions 11,594-19,841 of contig 
JMZW01084956; provirus ΙΙ at positions 14,164-23,469 of contig JMZW01174031; 
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provirus ΙΙΙ at positions 40,701-51,516 of contig JMZW01021293). All three detected 
proviruses in the genome are displayed in the Figure 14. The majority consensus 
sequence of the proviruses was used to construct the phylogenetic trees depicted in the 
Figure 13. 
To estimate the phylogenetic relationship of ELVgv to other lentiviruses, we have 
constructed phylogenetic trees using alignment of the amino acid sequences of reverse 
transcriptase. Reverse transcriptase is a highly conserved region of pol with sequences 
available from representatives of all retrovirus genera. In subsequent phylogenetic 
analysis using both, maximum likelihood (ML) and Bayesian methods, ELVgv RT clustered 
inside the Lentivirus clade with high support (ML bootstrap 100, Bayesian posterior 
probability = 1), see Figure 13 for reference. In accordance with this clustering, the 
highest-scoring BLASTp hits of ELVgv gag, pol and env genes were the genes from a 
Lentivirus, feline immunodeficiency virus (FIV; the similarity/identity to FIV counterparts 
of gag, pol and env genes were 48%/31%, 54%/35% and 27%/17%, respectively).  
 
Figure 13: Phylogenetic analysis of ELVgv. The sequence of ELVgv clusters with good support with 
other members of Lentivirus genus. Bootstrap supports as well as posterior probability of 
Bayesian tree is displayed at the nodes (left). The situation within the lentiviral genus is depicted 
as well (right). The endogenous lentiviruses are indicated by a dot. None of the endogenous 
forms of lentiviruses clusters in a group with recent lentiviruses. The numbers represent the 
bootstrap values.  
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To analyze the relationship of ELVgv to other lentiviruses in more detail, we have 
used the dataset of conserved regions of lentiviral gag and pol (Gilbert et al., 2009), 
adding the recently described ELVmpf to the analysis (Cui & Holmes, 2012a; Han & 
Worobey, 2012). The ML phylogeny analyzes indicate that ELVgv forms a deep branch in 
the Lentivirus tree, indicating its ancient origin and distinct position in the lentiviral 
genus. ML tree differed slightly from the phylogeny obtained by Bayesian analysis. While 
in the ML analysis ELVgv clustered with weak bootstrap support (46.7) together with the 
ovine/caprine Lentivirus subgroup, it formed an isolated deep branch in the Bayesian 
tree. Separate analysis of the gag and pol genes excluded any evident recombination 
event. Re-running the analysis with the three individual provirus sequences instead of 
the reconstructed ELVgv consensus sequence also did not influence the results (shown 
in the supplementary material of (Hron et al., 2014)). Based on these facts, the precise 
relationship of ELVgv to primate and nonprimate Lentivirus groups could not be 
determined. 
 
Figure 14: The assembly and structure of three ELVgv proviruses in the colugo genome; age 
estimation of individual ELVgv integrations based on LTR aging is depicted on right. Figure from 
(Hron et al., 2014). 
 
Dermoptera order contains only two extant species - Galeopterus variegatus and 
Cynocephalus volans. Dermoptera is considered the basal branch to primates. We 
obtained dermopteran genomic DNA samples in very low amounts. The samples were 
amplified by whole genome amplification and their correct identification was validated 
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by sequencing CHRNA1 control gene and comparing the sequences to the ones 
published in GenBank (alignment depicted in Figure 15). The identity of all samples was 
confirmed in this way. 
 
Figure 15: Sequence alignment of CHRNA1 control locus from dermopteran specimens analyzed . 
CHRNA1 locus was PCR-amplified and sequenced from dermopteran genomic DNA to confirm the 
identity of specimens analyzed. Sequences with the following GenBank accession numbers were 
used for comparison: CVO1 CHRNA1 (FJ151285), GVA5 CHRNA1 (FJ151283) and GVA3 CHRNA1 
(FJ151281).The polymorphic sites used for comparison are highlighted in black. 
 
 The presence of ELVgv in Galeopterus and Cynocephalus genome was confirmed 
by PCR detection of RT region from whole genome amplified (WGA) samples. The 
presence of ELVgv in both of the species confirms the prediction, that ELVgv integrated 
in the genome of ancestor of the currently living dermopteran species more than 20 





Figure 16: Presence/absence of ELVgv among species. The numbers associated with the nodes 
depict the time of the divergency of the species according to TimeTree 
(http://www.timetree.org/).  
 
 Further studies of the ELVgv confirmed the estimated age of the provirus and 
marginally dealt with the host-virus relationship. We were able to detect and sequence 
partial provirus from the other extant species from the Dermoptera clade. We partially 
sequenced the three endogenous copies of the provirus in three specimens. We looked 
for empty integration site from all of the proviruses, but detected none (see Figure 17). 
This fact indicates that the provirus insertion is homozygous and in the same genomic 
loci in all animals tested.  
 
Figure 17: Detection of ELVgv integrations in the dermopteran genomic samples. Upper: 
schematics of ELVgv provirus with primer positions. Lower: PCR amplifications using primers 
targeting two regions of the ELVgv reverse transcriptase (RT), the three individual virus-host 
junctions and their corresponding pre-integration sites (proviruses A, B, and C), and two control 
loci (FES, CHRNA1) in dermopteran genome (Janecka et al., 2008). CVO - C. volans; GVA3, GVA5 - 
G. variegatus specimens; NTC - non template PCR control. 
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 We were successful in sequencing proviral parts from the 5’ end of the provirus 
from all three dermopteran individuals (GVA3, GVA5, CVO). Due to the limited amount 
and fragmentary nature of whole genome-amplified DNA, we were not able to obtain 
longer sequences than the ones depicted in Figure 18. We compared the obtained 
sequences to the sequence assembled from the GenBank data.  
 Due to the mutated nature of proviruses, we were able to amplify only four 
fragments of approximately 3 kb and shorter fragments of 0.7 – 1 kb in length in another 
four analyzed proviruses. In the GVA3 specimen, we were able to amplify only the very 
end of the provirus C sequence, probably either due to the low quality of whole 
genome-amplified template DNA or due to the mutations/deletions in the regions 
targeted by the primers. All together, we obtained a total of 11 partial ELVgv sequences 
from four animals, including three provirus sequences reconstructed in silico in GVAgb 




Figure 18: Sequence variability of three ELVgv proviruses integrated in the dermopteran genome. 
Upper: Schematic depiction of ELVgv genomic organization (Hron, et al. 2014). Region analyzed 
by sequencing is highlighted by grey box. Lower: Graphical representation of individual partial 
proviral sequences, with scale indicated above. Each line represents one proviral sequence in 
particular specimen (CVO, GVA3, GVA5, GVAgb). Three blocks of lines correspond to the three 
proviral integrations (A, B, and C), where the sequence from GVAgb is taken in each case as a 
reference. Vertical lines indicate single nucleotide substitutions relative to the reference 
sequence. Insertions and deletions are depicted by upward and downward-pointing triangles, 
respectively, with the length indicated below. Heterozygous sites are indicated by asterisks. 
 
The A, B and C proviruses, which represent independent integration events, are 
mutually different. Moreover, each provirus differs in many sites between individual 
animals. These differences have accumulated in the provirus after the split of the 
dermopteran lineages analyzed. The differences detected include substitutions, short 
indels and three long insertions (formed by integrations of SINE and LINE repetitive 
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elements). For each provirus, the sequences in CVO always substantially differ from the 
sequences in Galeopterus (GVA3, GVA5, GVAgb), reflecting the separate evolution of the 
Cynocephalus and Galeopterus species. The pattern of sequence differences observed 
for each proviral integration enabled us to further analyze the ELVgv evolutionary 
history in Dermoptera. This included more detailed analysis of ELVgv evolutionary 
history, confirming its position as the oldest lentivirus detected to date, and analysis of 





4.1.2 Discovery of the first endogenous Deltaretrovirus in the 
genome of long-fingered bats (Chiroptera: Miniopteridae) 
 Deltaretroviruses are an enigmatic genus of retroviruses. Up to this finding, no 
endogenous copy of a Deltaretrovirus was detected. In our screening efforts, we have 
detected remnants of endogenous Deltaretrovirus in the genome of Miniopteridae bats. 
We denoted this provirus MINERVa (Miniopteridae endogenous retrovirus).  
 We proved that this provirus is present in the Miniopterus genome only in a 
single copy, by thoroughful screen of the avaliable NGS and RNAseq data and by utilizing 
highly quantitative digital droplet PCR with primers designed to amplify LTR and gag 
sequences (see attached Manuscript).  
 We obtained samples from several bat species and confirmed their identity by 
sequencing their cytB or RAG2 loci (see Table 5 for reference). The presence of MINERVa 
was confirmed by PCR detection using primers to amplify LTR (for detection of possible 
solo LTRs) and gag sequence, respectively. The MINERVa sequence was proven to be 
orthologous among all Miniopteridae specimens analyzed, but was not present in other 




Figure 19: Absence/presence analysis of the MINERVa sequence in the bat samples. The time 




 MINERVa sequence was annotated by comparisons to two other well described 
deltaretroviruses (BLV and HTLV1). Splice site donor and splice site acceptor sequences 
were predicted using FruitFly (http://www.fruitfly.org/seq_tools/splice.html). Two 
additional ORFs were detected, which we presume to encode accessory genes (see 





Figure 20: Annotation of the MINERVa sequence; PBS - primer binding site, p19 - matrix, p24 -
capsid, polyA - polyadenylation signal site, ORF - open reading frame, SD - splice donor, SA - 
splice acceptor, PPxY - late doomain in gag. 
 
Presence of the accessory gene coding for Rex in the genome was further 
indicated by prediction of stem loop structures characteristic for the Rex response 
element present in the LTR (see Figure 21). The predicted structure resembles the 




Figure 21: Prediction of a stem-loop structure in various deltaretroviruses using mfold software. 
The characteristic structures for the Rev Response element are highlighted in gray.  
 
The presence of an intact ORF in the gag sequence was indicative of the fact that 
the provirus might produce a functional peptide sequence, leading to its purifying 
selection during Miniopteridae evolution. However, a pilot mass spectrometry analysis 
of the miniopterus muscle tissue did not yield a result confirming a presence of such a 
peptide. However, a muscle tissue is not optimal as a sample source in mass 
87 
 
spectrometry analysis, but was the only accessible at the time the analysis was 
performed. 
This is the first report of a Deltaretrovirus possibly infecting a new mammalian 
order (Chiroptera). Interestingly, deltaretroviruses (namely BLV) are capable of 
replicating in a cell line derived from Tadarida species (personal communication with 
Kathryn Radke). Deltaretroviruses cause slow persistent infections in general, the viruses 
are predominantly spread via cell-to-cell transmission and if the immune cells are 
latently infected, clonal expansion occurs (Rafatpanah, Farid, Golanbar, & Jabbari Azad, 
2006). 
The deep evolutionary history of deltaretroviruses is not known. The sequences 
we detected and analyzed possess features of deltaretroviruses. Besides the mentioned 
sequential similarity to currently circulating deltaretroviruses, the sequence is cytosine-
rich. It was previously shown, that HTLV nucleotide composition is biased due to being 
cytosine-rich and adenine-poor whereas the opposite applies to HIV (Kypr, Mrazek, & 
Reich, 1989). 
Evidence of the presence of an endogenous Deltaretrovirus sequence is not only 
filling in the gap of knowledge of the last genus of retroviruses lacking in the currently 





4.2 Molecular biology characterization of the currently 
endogenizing retrovirus (CrERV) 
 CrERV was recently studied due to its high insertional polymorphism among mule 
deer population in North America. However, almost all of the studies were only 
sequence-based or computational, and a virological characterization of the virus was 
lacking.  
We were succesful in inducing the virus by cocultivation with susceptible human 
cells. The RT activity was measured in the coculture every week to monitor the start of 
the virus production. The normalized values of the RT activity and its growth during the 
analyzed time course is shown in the Figure 22.  
This approach was based on the experiments performed upon the discovery of 
the inducible deer Gammaretrovirus, named DKV (Deer kidney virus) at that time 
(Aaronson et al., 1976). It also provided a source of the infectious virus at the first stages 
of the experimental work.  
 
Figure 22: The relative RT activity of the medium on various days of cocultivation. 
 
Because these experiments provided the first definitive virological identification 
of CrERV, and the titers obtained were extremely low, the particles of the induced CrERV 
were analyzed by various aproaches. First, we performed a gradient ultracentrifugation 
to test whether the virus sediments in the characteristic region of the Iodixanol gradient 
(See Figure 23). In sucrose density gradients, retrovirus particles sediment around 1.16 
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mg/ml (Contreras-Galindo et al., 2012). Iodixanol ultracentrifugation and visualisation of 
retroviral particles were performed on PERV in parallel. PERV and CrERV were used for 
comparison due to the fact, that PERV is widely studied in context of 
xenotransplantation and therefore a well characterized endogenous Gammaretrovirus 
(Kimsa et al., 2014).  
 
Figure 23: Presence of RT activity in Iodixanol gradient fractions for CrERV (left) and PERV(right) 
Comparisons of these fractions from two gradients confirmed, that the induced CrERV sediments 
in the fraction with density characteristic for retroviruses (A). Electron microscopy pictures of the 
retrovirus particles- CrERV (left) and PERV (right).  
 
Second, we sequenced the full genome of the induced provirus and compared it 
to four closest full-lenght endogenous CrERV copies present and annotated in the mule 
deer genome (Kamath et al., 2014). As expected, the induced virus is the most similar to 
the endogenous copies estimated to be the youngest and differs the most from the 
proviruses with the oldest integration time estimates. This is in agreement with the 
assumption that among the hundreds of CrERV copies present in the mule deer genome, 
the evolutionary youngest copies have the greatest potential for induction and particle 
production. Based on the analysis of the obtained sequence of the induced virus and its 
comparison to other proviruses, the viral env presumably mutates at the fastest rate and 
the viral pol remains more conserved (Fig. 24). Based on the origin of the virus 
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(cocultivation by cells used by (Aaronson et al., 1976)), this comparison confirms the 
supposed identity of CrERV and DKV. 
 
Figure 24: Comparison of full length seqences of the induced CrERV and its endogenous copies. 
The ticks representing the mutations in LTR and other noncoding viral sequences are aligned to 
center of the line representing each sequence. The ticks aligned above the line representing the 
sequence represents nonsynonymous mutations and the ticks aligned below the line represents 
the synonymous mutation. The ratio of mis-sense to sense mutation in individual genes is 
depicted above the individual lines representing the virus sequence. Insertions are depicted by 
triangles pointing towards the line, the deletions are depicted by triangles pointed outwards the 
line. Deletions or insertions in frame are depicted by black triangles, the frameshift indels are 
depicted by white triangles. The letters on both sides of the line represent the TSD sequence.  
 
 We further confirmed that the induced infectious virus (CrERV-IND) clusters with 
the evolutionary youngest copies in the mule deer genome by constructing a 
phylogenetic tree using 1 kb sequences from endogenous CrERV proviruses (Fig. 25). The 
extent of the 1 kb sequence was selected to minimize the impact of recombination 





Figure 25: Phylogenetic analysis of the induced CrERV and other CrERV copies in the mule deer 
genome using 1 kb sequence located at the 3‘ end of the provirus. The induced virus clusters with 
the evolutionary young copies.  
 
 The early and late infectious kinetics of the induced provirus was studied. The 
amount of newly made virus DNA (env gene product) of CrERV was estimated up to 48 h 
after infection. The experiment was performed in parallel with PERV and the infectious 
kinetics of the two viruses were compared (Figure 26). Early virus infection kinetics was 
shown to be regular, however only tiny fraction of cells was infected by CrERV (left); 
during long term infection of human cells, copy number around 1 viral DNA per cell was 
reached (right). The long-term spread of infection in the culture was also documented 
by repeated RT measurements.  
 
Figure 26: Early virus infection kinetics depicted (left), comparison of CrERV (circles) and PERV 
(triangles) env copy numbers per diploid cell up to 48 hours post infection; Long term infection of 
human cells, monitored up to 32 days post infection (right). 
 
Despite being efficient in creating new endogenous copies, the virus shows 
xenotropic behavior (see Figure 31), in agreement with the previous observations of the 
Aaronson laboratory (Barbacid, Daniel, & Aaronson, 1980). For subsequent work, we 
prepared and tested an infectious molecular clone of the provirus. To be able to 
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genetically distinguish the endogenous CrERV proviruses and also the the newly made 
clone, we introduced four point mutation in the pro gene region to generate a mutant 
version of the molecular clone, CrERVmut (Fig. 27). 
This allowed us to design PCR primers that amplified only the newly generated 
CrERVmut DNA and not any of the endogenous CrERV copies or the parental CrERV virus 
(Figure 27, lanes 7 and 8). The infectivity of the CrERVmut was confirmed on HEK293T 
cells (Figure 27, lanes 5 and 6). However, no viral DNA was detected when the CrERVmut 
virus was used to infect deer OHK cells (Figure 27, lanes 1 and 2). We therefore 
proposed the existence of a replication block in deer cells, occuring at a receptor level or 
a block occuring at an early stage of the retrovirus infection (virus uncoating or start of 
reverse transcription) blocking the efficient production of virus DNA. To analyze the 
capacity of CrERV to elicit a receptor interference, HEK293T cells were infected with 
wild-type exogenous CrERV and subsequently infected with CrERVmut. The cells 
chronically infected with wild type CrERV had close to one copy per cellular genome 
equivalent and presumably all expressed the virus envelope with the potential to block 
cellular receptors used for virus entry. The wild-type CrERV infected HEK293T cells did 
not exhibit production of CrERVmut virus DNA (Figure 27, lanes 3 and 4), in contrast with 
naive HEK293T cells. This is consistent with receptor interference being the cause of the 





Figure 27: Construction of a CrERV molecular clone and its mutated form in order to distinguish 
endogenous and introduced copies of CrERV (A). CrERV-mut was used to infect deer OHK cells 
(lane 1), HEK 293 T cells (lane 5) and HEK 293 T cells chronically infected with CrERV-IND (lane 3). 
Heat-inactivated (h.i.) virus was used in each case as a negative control to exclude virus DNA 
contamination (lanes 2, 4, and 6). Cells were harvested 20 h after infection and cellular lysates 
were prepared as described in Methods. CrERV-mut (lane 7) and CrERV-IND (lane 8) plasmid DNA 
was used as a control for speci fi city of PCR amplification. The upper panel shows PCR products 
generated with primers mut-fw and mut-rv, which detect speci fi cally the CrERVmut DNA. The 
lower panel shows PCR products generated with primers WT-fw and WT-rv. These primers 
amplify the “ wild-type ” variants of CrERV, i.e. the endogenous CrERVs in deer cells (lanes 1 and 
2), and CrERV-IND in chronically infected 293 T cells (lanes 3 and 4). The experiments were 
performed twice with identical results; one representative experiment is displayed. M, molecular 
size marker; NTC, non-template control. (B). 
 
The cellular receptor for CrERV is not known and the possibility that it might be 
mutated in deer remains unresolved. The mutation of CrERV receptor in mule deer 
might be an alternative explanation for the xenotropic behaviour of CrERV. Mutations of 
ERV receptors have been described in endogenous ALVs and MLVs (Barnard, Elleder, & 
Young, 2006; Kozak, 2014). The treatment of the cells with tunicamycin (inhibitor of N-
linked glycosylation) has been shown to deglycosylate the cellular receptors or virus Env 
and thus enable the retrovirus entry by overcoming the receptor block (Koo, 
Parthasarathi, Ron, & Dougherty, 1994; Miller & Miller, 1992). However, tunicamycin 
treatment of both, deer and chronically infected cells did not rescue the cells 
susceptibility to virus infection (data not shown).  
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More variants of CrERV envelope genes may exist, utilizing different receptors 
and hence can overcome the interference blocks (Mary Poss, personal communication). 
This mechanism was described in FeLV and KoRV (Overbaugh et al., 2001; Xu, Gorman, 
Santiago, Kluska, & Eiden, 2015). More complex mechanisms were described for PERV, 
where disruption of a highly conserved PHQ motif in the N-terminus of Env enables 
transactivation of such viruses by unrelated gammaretroviral envelopes (Lavillette & 
Kabat, 2004). The PERVs with disrupted PHQ motif gain the ability to infect cells that lack 
the cognate PERV receptors and also to overcome restrictions caused by receptor 
interference. This property was suggested to provide novel opportunities to infect germ 
cells (Lavillette & Kabat, 2004). Interestingly, we observe a tendency toward disruption 
of the PHQ motif in the evolutionarily young CrERVs (data not shown).  
Besides the phylogenetic analyzes of the CrERV induced by cocultivation, we 
performed further phylogenetic analyzes using a broad collection of gammaretroviral 
sequences. The accession numbers of the sequences are listed in the legend of the 
Figure 28. The ProtTest analysis of pol sequences of various retroviruses suggests that 
the closest endogenous retrovirus among the vertebrate endogenous retrovirus 
reservoir is an endogenous retrovirus in Greater horseshoe bat (Rhinolophus 
ferrumequinum). This result supports the notion that mammalian gammaretroviruses 
originated in bats (Cui et al., 2012). However, we did not include poorly characterized 
OERV (Ovine endogenous retrovirus) (Klymiuk, Muller, Brem, & Aigner, 2003) in this 
analysis, which could be evolutionary closer to CrERV than the aforementioned RfRV 




Figure 28: CrERV position in Gammaretrovirus phylogeny: Pol sequences were used for 
calculating the best fit tree to depict the protein evolution by algorithm used in Prot Test 
analysis; numbers displayed at nodes are the predicted age estimates calculated in ProtTest 
analysis; the accession numbers of the sequences used for the construction of the tree are: 
BaEV_BAA89659.1 (Baboon endogenous virus), FeLV_NP_955577.1 (Feline leukemia virus), F-
MuLV_NP_040333.1 (Friend murine leukemia virus), GaLV_NP_056790 (Gibbon ape leukemia 
virus), KoRV_BAM67146.1 (Koala retrovirus), McERV_AGP25480.1 (Mus caroli endogenous 
retrovirus), MDEV_AAC31805.1 (Mus dunni endogenous virus), MIRV_AFM52260.1 (Megaderma 
lyra retrovirus), M-MuLV_NP_057933.1 (Moloney murine leukemia virus), PERV-A_AAM29192.1 
(Porcine endogenous retrovirus A), PERV-B_AAM29194.1 (Porcine endogenous retrovirus B), 
PERV-C_CAC39617.1 (Porcine endogenous retrovirus C), RaLV_AAC78249.1 (Rat leukemia virus), 
REV_YP_223871.1 (Reticuloendotheliosis virus), RfRV_AFA52559.1 (Rhinolophus ferrumequinum 
retrovirus), RIRV_AFM52262.1 (Rousettus leschenaultii retrovirus), R-MuLV_NP_044738.1 
(Rauscher murine leukemia virus), WMSV_YP_001165470.1 (Woolly monkey sarcoma virus), 
DIAV_AGV92859.1 (Duck infectious anemia virus), Echidna_ERV_AGV92856.1, 
Galidia_ERV_AGV92853.1, CrERV_AKA58521.1 (Cervid endogenous retrovirus). 
 
4.2.1 Screening for CrERV polymorphism by pattern PCR 
PCR between CrERV LTR and ubiquitous ungulate genomic SINE repeat was 
previously shown to yield pattern of bands, each corresponding to individual CrERV 
integration site (see Figure 29). This simple PCR-based assay can be used to screen for 
the presence of retrovirus integration site polymorphism, without the need to perform 




Figure 29: Strategy for determining the CrERV integration sites using primers targeting the 
abundant BovTA repeat and proviral LTR (left). Pattern PCR using these primers on various mule 
deer genomic samples (results of the further PCRs designed to amplify individual CrERV 
integrations are depicted in (Elleder et al., 2012). 
 
By using the primers designed to amplify the BovTa repeat abundantly present in 
the Cervidae genomes, we tried to perform the pattern PCR to show the integration 
polymorphism of CrERV in other deer species (see Figure 30).  
Figure 30: Pattern PCR from various Cervidae species. First lane is the molecular weight marker, 
next three lanes are various mule deer genomic samples and following three are various elk 
(Cervus canadensis) genomic samples (left ELFO). The right ELFO depicts the result of pattern PCR 
from various 15 red deer (Cervus elaphus) genomic samples (G1-15) and a genomic sample (G16) 
from European roe deer (Capreolus capreolus). 
 
 The pattern PCR assay performed did not distinguish between individual animals. 
However, the patterns of integration differs between species, indicating that BovTA 
repeat and CrERV were not present in the same loci in the common ancestor of the 
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analyzed Cervidae species. According to our current data, CrERV is present in all cervid 
species, however the extensive insetional polymorphism and continuing recent 
endogenization was only detected in the Odocoileus genus (mule deer and white-tailed 
deer (Elleder et al., 2012)) 
4.2.2 Further studies of CrERV tropism 
 As stated previously and in the presented work (Fabryova et al., 2015), CrERV 
exhibits xenotropic behavior. This finding is in contrast with the fact that CrERV is very 
efficient in creating new germ line copies, hence the high polymorphism among mule 
deer populations (Elleder et al., 2012). We tried to further characterize the replication 
blocks in CrERV infection, with emphasis on receptor-mediated stage of infection, using 
retroviral pseudotypes of CrERV and amphotropic MLV. We performed a marker rescue 
assay on permanently transfected human cells with CrERV using the VSV-G envelope 
(see the chapter 4.2.2.3 Marker rescue assays). The fact that titers of CrERV are 
extremely low caused large technical problems in reproducibility and conclusiveness of 
our results. Therefore, the results if this section are of preliminary nature and this topic 
is still actively persued in our laboratory. 
 
Figure 31: Infectivity of the amphotropic virus tested versus the infectivity of CrERV. Amphotropic 
virus infects both, the cells of the host as well as cells of other species, whereas xenotropic virus is 
not able to infect the cells obtained from the original host. The pictures of GFP positive cells are 
illustrative. 
 
4.2.2.1 Retrovirus envelope pseudotypes 
 As mentioned above, in the experiments producing pseudotypes we struggled 
with a low titer of infectious particles produced. Some of the experimental results were 
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obtained by using flow cytometry, but due to low percentage of GFP-positive cells, the 
results could be biased by ambiguous setting of the threshold values.  
 Viral envelope-expressing constructs bearing a FLAG tag were also prepared to 
enable detection of particles by Western blot, and to check for levels of env expression 
and particle incorporation. Due to the very low env expression, the Western blots were 
not amenable to quantify the signals obtained. However, these vectors were proven to 
infect the cells more effectively than wild-type CrERV Env.  
After many failed attempts to detect the percentage of GFP-positive cells using 
flow cytometry, we tried to observe the foci of green cells under fluorescent microscope 
3 dpi. The first three infections were performed in weekly period on a 100 mm tissue 
culture dish yielding the following results: 
Experiment 1: The cells were infected with AmphoenvFLAG construct, CrERVenvFLAG 
construct produced by transfection of HEK293T cells by according plasmids. For the 
reference about the experiment set up see Table 9. Transfection of sole gag-pol 
construct was was used as negative control in infectivity. The infection with construct 
with AmphoenvFLAG yielded 24 GFP-positive foci and construct with CrERVenvFLAG 
yielded 20 foci after infection of HEK293T cells. 
Experiment 2: This experiment was a replication of the Experiment 1. Transfection of 
sole gag-pol construct was inefficient; the infection with construct with AmphoenvFLAG 
yielded 48 foci and construct with CrERVenvFLAG yielded 15 foci after infection of 
HEK293T cells. 
Experiment 3: The aim of this experiment was to repeat Experiments 1 and 2 and try to 
increase the number of yielded GFP-positive cells by using RetroNectin. The infection of 
sole gag-pol construct yielded no GFP positive cells; the infection with construct with 
AmphoenvFLAG yielded 75 foci and construct with CrERVenvFLAG yielded 5 foci after 
infection of HEK293T cells. We tried to enhance the effectivity of infection using 
RetroNectin (see the chapter 3.2.8 Infection for reference about the mechanism of 





Figure 32: RetroNectin treatment of the tissue culture plates increases the number of infected 
cells by an amphotropic virus. The results of FACS analysis of infection without the use of 
RetroNectin (left) and with RetroNectin (right) indicate the more than two fold increase. 
  
We examined the potential of elevating the number of infected cells by using 
RetroNectin using medium from the cells stably producing a virus with amphotropic 
properties. The usage of RetroNectin elevated the number of infected cells more than 
two-fold (see Figure 32 for reference).  
Experiment 4: The RetroNectin-coated 6-well plates with 4 ml of produced virus spun on 
them were used. Cells HEK293T were seeded in 10% confluence and green foci were 
counted 3 dpi. The usage of RetroNectin did not significantly increase the number of 
GFP-positive cells after infection with a construct with an amphotropic Env. However, it 
was shown to increase the number of GFP-positive cells afer infection with a construct 
CrERVenvFLAG (see Table 10). 
Table 10: Increasing the virus infectivity on HEK 293T cells by coating the dishes with RetroNectin. 
The numbers represent the number of GFP-positive cell foci on the analyzed dishes. 




4ml of virus per 
well 
With RetroNectin 
2ml of virus per 
well 
With RetroNectin 
Gag-pol only 0 0 0 
AmphoenvFLAG 8 11 10 




Experiment 5: Juxtaposition of infectivity of the pseudotyped virus on HEK293T cells and 
and HEK293T cells bearing a copy of CrERV (denoted Cr5). The number of cell foci is 
counted on day 3 and on the day 4 (depicted as number of foci at day3/ number of foci 
at day4). What came as a surprise in this experiment was the fact, that Cr5 cells did not 
exhibit a decreased sensitivity to a pseudotype with a CrERVenv compared to HEK293T 
cells. This result was never replicated. 
Table 11: Juxtaposition of infectivity of the pseudotyped virus on HEK293T cells and and HEK293T 
cells bearing a copy of CrERV (denoted Cr5). The number of cell foci is counted on day 3 and on 
the day 4 (depicted as number of foci at day3/ number of foci at day4). 
Construct Cr5 HEK293T 
Gagpol only ND 0/0 
CrERVenvFLAG 7/9 4/9 
AmphoenvFLAG 9/10 59/uncountable 
 
Experiment 6: Juxtaposition of infectivity of the pseudotyped virus on HEK293T cells and 
and HEK293T cells bearing a copy of CrERV (denoted Cr5). RetroNectin was used this 
time, but cells were seeded at a low confluence (15,000 cells/well in 6 well plate). The 
number of foci was counted 7 dpi. Due to the result from the previous experiment, we 
infected Cr5 cells also with the medium from C10 cells (HEK293T cells producing CrERV 
and transfected with a plasmid with GFP). The Cr5 cells were shown not to be 
susceptible to either, infection by CrERVenvFLAG pseudotype nor C10 supernatant (see 
Table 12). 
Table 12: Comparison of HEK293T cells susceptibility and HEK293T cell line chronically infected 
with CrERV construct 
Infected by Cr5 cell line HEK293T 
C10 supernatant 0 17 
CrERVenvFLAG 0 2 
AmphoenvFLAG 12 2 
 
Experiment 7: The previous experiments were repeated. This time the flow cytometry 
analysis to estimate the percentage of GFP positive cells was used. Due to low 
percentage of GFP-positive cells, the results could be biased by ambiguous setting of the 
threshold values. All of the cells infected with the medium from cells transfected only 
with gag-pol and pLG plasmid (to control possible contamination with GFP-positive cells 
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from the transfected cells) examined by eye were considered negative. However, these 
measurements indicate that HEK293T cells are infected by constructs with 
CrERVenvFLAG approximately ten times more effectively than Cr5 cells (see Table 13).  
Table 13: Percentage of GFP positive cells after infection 
Construct HEK293T Cr5 




0.002 0.0026 0.0064 0.0016 
CrERVenvFLAG 0.05 0.035 0.0016 0.0037 
AmphoenvFLAG 0.033 0.017 0.014 0.014 
 
Experiment 8: After obtaining cells from two different cervid species, we infected them 
with our pseudotype constructs. We used 10 cm plates and infected the cells with 12 ml 
of the prepared construct. The foci were counted 7 dpi. Cells were fixed (see chapter 
3.2.12 Cell fixation for DAPI staining) and the pictures were taken using fluorescent 
microscope (see Table 14). 
Table 14: Infecting deer species and human cells with various viral constructs 
Cells infected Gag-pol  CrERVenvFLAG Ampho 
RED DEER 0 0 1 
FALLOW DEER 0 0 0 
OHK 0 0 3 
HEK 293T 0 0 10 
 
 This result indicate that the replication block is not present only in mule deer 
cells (OHK) but presumably also in cells obtained from other Cervidae species (see Table 
14). Cells from Cervidae species were proven to be less sensitive to infection by both 




Figure 33: Outcome of the pseudotyping experiment 8. The cells photographed in bright field are 
displayed in the upper rows, the capture of the GFP positive cells is displayed in the lower rows.  
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Despite the fact that we repeatedly confirmed that the constructs with MLV envelope 
are able to infect mule deer, red deer, and fallow deer cells whereas the constructs with 
CrERV envelope are not, we always detected only a small number of GFP-positive cells in 
the experiment set up with the susceptible cells. HEK293T cells were generally shown to 
be more susceptible to infection. After repeated attempts and only minor success in 
elevating the percentage of GFP-positive cells to enable us to provide more rigid data, 
we started using the marker rescue assays as an alternative approach.  
4.2.2.2 Increasing the effectivity of the CrERV by removing the cytoplasmic 
domain of the env  
In order to increase the effectivity of the infection, we constructed a plasmid 
with env lacking the cytoplasmic domain (aforementioned envnT in methods). This 
approach was proven to enhance the effectivity of the infection in SIV (Kuwata, Kaori, 
Enomoto, Yoshimura, & Matsushita, 2013), HIV (Ye et al., 2004), and enhance specifity in 
immunoblotting assay in HTLV1 and HTLV2 detection (Varma et al., 1995). However, we 
were not successful in elevating the efficiency of the infection sufficiently to enhance 
the quality of the outcomes of the pseudotyping experiments.  
4.2.2.3 Marker rescue assays 
 For the first experiment with marker rescue assay, 2 ml of fresh C10 cells medium 
was used for infection or 1 ml of medium of CrERV positive cells transfected with VSV 
envelope. Three days after infection, cells were fixed and stained with DAPI to yield 
highly fluorescent nuclei and no detectable cytoplasmic fluorescence. After two weeks, 
PERT assay was performed to estimate the RT activity in the medium.  
 After infecting Cervidae cells with medium from CrERV positive cells, no GFP 
signal was detected under fluorescent microscope (data not shown) contrary to infecting 
HEK293T cells. After infecting both Cervidae and human cells with medium from CrERV 
positive cells transfected with VSV-G envelope GFP signal was observed (see Figure 35). 
The medium from cells cotransfected with GFP plasmid, MLV gag-pol and VSV-G env was 
used as a control. However, the cotransfection did not produce replication competent 
virus, so no reverse transcriptase activity was detected in the medium two weeks post 




Figure 34: PERT assay after two weeks post infection with CrERV rescued VSV env. The 
experiments were performed in a technical duplicates and tetraplicates. The numbers on the y 
axis represent the relative RT activity. The individual columns (from left, duplicates) represent 
uninfected mule deer cells, uninfected red deer cells, uninfected fallow deer cells, uninfected 
HEK293T cells. The mule deer cells infected with medium from C10 cells (tetraplicate), the mule 
deer cells infected with medium from C10 cells transfected with VSV envelope (tetraplicate), with 
medium from C10 cells (tetraplicate), with construct with MLV gag and pol and VSV env unable 
to replicate itself (tetraplicate). The red deer cells and fallow deer cells were infected in 
duplicates in the same fashion. The HEK293T cells were infected in the same manner as mule 
deer cells in tetraplicates.  
  
The marker rescue is an alternative approach to pseudotype experiments. The 
infection by a medium from C10 cells transfected with a VSV-G plasmid yields GFP-
positive cells. The medium from HEK293T cells co-transfected with an MLV gag-pol 
plasmid, VSV env and a plasmid with a GFP signal yields a number of GFP positive cells 




Figure 35: The marker rescue experiment - 3 days post infection. Cells used for infection are listed 
next to the row, the virus construct strategy is denoted above the pictures. The outcomes of 
infection by C10 medium are not displayed for fallow deer, red deer, and mule deer cells for they 
were all negative.  
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4.2.2.4 Late block of CrERV infection 
 Based on the previous results, we concluded that a late block of replication might 
be present in CrERV infection of deer cells. We therefore transfected the cells using Cell 
Line Nucleofector Kit (LONZA, Switzerland), and thus made sure that virus is delivered 
directly to the nucleus. RT activity in the medium using PERT assay was measured after 
transfection, three days post transfection, six days post transfection, and seventeen 
days post transfection. However, we detected RT activity only in the medium of 
HEK293T cells after transfection and not in the mule deer, fallow deer and red deer cells. 
Three days post transfection we did not detect the RT activity even in the medium of 
HEK293T cells. Six and seventeen days post transfection all of the transfected cells (or 
rather the medium in which they were cultivated) remained negative.  




4.2.3 Host restriction factor assembly and analysis 
4.2.3.1 APOBEC 
 
Figure 36: The Neighbor joining tree using Muscle alignment of APOBECs available in NCBI 
nucleotide database (accession numbers displayed in the tree) and APOBECs, AIDs, and ADARs 
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listed in (Conticello, Thomas, Petersen-Mahrt, & Neuberger, 2005). Mule deer APOBEC assembled 
from NGS data is highlighted in blue.  
 
 We attempted to assemble APOBEC3 gene using the mule deer NGS data. 
However, the data available yielded low coverage in some areas of the gene. Because 
APOBEC isoforms are poorly described in Cervidae species (see Figure 36) we were 
unable to neither determine nor assemble precisely one particular isoform of the 
APOBEC. Hence, we were unable to perform analysis of positive selection for it would be 
greatly biased.  
4.2.3.2 SAMHD1 
 
Figure 37 The Neighbor joining tree using Muscle alignment of SAMHD1s available in NCBI 
nucleotide database (accession numbers displayed in the tree) and SAMHD1 sequences 
assembled in CLC Workbench (denoted as asmbl). 
 
 We assembled SAMHD1 in the mule deer using SRA data from lymph nodes. 
SAMHD1 was assembled in additional species, being sika deer (Cervus nippon), 
Przewalski’s horse (Equus przewalski), and European roe deer (Capreolus capreolus). We 
constructed a phylogenetic tree using SAMHD1 sequences avaliable at NCBI. The 
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obtained sequences cluster with related species with high bootstrap supports (shown at 
the nodes in Figure 37). 
4.2.3.2.1 Branch-site REL (random effects likelihood) analysis 
 
Figure 38: Branch site REL analysis of the SAMHD1 gene. The accession numbers of the used 
sequences are depicted in the branches. Sika, Equus przewalski, mule deer, and Capreolus are de 
novo assembled sequences of the sika deer (Cervus Nippon), Przewalski’s horse (Equus 
przewalski), mule deer (Odocoileus hemionus), and European roe deer (Capreolus capreolus). 
 
 The obtained sequences were analyzed in respect to possible presence of their 
positive selection. The results are depicted in the Figure 38. The thickness of the 
horizontal lines represent p-values calculated for each branches, the thickness of vertical 
lines depicts the p-value calculated for the nodes. The thick line depicts the p-value of 
less than 0,05. The length of the branch displays the number of nucleotide changes 
compared to the neighbor sequences. The hue of each color indicates strength of 
selection, with primary red corresponding to dN/dS >5, primary blue to dN/dS = 0 and 
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grey to dN/dS = 1. The width of each color component represents the proportion of sites 
in the corresponding class (Kosakovsky Pond et al., 2011). 
Hence we can state the most SAMHD1 nucleotide sites of mule deer is under 
neutral selection based on the dN/dS calculation with significant p-value calculated for 
the analyzed branch. However, some nucleotides under positive selection (dN/dS >5) are 
present, but they are low in number and their presence is not eligible from the 




4.3 Analysis of the infection block in CHOK1 cells 
Mounting evidence supports the concept of products (or secreted products) of 
some endogenous retroviruses blocking infection by particular exogenous retroviruses 
(Malfavon-Borja & Feschotte, 2015). CHOK1 cells are not susceptible to infection by 
exogenous retrovirus with an amphotropic envelope. Introduction of human 
amphotropic or mouse ecotropic retrovirus receptor or tunicamycin treatment of the 
cells was shown to rescue the aforementioned susceptibility. However, at the time of 
these findings, current methods were not available and the exact mechanism of the 
resistance was not explained. The sequence of the CHOK1 genome (Lewis et al., 2013) as 
well as availability of the proteome (Baycin-Hizal et al., 2012) became accessible only 
recently and the cells are still being characterized from various aspects (Hefzi et al., 
2016). 
We were successful in rescuing the CHOK1 susceptibility to amphotropic MLV 
vector by tunicamycin treatment (see Table 15), which is probably modifying the cell 
receptor properties. Importantly, previous reports indicate inhibitory effect of the 
medium conditioned by CHOK1 cells and detect the presence of secreted inhibitors of 
retrovirus infection of protein nature. This protein was proven not be an interferon by 
replicating the infectivity experiments on CHOK1 deficient in the interferon production 
(Miller & Miller, 1992). The inhibitory agent is presumed to be a protein secreted by 
hamster cell lines; it is also present in the Syrian hamster (Mesocricetus auratus) and 
Chinese hamster (Cricetulus griseus) serum. Mutation in the glycosylation pathway was 





Table 15: Reproduction of the infectivity experiment using CHOK1 cells performed by (Miller & 
Miller, 1992, 1993). The conditioned medium column depicts the addition (+) or absence (-) of the 
medium in which CHO cells were grown for 24 hours. This medium contains the studied secreted 
inhibitors (Miller & Miller, 1992). For details about the infections see the chapter 3.3 Methods 
related to the CHOK1 cells project. 
Tunicamycin 
treatment 
Conditioned medium RetroNectin 
 
GFP positive cells (%) 
3 d.p.i. 
+ - - 1.76 
+ - + 0.016 
+ + - 0.012 
+ + + 0 
+ + (without serum) - 0.42 
- - - 0.057 
- - + 0.01 
  
As previously displayed (see Figure 32) the usage of RetroNectin elevated the number of 
infected cells more than two-fold. However, RetroNectin did not increase the number of 
the infected cells in this experimental setup (Table 15), possibly due to the fact that it 
might interfere with the deglycosylation of the receptors mediated by Tunicamycin. We 
also tested the inhibitory activity of the conditioned medium without serum; the use of 
serum-free medium is necessary for our planned mass spectrometry analysis. The 
presence of the serum was shown not to interfere with the block to virus infection (see 
Table 15, lane 5). However, depletion of the serum decreased the inhibitory activity of 
the conditioned medium to some extent. This might be due to the fact that the cultured 
cells were deficient for some nutrients for 24 hours, which might lead to the decreased 
secretion of the inhibitory proteins into the medium. 
After replicating the previously reported experiments, we concentrated and 
fractionated the conditioned medium by gel filtration. Thirty-two fractions of the 
medium were harvested. The secreted inhibitors were reported to have molecular 
weight between 10-50 kDa (Miller & Miller, 1992). These expected molecular weights 
were supposed to be present in fractions 9 – 22. The fractions 1-8 presumably contained 
the proteins larger than 70 kDa. The concentration of the proteins was checked by SDS-




Figure 39: SDS-PAGE analysis of the CHOK1 conditioned medium. The largest band probably 
represents the leftover BSA (66 kDa) present in the medium. This analysis was performed in the 
Laboratory of Structural Biology (BIOCEV). 
 
The inhibitory effect of individual fractions was determined. The major inhibitory 
effect was observed in the fractions 7, 8, and 9 (Figure 40). These fractions were mixed 
and submitted for the mass spectrometry analysis to identify the spectrum of proteins 
present.  
Due to the fact that mass spectrometry analysis does not generally provide data 
for organisms without the existing protein database, the obtained amino acid sequences 
were first used in blast search against a database consisting of retroviral genes and 
CHOK1 proteome. These searches only yielded results with a high background probably 
caused by the carryover serum proteins present in the analyzed medium. We proceeded 
with the search using a personalized database, generated from retroviral envelope 
genes predicted in the CHOK1 genome. Due to their repetitive nature, retroviral gene 
products are generally not annotated in commonly used proteins databases such as 
Uniprot. 
Seven peptides were identified by analysis of the mass spectrometry data using 
the CHOK1 endogenous retrovirus database. Importantly, two of the peptides were 
scored as high confidence hits (NW_003617793.1_49834_49998 and 
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NW_003614069.1_559612_559788). Each of the identified proteins was present only on 
one peptide, which might be caused by the short sequences provided in the database. 
 Analysis of protein sequences of these two hits showed that they originate from 
gammaretrovirus envelopes related to, but not identical, to FeLV. This is consistent with 
the previous hypothesis that the secreted inhibitors are soluble fragments of envelope 
glycoproteins, produced from ERVs in the hamster genome (Miller & Miller, 1992). 
These proteins would have the ability to bind to and saturate the amphotropic receptor 
and cause the infection block. Our results enable us to test specific hamster endogenous 
retrovirus loci for the capability to block the amphotropic MLV infection. These 




Figure 40 (left): Inhibitory effects of 
fractions of CHOK1 medium. The y axis 
depicts the number of GFP-positive foci. 
The assays were performed in duplicates. 
All of the infections were performed using 
the same virus with an amphotropic 
envelope. The fractions were tested in 
three consecutive experiments. The first 
experiment is depicted in red, second in 
light blue and third in dark green. In third 
experiment, half the amount of the virus 
was used compared to the amount used 
in testing the first two experiments. The 
first group of columns depicts the amount 
of foci if CHOK1 cells were infected 
without previous tunicamycin treatment. 
The second group of columns depicts the 
infectivity of the virus on the tunicamycin 
treated cells with fresh medium in the 
culture. The third group of columns 
depicts the infectivity of the of the virus 
on the tunicamycin treated cells with 
conditioned CHOK1 medium in the 
culture. The fourth and fifth group of 
columns depicts the inhibitory effect of 
the 10x concentrated CHOK1 conditioned 
medium; the 10x concentrated medium is 
further 10x diluted in the fourth column 
to check the strenght of the inhibition. All 
of the subsequent groups of columns 
depict the the infectivity of the virus on 
the tunicamycin treated cells with 
particular medium fractions in the 
culture. The GFP-positive foci were always 






5.1 Screening for endogenous retrovirus presence 
 We performed several computational screens in order to find unusual 
endogenous retroviruses in vertebrate genomes. The most compelling cases from these 
screens were further characterized computationally and genetically. 
5.1.1 ELVgv 
 We detected a novel endogenous Lentivirus (ELVgv) in the genome of 
Galeopterus variegatus, a close relative of primates. The outstanding evolutionary age of 
this novel lentiviral lineage (up to 60 MYA) was confirmed with three approaches:  
 Orthologous integrations in extant dermopteran species were present (we 
detected an orthologous endogenous Lentivirus in the only other extant species 
– Cynocephalus volans – in the Dermoptera clade.). 
 Sequence comparison and phylogenetic analysis of three complete ELVgv 
proviruses indicated the estimated age. 
 LTR aging method confirmed the predicted age.  
 Considering this and the fact that endogenous lentiviruses are still rare (only four 
documented cases in mammals up to date), this finding provides new insight on the 
earliest lentiviral evolution and endogenization. 
5.1.2 MINERVa 
We detected remnants of endogenous Deltaretrovirus (MINERVa) in the genome 
of Miniopterus natalensis. This is the first report of an endogenous Deltaretrovirus. In 
addition, it is the first Deltaretrovirus described in the order Chiroptera. We detected 
and sequenced the provirus orthologues in other species of miniopterid bats.  
 The MINERVa provirus is present in the Miniopterus genome only in one (diploid) 
copy. 
 Orthologous MINERVa proviruses were detected in all other miniopterid species 
analyzed and not in species from other bat families.  
 The described provirus contains a large internal deletion, encompassing the pol 
and env genes; however both LTRs are present in the sequence. 
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 Additional ORFs presumably coding for virus accessory genes were detected. 
 The presence of presumed rex accessory gene was further indicated by 
predicting the characteristic RNA secondary structure of Rex Response element 
in the LTR of MINERVa. 
 The predicted protein product of ORF present in the gag gene was not detected 
in the analyzed muscle sample by mass spectrometry. 
5.2 Host-virus relationship of currently endogenizing CrERV 
 We were able to induce the endogenous retrovirus by co-cultivation of mule deer 
cells with susceptible human cells. We sequenced the induced virus and performed 
phylogenetic and sequence analyzes which confirmed that it is closely related to the 
young endogenous CrERV copies present in the deer genome. The induced virus shows 
xenotropic behavior despite the fact that CrERV is described as very effective in creating 
new endogenous copies.  
 The induced CrERV particles sediment in the density gradient regions 
characteristic for retroviruses. 
 The sequence of the induced provirus clusters closely with young ERVs in the 
mule deer genome. 
 Retrovirus pseudotypes and marker rescue experiments indicate the presence of 
a block at the level of receptor-mediated virus entry, which could at least partly 
explain the xenotropic nature of CrERV. However, continuous struggle with low 
virus titers is preventing definitive conclusions to be made. 
 Mule deer, fallow deer, and red deer primary cells all interact with CrERV in the 
similar fashion. 
 Marker rescue experiments indicate the presence of the rescued provirus (GFP 
marker) several days after infection, but PERT assay on these cells indicate that 
the virus is probably inable to propagate in the deer cells. 
 Nucleofection experiments indicate that the block of CrERV infection might also 
occur at the later stages of the infection. 
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 We tried to assemble several retroviral restriction factors from the mule deer 
genome, but currently we were successful only with SAMHD1 because we did 
not possess enough sequence data to assemble other restriction factors reliably. 
 
5.3 Determining the infection block in the CHOK1 cells 
We were successful in replicating the experiments, which lead to conclusion that a 
secreted protein factor produced by CHOK1 cells has an inhibitory effect on infection by 
a virus with amphotropic envelope glycoprotein. The preliminary analyzes of the 
medium fraction with the highest inhibitory activity are in agreement with the 
previously published proposal that the infection block is mediated by the presence of an 
endogenous retrovirus-encoded Env protein. We propose a competitive inhibition 
mediated by the defective product of the env gene of the presumably present 
endogenous retrovirus in the CHOK1 cells genome.  
 We replicated the previously reported experiments rendering the susceptibility 
of CHOK1 cells to the infection by amphotropic retrovirus. 
 We fractionated the proteins present in the medium conditioned by CHOK1 cells. 
The fractions of the conditioned CHOK1 medium containing inhibitory proteins 
with the size predicted in previous studies were tested and proved to be 
inhibitory in infections with amphotropic MLV virus. 
 The mass spectrometry analysis of the fractions inhibiting the infection yielded 
data indicative of the fact that the inhibitory effect is mediated by the presence 
of an endogenous gammaretroviral env gene producing Env protein. The 




6 SIGNIFICANCE OF RESULTS AND FUTURE PROSPECTS 
We discovered the fourth endogenous Lentivirus lineage known up to date, present 
in the genome of Galeopterus variegatus. We showed that this virus lineage constitutes 
currently the oldest known Lentivirus. Based on ancient nature of the virus, structural 
studies of any of the proteins possibly produced by the ELVgv provirus might provide an 
insight into the evolution of viral genes and their products. 
We detected remnants of endogenous Deltaretrovirus in the genome of 
Miniopterus natalensis. Even though the remnants of a provirus were found only in a 
single copy, its orthologues were found among Miniopteridae bats. Deltaretroviruses 
were the last genus of retroviruses lacking in an endogenous form across the sequenced 
genomes, so this finding is filling in the gap of evolutionary evidence. 
We induced an endogenous mammalian gammaretrovirus (CrERV), which is 
presumed to be currently endogenizing in the genome of mule deer. This was the first 
study which aimed to analyze CrERV not only from sequential, but also virological 
perspective. We were partially successful in analyzing its xenotropic behavior. However, 
the results need to be further validated and the behavior presumably compared to other 
well characterized endogenous gammaretroviruses (e.g. PERV). Establishing CrERV as a 
model of mammalian ERV endogenization will enable us to characterize epigenetic 
modifications across a large spectrum of endogenous copies with various evolutionary 
ages (T. Hron et al, manuscript in preparation). 
We detected presence of products of endogenous retroviruses in the culture 
medium from Chinese hamster ovary cells (CHOK1). These products presumably have an 
inhibitory effect on amphotropic retrovirus infection. Further causative studies (using 
CRISPR-Cas technology and ectopic overexpression the inhibitory product of the 
endogenous retrovirus) are needed in order to validate our current data and specify the 
inhibitory ERV elements in the CHOK1 genome. 
It is indeniable that endogenous retroviruses shape the genetic information we bear 
within. For this, I believe that by studying the perplexity of the interactions between 
endogenous retroviruses and their hosts, we would be able to grasp the concept of our 
co-evolution. By understanding the concept and answering some of the questions from 
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the occurring pleiad, we would understand not only the evolution of viruses, but origin 
and development of the other forms of life as well.  
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7 INVOLVEMENT OF THE STUDENT IN THE PUBLICATIONS  
The published papers and a currently reviewed manuscript associated with this thesis 
are in the Supplement of this thesis.  
Publication 1: Endogenous Lentivirus in Malayan colugo (Galeopterus 
variegatus), a close relative of primates 
Shared first authorship 
 Help with the preparation of BLAST database 
 Phylogeny analyzes 
Publication 2: Life History of the Oldest Lentivirus: Characterization of ELVgv 
Integrations in the Dermopteran Genome 
Second author 
 PCR amplification and Sanger sequencing of the provirus sequences 
 PCR amplification and Sanger sequencing of the control loci 
 Participation in phylogenetic analyzes 
Publication 3: Discovery of the first endogenous Deltaretrovirus, in the genome 
of long-fingered bats (Miniopteridae) 
Shared first authorship 
 PCR amplification and Sanger sequencing of the provirus sequences 
 PCR amplification and Sanger sequencing of the control loci 
 Annotation of the sequence 
 Prediction of the secondary structures in LTRs 
Publication 4: Induction and characterization of a replication competent cervid 
endogenous Gammaretrovirus (CrERV) from mule deer cells 
Shared first authorship 
 Maintenance of the co-culture, other cell cultures and virological assays 
 Preparation of the cells for electron microscopy 
 PERT assays 
 Centrifugation methods 
 Western blotting 
 Participation in PCR amplifications and Sanger sequencing 
7.1.1 Prospective publications 
Publication 5: Characterization of xenotropic behavior of CrERV and its later 
replication blocks 
 Pseudotyping experiments 
 Marker rescue experiments 
Publication 6: Elucidation of the block to amphotropic MLV infection in CHOK1  






Aaronson, S. A., Tronick, S. R., & Stephenson, J. R. 1976. Endogenous type C RNA virus of 
Odocoileus hemionus, a mammalian species of New World origin. Cell, 9(3): 489-494. 
Abascal, F., Zardoya, R., & Posada, D. 2005. ProtTest: selection of best-fit models of protein 
evolution. Bioinformatics, 21(9): 2104-2105. 
Abe, M., Fukuma, A., Yoshikawa, R., Miyazawa, T., & Yasuda, J. 2014. Inhibition of 
budding/release of porcine endogenous retrovirus. Microbiol Immunol, 58(8): 432-438. 
Ahn, J. 2016. Functional organization of human SAMHD1 and mechanisms of HIV-1 restriction. 
Biol Chem, 397(4): 373-379. 
Aiewsakun, P., & Katzourakis, A. 2015. Endogenous viruses: Connecting recent and ancient viral 
evolution. Virology, 479-480: 26-37. 
Aiewsakun, P., & Katzourakis, A. 2017. Marine origin of retroviruses in the early Palaeozoic Era. 
Nat Commun, 8: 13954. 
Albritton, L. M., Tseng, L., Scadden, D., & Cunningham, J. M. 1989. A putative murine ecotropic 
retrovirus receptor gene encodes a multiple membrane-spanning protein and confers 
susceptibility to virus infection. Cell, 57(4): 659-666. 
Alfano, N., Michaux, J., Morand, S., Aplin, K., Tsangaras, K., Lober, U., Fabre, P. H., Fitriana, Y., 
Semiadi, G., Ishida, Y., Helgen, K. M., Roca, A. L., Eiden, M. V., & Greenwood, A. D. 2016. 
Endogenous Gibbon Ape Leukemia Virus Identified in a Rodent (Melomys burtoni subsp.) 
from Wallacea (Indonesia). J Virol, 90(18): 8169-8180. 
Anderson, M. M., Lauring, A. S., Burns, C. C., & Overbaugh, J. 2000. Identification of a cellular 
cofactor required for infection by feline leukemia virus. Science, 287(5459): 1828-1830. 
Armezzani, A., Arnaud, F., Caporale, M., di Meo, G., Iannuzzi, L., Murgia, C., & Palmarini, M. 
2011. The signal peptide of a recently integrated endogenous sheep betaretrovirus 
envelope plays a major role in eluding gag-mediated late restriction. J Virol, 85(14): 
7118-7128. 
Arnaud, F., Black, S. G., Murphy, L., Griffiths, D. J., Neil, S. J., Spencer, T. E., & Palmarini, M. 2010. 
Interplay between ovine bone marrow stromal cell antigen 2/tetherin and endogenous 
retroviruses. J Virol, 84(9): 4415-4425. 
Arnaud, F., Caporale, M., Varela, M., Biek, R., Chessa, B., Alberti, A., Golder, M., Mura, M., Zhang, 
Y. P., Yu, L., Pereira, F., Demartini, J. C., Leymaster, K., Spencer, T. E., & Palmarini, M. 
2007a. A paradigm for virus-host coevolution: sequential counter-adaptations between 
endogenous and exogenous retroviruses. PLoS Pathog, 3(11): e170. 
Arnaud, F., Murcia, P. R., & Palmarini, M. 2007b. Mechanisms of late restriction induced by an 
endogenous retrovirus. J Virol, 81(20): 11441-11451. 
Aswad, A., & Katzourakis, A. 2014. The first endogenous herpesvirus, identified in the tarsier 
genome, and novel sequences from primate rhadinoviruses and lymphocryptoviruses. 
PLoS Genet, 10(6): e1004332. 
Avila-Arcos, M. C., Ho, S. Y., Ishida, Y., Nikolaidis, N., Tsangaras, K., Honig, K., Medina, R., 
Rasmussen, M., Fordyce, S. L., Calvignac-Spencer, S., Willerslev, E., Gilbert, M. T., Helgen, 
K. M., Roca, A. L., & Greenwood, A. D. 2013. One hundred twenty years of koala 
retrovirus evolution determined from museum skins. Mol Biol Evol, 30(2): 299-304. 
Bae, E. H., & Jung, Y. T. 2014a. Comparison of the effects of retroviral restriction factors involved 
in resistance to porcine endogenous retrovirus. J Microbiol Biotechnol, 24(4): 577-583. 
Bae, E. H., & Jung, Y. T. 2014b. Tetherins of various species inhibit the release of porcine 
endogenous retrovirus from human cells. Acta Virol, 58(1): 53-60. 
Baltimore, D. 1995. Discovery of the reverse transcriptase. FASEB J, 9(15): 1660-1663. 
123 
 
Ban, J., Portetelle, D., Altaner, C., Horion, B., Milan, D., Krchnak, V., Burny, A., & Kettmann, R. 
1993. Isolation and characterization of a 2.3-kilobase-pair cDNA fragment encoding the 
binding domain of the bovine leukemia virus cell receptor. J Virol, 67(2): 1050-1057. 
Banerji, N., Kapur, V., & Kanjilal, S. 2007. Association of germ-line polymorphisms in the feline 
p53 gene with genetic predisposition to vaccine-associated feline sarcoma. J Hered, 
98(5): 421-427. 
Barbacid, M., Daniel, M. D., & Aaronson, S. A. 1980. Immunological relationships of OMC-1, an 
endogenous virus of owl monkeys, with mammalian and avian type C viruses. J Virol, 
33(1): 561-566. 
Barnard, R. J., Elleder, D., & Young, J. A. 2006. Avian sarcoma and leukosis virus-receptor 
interactions: from classical genetics to novel insights into virus-cell membrane fusion. 
Virology, 344(1): 25-29. 
Bartosch, B., Stefanidis, D., Myers, R., Weiss, R., Patience, C., & Takeuchi, Y. 2004. Evidence and 
consequence of porcine endogenous retrovirus recombination. J Virol, 78(24): 13880-
13890. 
Baycin-Hizal, D., Tabb, D. L., Chaerkady, R., Chen, L., Lewis, N. E., Nagarajan, H., Sarkaria, V., 
Kumar, A., Wolozny, D., Colao, J., Jacobson, E., Tian, Y., O'Meally, R. N., Krag, S. S., Cole, 
R. N., Palsson, B. O., Zhang, H., & Betenbaugh, M. 2012. Proteomic analysis of Chinese 
hamster ovary cells. J Proteome Res, 11(11): 5265-5276. 
Bednarik, D. P., Cook, J. A., & Pitha, P. M. 1990. Inactivation of the HIV LTR by DNA CpG 
methylation: evidence for a role in latency. EMBO J, 9(4): 1157-1164. 
Bibollet-Ruche, F., Bailes, E., Gao, F., Pourrut, X., Barlow, K. L., Clewley, J. P., Mwenda, J. M., 
Langat, D. K., Chege, G. K., McClure, H. M., Mpoudi-Ngole, E., Delaporte, E., Peeters, M., 
Shaw, G. M., Sharp, P. M., & Hahn, B. H. 2004. New simian immunodeficiency virus 
infecting De Brazza's monkeys (Cercopithecus neglectus): evidence for a cercopithecus 
monkey virus clade. J Virol, 78(14): 7748-7762. 
Biek, R., Drummond, A. J., & Poss, M. 2006. A virus reveals population structure and recent 
demographic history of its carnivore host. Science, 311(5760): 538-541. 
Bittner, J. J. 1936. Some Possible Effects of Nursing on the Mammary Gland Tumor Incidence in 
Mice. Science, 84(2172): 162. 
Blazkova, J., Trejbalova, K., Gondois-Rey, F., Halfon, P., Philibert, P., Guiguen, A., Verdin, E., Olive, 
D., Van Lint, C., Hejnar, J., & Hirsch, I. 2009. CpG methylation controls reactivation of HIV 
from latency. PLoS Pathog, 5(8): e1000554. 
Blissenbach, M., Grewe, B., Hoffmann, B., Brandt, S., & Uberla, K. 2010. Nuclear RNA export and 
packaging functions of HIV-1 Rev revisited. J Virol, 84(13): 6598-6604. 
Boid, R., McOrist, S., Jones, T. W., Easterbee, N., Hubbard, A. L., & Jarrett, O. 1991. Isolation of 
FeLV from a wild felid (Felis silvestris). Vet Rec, 128(11): 256. 
Bowser, P. R., Wolfe, M. J., Forney, J. L., & Wooster, G. A. 1988. Seasonal prevalence of skin 
tumors from walleye (Stizostedion vitreum) from Oneida Lake, New York. J Wildl Dis, 
24(2): 292-298. 
Bulli, L., Apolonia, L., Kutzner, J., Pollpeter, D., Goujon, C., Herold, N., Schwarz, S. M., Giernat, Y., 
Keppler, O. T., Malim, M. H., & Schaller, T. 2016. Complex Interplay between HIV-1 
Capsid and MX2-Independent Alpha Interferon-Induced Antiviral Factors. J Virol, 90(16): 
7469-7480. 
Bush, S., & Tebit, D. M. 2015. HIV-1 Group O Origin, Evolution, Pathogenesis, and Treatment: 
Unraveling the Complexity of an Outlier 25 Years Later. AIDS Rev, 17(3): 147-158. 
Campbell, E. M., Weingart, J., Sette, P., Opp, S., Sastri, J., O'Connor, S. K., Talley, S., Diaz-Griffero, 
F., Hirsch, V., & Bouamr, F. 2015. TRIM5alpha-Mediated Ubiquitin Chain Conjugation Is 




Canfield, P. J., Sabine, J. M., & Love, D. N. 1988. Virus particles associated with leukaemia in a 
koala. Aust Vet J, 65(10): 327-328. 
Cohen, C. J., Lock, W. M., & Mager, D. L. 2009. Endogenous retroviral LTRs as promoters for 
human genes: a critical assessment. Gene, 448(2): 105-114. 
Cohen, S., Au, S., & Pante, N. 2011. How viruses access the nucleus. Biochim Biophys Acta, 
1813(9): 1634-1645. 
Conticello, S. G., Thomas, C. J., Petersen-Mahrt, S. K., & Neuberger, M. S. 2005. Evolution of the 
AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases. Mol Biol Evol, 22(2): 
367-377. 
Contreras-Galindo, R., Kaplan, M. H., Contreras-Galindo, A. C., Gonzalez-Hernandez, M. J., 
Ferlenghi, I., Giusti, F., Lorenzo, E., Gitlin, S. D., Dosik, M. H., Yamamura, Y., & Markovitz, 
D. M. 2012. Characterization of human endogenous retroviral elements in the blood of 
HIV-1-infected individuals. J Virol, 86(1): 262-276. 
Cornelis, G., Vernochet, C., Carradec, Q., Souquere, S., Mulot, B., Catzeflis, F., Nilsson, M. A., 
Menzies, B. R., Renfree, M. B., Pierron, G., Zeller, U., Heidmann, O., Dupressoir, A., & 
Heidmann, T. 2015. Retroviral envelope gene captures and syncytin exaptation for 
placentation in marsupials. Proc Natl Acad Sci U S A, 112(5): E487-496. 
Cui, J., & Holmes, E. C. 2012a. Endogenous lentiviruses in the ferret genome. J Virol, 86(6): 3383-
3385. 
Cui, J., & Holmes, E. C. 2012b. Evidence for an endogenous papillomavirus-like element in the 
platypus genome. J Gen Virol, 93(Pt 6): 1362-1366. 
Cui, J., Tachedjian, G., Tachedjian, M., Holmes, E. C., Zhang, S., & Wang, L. F. 2012. Identification 
of diverse groups of endogenous gammaretroviruses in mega- and microbats. J Gen 
Virol, 93(Pt 9): 2037-2045. 
Cui, J., & Wang, L. F. 2015. Genomic Mining Reveals Deep Evolutionary Relationships between 
Bornaviruses and Bats. Viruses, 7(11): 5792-5800. 
Cui, P., Lober, U., Alquezar-Planas, D. E., Ishida, Y., Courtiol, A., Timms, P., Johnson, R. N., Lenz, 
D., Helgen, K. M., Roca, A. L., Hartman, S., & Greenwood, A. D. 2016. Comprehensive 
profiling of retroviral integration sites using target enrichment methods from historical 
koala samples without an assembled reference genome. PeerJ, 4: e1847. 
Cunningham, M. W., Brown, M. A., Shindle, D. B., Terrell, S. P., Hayes, K. A., Ferree, B. C., 
McBride, R. T., Blankenship, E. L., Jansen, D., Citino, S. B., Roelke, M. E., Kiltie, R. A., 
Troyer, J. L., & O'Brien, S. J. 2008. Epizootiology and management of feline leukemia 
virus in the Florida puma. J Wildl Dis, 44(3): 537-552. 
Czernilofsky, A. P., Levinson, A. D., Varmus, H. E., Bishop, J. M., Tischer, E., & Goodman, H. M. 
1980. Nucleotide sequence of an avian sarcoma virus oncogene (src) and proposed 
amino acid sequence for gene product. Nature, 287(5779): 198-203. 
Dalgleish, A. G., Beverley, P. C., Clapham, P. R., Crawford, D. H., Greaves, M. F., & Weiss, R. A. 
1984. The CD4 (T4) antigen is an essential component of the receptor for the AIDS 
retrovirus. Nature, 312(5996): 763-767. 
Davis, H. E., Morgan, J. R., & Yarmush, M. L. 2002. Polybrene increases retrovirus gene transfer 
efficiency by enhancing receptor-independent virus adsorption on target cell 
membranes. Biophys Chem, 97(2-3): 159-172. 
Delport, W., Poon, A. F., Frost, S. D., & Kosakovsky Pond, S. L. 2010. Datamonkey 2010: a suite of 
phylogenetic analysis tools for evolutionary biology. Bioinformatics, 26(19): 2455-2457. 
Denner, J., & Young, P. R. 2013. Koala retroviruses: characterization and impact on the life of 
koalas. Retrovirology, 10: 108. 
Derse, D., Crise, B., Li, Y., Princler, G., Lum, N., Stewart, C., McGrath, C. F., Hughes, S. H., Munroe, 
D. J., & Wu, X. 2007. Human T-cell leukemia virus type 1 integration target sites in the 
human genome: comparison with those of other retroviruses. J Virol, 81(12): 6731-6741. 
125 
 
Dimmic, M. W., Rest, J. S., Mindell, D. P., & Goldstein, R. A. 2002. rtREV: an amino acid 
substitution matrix for inference of retrovirus and reverse transcriptase phylogeny. J 
Mol Evol, 55(1): 65-73. 
Doehle, B. P., Schafer, A., Wiegand, H. L., Bogerd, H. P., & Cullen, B. R. 2005. Differential 
sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by 
virion exclusion. J Virol, 79(13): 8201-8207. 
Donahue, P. R., Quackenbush, S. L., Gallo, M. V., deNoronha, C. M., Overbaugh, J., Hoover, E. A., 
& Mullins, J. I. 1991. Viral genetic determinants of T-cell killing and immunodeficiency 
disease induction by the feline leukemia virus FeLV-FAIDS. J Virol, 65(8): 4461-4469. 
Edgar, R. C. 2004. MUSCLE: multiple sequence alignment with high accuracy and high 
throughput. Nucleic Acids Res, 32(5): 1792-1797. 
Elleder, D., Kim, O., Padhi, A., Bankert, J. G., Simeonov, I., Schuster, S. C., Wittekindt, N. E., 
Motameny, S., & Poss, M. 2012. Polymorphic integrations of an endogenous 
gammaretrovirus in the mule deer genome. J Virol, 86(5): 2787-2796. 
Elleder, D., Pavlicek, A., Paces, J., & Hejnar, J. 2002. Preferential integration of human 
immunodeficiency virus type 1 into genes, cytogenetic R bands and GC-rich DNA regions: 
insight from the human genome sequence. FEBS Lett, 517(1-3): 285-286. 
Elleder, D., Plachy, J., Hejnar, J., Geryk, J., & Svoboda, J. 2004. Close linkage of genes encoding 
receptors for subgroups A and C of avian sarcoma/leucosis virus on chicken 
chromosome 28. Anim Genet, 35(3): 176-181. 
Esnault, C., Heidmann, O., Delebecque, F., Dewannieux, M., Ribet, D., Hance, A. J., Heidmann, T., 
& Schwartz, O. 2005. APOBEC3G cytidine deaminase inhibits retrotransposition of 
endogenous retroviruses. Nature, 433(7024): 430-433. 
Fabryova, H., Hron, T., Kabickova, H., Poss, M., & Elleder, D. 2015. Induction and characterization 
of a replication competent cervid endogenous gammaretrovirus (CrERV) from mule deer 
cells. Virology, 485: 96-103. 
Fadel, H. J., Saenz, D. T., Guevara, R., von Messling, V., Peretz, M., & Poeschla, E. M. 2012. 
Productive replication and evolution of HIV-1 in ferret cells. J Virol, 86(4): 2312-2322. 
Farnet, C. M., & Haseltine, W. A. 1990. Integration of human immunodeficiency virus type 1 DNA 
in vitro. Proc Natl Acad Sci U S A, 87(11): 4164-4168. 
Feschotte, C., & Gilbert, C. 2012. Endogenous viruses: insights into viral evolution and impact on 
host biology. Nat Rev Genet, 13(4): 283-296. 
Frankel, W. N., Stoye, J. P., Taylor, B. A., & Coffin, J. M. 1990. A linkage map of endogenous 
murine leukemia proviruses. Genetics, 124(2): 221-236. 
Genome, K. C. o. S. 2009. Genome 10K: a proposal to obtain whole-genome sequence for 10,000 
vertebrate species. J Hered, 100(6): 659-674. 
Genomes Project, C., Abecasis, G. R., Altshuler, D., Auton, A., Brooks, L. D., Durbin, R. M., Gibbs, 
R. A., Hurles, M. E., & McVean, G. A. 2010. A map of human genome variation from 
population-scale sequencing. Nature, 467(7319): 1061-1073. 
Gifford, R. J., Katzourakis, A., Tristem, M., Pybus, O. G., Winters, M., & Shafer, R. W. 2008. A 
transitional endogenous lentivirus from the genome of a basal primate and implications 
for lentivirus evolution. Proc Natl Acad Sci U S A, 105(51): 20362-20367. 
Gilbert, C., Maxfield, D. G., Goodman, S. M., & Feschotte, C. 2009. Parallel germline infiltration of 
a lentivirus in two Malagasy lemurs. PLoS Genet, 5(3): e1000425. 
Gilbert, C., Meik, J. M., Dashevsky, D., Card, D. C., Castoe, T. A., & Schaack, S. 2014. Endogenous 
hepadnaviruses, bornaviruses and circoviruses in snakes. Proc Biol Sci, 281(1791): 
20141122. 
Gilbert, J. M., Bates, P., Varmus, H. E., & White, J. M. 1994. The receptor for the subgroup A 
avian leukosis-sarcoma viruses binds to subgroup A but not to subgroup C envelope 
glycoprotein. J Virol, 68(9): 5623-5628. 
126 
 
Goldstone, D. C., Yap, M. W., Robertson, L. E., Haire, L. F., Taylor, W. R., Katzourakis, A., Stoye, J. 
P., & Taylor, I. A. 2010. Structural and functional analysis of prehistoric lentiviruses 
uncovers an ancient molecular interface. Cell Host Microbe, 8(3): 248-259. 
Goodrich, D. W., & Duesberg, P. H. 1990. Retroviral recombination during reverse transcription. 
Proc Natl Acad Sci U S A, 87(6): 2052-2056. 
Goto, T., Kennel, S. J., Abe, M., Takishita, M., Kosaka, M., Solomon, A., & Saito, S. 1994. A novel 
membrane antigen selectively expressed on terminally differentiated human B cells. 
Blood, 84(6): 1922-1930. 
Goujon, C., Moncorge, O., Bauby, H., Doyle, T., Ward, C. C., Schaller, T., Hue, S., Barclay, W. S., 
Schulz, R., & Malim, M. H. 2013. Human MX2 is an interferon-induced post-entry 
inhibitor of HIV-1 infection. Nature, 502(7472): 559-562. 
Grewe, B., & Uberla, K. 2010. The human immunodeficiency virus type 1 Rev protein: menage a 
trois during the early phase of the lentiviral replication cycle. J Gen Virol, 91(Pt 8): 1893-
1897. 
Guo, F., Cen, S., Niu, M., Saadatmand, J., & Kleiman, L. 2006. Inhibition of tRNA(3)(Lys)-primed 
reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 
replication. J Virol, 80(23): 11710-11722. 
Han, G. Z., & Worobey, M. 2012. Endogenous lentiviral elements in the weasel family 
(Mustelidae). Mol Biol Evol, 29(10): 2905-2908. 
Han, G. Z., & Worobey, M. 2015. A primitive endogenous lentivirus in a colugo: insights into the 
early evolution of lentiviruses. Mol Biol Evol, 32(1): 211-215. 
Hanger, J. J., Bromham, L. D., McKee, J. J., O'Brien, T. M., & Robinson, W. F. 2000. The nucleotide 
sequence of koala (Phascolarctos cinereus) retrovirus: a novel type C endogenous virus 
related to Gibbon ape leukemia virus. J Virol, 74(9): 4264-4272. 
Hasan, M., & Yan, N. 2014. Safeguard against DNA sensing: the role of TREX1 in HIV-1 infection 
and autoimmune diseases. Frontiers in Microbiology, 5. 
Hayward, A., Grabherr, M., & Jern, P. 2013. Broad-scale phylogenomics provides insights into 
retrovirus-host evolution. Proc Natl Acad Sci U S A, 110(50): 20146-20151. 
Hefzi, H., Ang, K. S., Hanscho, M., Bordbar, A., Ruckerbauer, D., Lakshmanan, M., Orellana, C. A., 
Baycin-Hizal, D., Huang, Y., Ley, D., Martinez, V. S., Kyriakopoulos, S., Jimenez, N. E., 
Zielinski, D. C., Quek, L. E., Wulff, T., Arnsdorf, J., Li, S., Lee, J. S., Paglia, G., Loira, N., 
Spahn, P. N., Pedersen, L. E., Gutierrez, J. M., King, Z. A., Lund, A. M., Nagarajan, H., 
Thomas, A., Abdel-Haleem, A. M., Zanghellini, J., Kildegaard, H. F., Voldborg, B. G., 
Gerdtzen, Z. P., Betenbaugh, M. J., Palsson, B. O., Andersen, M. R., Nielsen, L. K., Borth, 
N., Lee, D. Y., & Lewis, N. E. 2016. A Consensus Genome-scale Reconstruction of Chinese 
Hamster Ovary Cell Metabolism. Cell Syst, 3(5): 434-443 e438. 
Henzy, J. E., Gifford, R. J., Kenaley, C. P., & Johnson, W. E. 2016. An Intact Retroviral Gene 
Conserved in Spiny-Rayed Fishes for over 100 My. Mol Biol Evol. 
Herrmann, A., Happel, A. U., & Gramberg, T. 2016. SAMHD1 in Retroviral Restriction and Innate 
Immune Sensing--Should We Leash the Hound? Curr HIV Res, 14(3): 225-234. 
Hizi, A., & Herzig, E. 2015. dUTPase: the frequently overlooked enzyme encoded by many 
retroviruses. Retrovirology, 12: 70. 
Holmes, R. K., Koning, F. A., Bishop, K. N., & Malim, M. H. 2007. APOBEC3F can inhibit the 
accumulation of HIV-1 reverse transcription products in the absence of hypermutation. 
Comparisons with APOBEC3G. J Biol Chem, 282(4): 2587-2595. 
Holt, M. P., Shevach, E. M., & Punkosdy, G. A. 2013. Endogenous mouse mammary tumor viruses 
(mtv): new roles for an old virus in cancer, infection, and immunity. Front Oncol, 3: 287. 
Horie, M., Honda, T., Suzuki, Y., Kobayashi, Y., Daito, T., Oshida, T., Ikuta, K., Jern, P., Gojobori, T., 
Coffin, J. M., & Tomonaga, K. 2010. Endogenous non-retroviral RNA virus elements in 
mammalian genomes. Nature, 463(7277): 84-87. 
127 
 
Hoss, M., Robins, P., Naven, T. J. P., Pappin, D. J. C., Sgouros, J., & Lindahl, T. 1999. A human DNA 
editing enzyme homologous to the Escherichia coli DnaQ/MutD protein. Embo Journal, 
18(13): 3868-3875. 
Hron, T., Fabryova, H., Paces, J., & Elleder, D. 2014. Endogenous lentivirus in Malayan colugo 
(Galeopterus variegatus), a close relative of primates. Retrovirology, 11: 84. 
Huder, J. B., Boni, J., Hatt, J. M., Soldati, G., Lutz, H., & Schupbach, J. 2002. Identification and 
characterization of two closely related unclassifiable endogenous retroviruses in pythons 
(Python molurus and Python curtus). J Virol, 76(15): 7607-7615. 
Huelsenbeck, J. P., & Ronquist, F. 2001. MRBAYES: Bayesian inference of phylogenetic trees. 
Bioinformatics, 17(8): 754-755. 
Hussain, A., Wesley, C., Khalid, M., Chaudhry, A., & Jameel, S. 2008. Human immunodeficiency 
virus type 1 Vpu protein interacts with CD74 and modulates major histocompatibility 
complex class II presentation. J Virol, 82(2): 893-902. 
Chessa, B., Pereira, F., Arnaud, F., Amorim, A., Goyache, F., Mainland, I., Kao, R. R., Pemberton, J. 
M., Beraldi, D., Stear, M. J., Alberti, A., Pittau, M., Iannuzzi, L., Banabazi, M. H., Kazwala, 
R. R., Zhang, Y. P., Arranz, J. J., Ali, B. A., Wang, Z., Uzun, M., Dione, M. M., Olsaker, I., 
Holm, L. E., Saarma, U., Ahmad, S., Marzanov, N., Eythorsdottir, E., Holland, M. J., 
Ajmone-Marsan, P., Bruford, M. W., Kantanen, J., Spencer, T. E., & Palmarini, M. 2009. 
Revealing the history of sheep domestication using retrovirus integrations. Science, 
324(5926): 532-536. 
Chuong, E. B., Elde, N. C., & Feschotte, C. 2016. Regulatory evolution of innate immunity through 
co-option of endogenous retroviruses. Science, 351(6277): 1083-1087. 
Imakawa, K., Nakagawa, S., & Miyazawa, T. 2015. Baton pass hypothesis: successive 
incorporation of unconserved endogenous retroviral genes for placentation during 
mammalian evolution. Genes Cells, 20(10): 771-788. 
Ishida, Y., Zhao, K., Greenwood, A. D., & Roca, A. L. 2015. Proliferation of endogenous 
retroviruses in the early stages of a host germ line invasion. Mol Biol Evol, 32(1): 109-
120. 
Ito, J., Baba, T., Kawasaki, J., & Nishigaki, K. 2015. Ancestral Mutations Acquired in Refrex-1, a 
Restriction Factor against Feline Retroviruses, during its Cooption and Domestication. J 
Virol, 90(3): 1470-1485. 
Ito, J., Watanabe, S., Hiratsuka, T., Kuse, K., Odahara, Y., Ochi, H., Kawamura, M., & Nishigaki, K. 
2013. Refrex-1, a soluble restriction factor against feline endogenous and exogenous 
retroviruses. J Virol, 87(22): 12029-12040. 
Janecka, J. E., Helgen, K. M., Lim, N. T. L., Baba, M., Izawa, M., & Murphy, W. J. 2008. Evidence 
for multiple species of Sunda colugo. Current Biology, 18(21): R1001-R1002. 
Jarmuz, A., Chester, A., Bayliss, J., Gisbourne, J., Dunham, I., Scott, J., & Navaratnam, N. 2002. An 
anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. 
Genomics, 79(3): 285-296. 
Jha, A. R., Pillai, S. K., York, V. A., Sharp, E. R., Storm, E. C., Wachter, D. J., Martin, J. N., Deeks, S. 
G., Rosenberg, M. G., Nixon, D. F., & Garrison, K. E. 2009. Cross-sectional dating of novel 
haplotypes of HERV-K 113 and HERV-K 115 indicate these proviruses originated in Africa 
before Homo sapiens. Mol Biol Evol, 26(11): 2617-2626. 
Johnson, M., Zaretskaya, I., Raytselis, Y., Merezhuk, Y., McGinnis, S., & Madden, T. L. 2008. NCBI 
BLAST: a better web interface. Nucleic Acids Res, 36(Web Server issue): W5-9. 
Johnson, W. E. 2015. Endogenous Retroviruses in the Genomics Era. Annu Rev Virol, 2(1): 135-
159. 
Johnson, W. E., & Coffin, J. M. 1999. Constructing primate phylogenies from ancient retrovirus 
sequences. Proc Natl Acad Sci U S A, 96(18): 10254-10260. 
128 
 
Jolicoeur, P., & Baltimore, D. 1976. Effect of Fv-1 gene product on proviral DNA formation and 
integration in cells infected with murine leukemia viruses. Proc Natl Acad Sci U S A, 
73(7): 2236-2240. 
Jung, Y. T., Lyu, M. S., Buckler-White, A., & Kozak, C. A. 2002. Characterization of a polytropic 
murine leukemia virus proviral sequence associated with the virus resistance gene Rmcf 
of DBA/2 mice. J Virol, 76(16): 8218-8224. 
Kalter, S. S., Helmke, R. J., Heberling, R. L., Panigel, M., Fowler, A. K., Strickland, J. E., & Hellman, 
A. 1973. Brief communication: C-type particles in normal human placentas. J Natl Cancer 
Inst, 50(4): 1081-1084. 
Kamath, P. L., Elleder, D., Bao, L., Cross, P. C., Powell, J. H., & Poss, M. 2014. The population 
history of endogenous retroviruses in mule deer (Odocoileus hemionus). J Hered, 105(2): 
173-187. 
Kambol, R., Kabat, P., & Tristem, M. 2003. Complete nucleotide sequence of an endogenous 
retrovirus from the amphibian, Xenopus laevis. Virology, 311(1): 1-6. 
Kane, M., Yadav, S. S., Bitzegeio, J., Kutluay, S. B., Zang, T., Wilson, S. J., Schoggins, J. W., Rice, C. 
M., Yamashita, M., Hatziioannou, T., & Bieniasz, P. D. 2013. MX2 is an interferon-induced 
inhibitor of HIV-1 infection. Nature, 502(7472): 563-566. 
Kang, J., Ido, E., Pawling, J., Beutner, U., Huber, B. T., & Hozumi, N. 1994. Expression of Mtv-7 sag 
gene in vivo using a retroviral vector results in selective inactivation of superantigen 
reactive T cells. J Immunol, 152(3): 1039-1046. 
Katzourakis, A., & Gifford, R. J. 2010. Endogenous viral elements in animal genomes. PLoS Genet, 
6(11): e1001191. 
Katzourakis, A., Gifford, R. J., Tristem, M., Gilbert, M. T., & Pybus, O. G. 2009. Macroevolution of 
complex retroviruses. Science, 325(5947): 1512. 
Katzourakis, A., Rambaut, A., & Pybus, O. G. 2005. The evolutionary dynamics of endogenous 
retroviruses. Trends Microbiol, 13(10): 463-468. 
Katzourakis, A., Tristem, M., Pybus, O. G., & Gifford, R. J. 2007. Discovery and analysis of the first 
endogenous lentivirus. Proc Natl Acad Sci U S A, 104(15): 6261-6265. 
Kawakami, T. G., Kollias, G. V., Jr., & Holmberg, C. 1980. Oncogenicity of gibbon type-C 
myelogenous leukemia virus. Int J Cancer, 25(5): 641-646. 
Keckesova, Z., Ylinen, L. M., Towers, G. J., Gifford, R. J., & Katzourakis, A. 2009. Identification of a 
RELIK orthologue in the European hare (Lepus europaeus) reveals a minimum age of 12 
million years for the lagomorph lentiviruses. Virology, 384(1): 7-11. 
Keeble, A. H., Khan, Z., Forster, A., & James, L. C. 2008. TRIM21 is an IgG receptor that is 
structurally, thermodynamically, and kinetically conserved. Proc Natl Acad Sci U S A, 
105(16): 6045-6050. 
Kimsa, M. C., Strzalka-Mrozik, B., Kimsa, M. W., Gola, J., Nicholson, P., Lopata, K., & Mazurek, U. 
2014. Porcine endogenous retroviruses in xenotransplantation--molecular aspects. 
Viruses, 6(5): 2062-2083. 
Kinney, M. E., & Pye, G. W. 2016. Koala Retrovirus: A Review. J Zoo Wildl Med, 47(2): 387-396. 
Klatzmann, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Hercend, T., Gluckman, J. C., 
& Montagnier, L. 1984. T-lymphocyte T4 molecule behaves as the receptor for human 
retrovirus LAV. Nature, 312(5996): 767-768. 
Klucking, S., Adkins, H. B., & Young, J. A. 2002. Resistance to infection by subgroups B, D, and E 
avian sarcoma and leukosis viruses is explained by a premature stop codon within a 
resistance allele of the tvb receptor gene. J Virol, 76(15): 7918-7921. 
Klymiuk, N., Muller, M., Brem, G., & Aigner, B. 2003. Characterization of endogenous 
retroviruses in sheep. J Virol, 77(20): 11268-11273. 
Koepfli, K. P., Paten, B., Genome, K. C. o. S., & O'Brien, S. J. 2015. The Genome 10K Project: a 
way forward. Annu Rev Anim Biosci, 3: 57-111. 
129 
 
Konig, R., Zhou, Y., Elleder, D., Diamond, T. L., Bonamy, G. M., Irelan, J. T., Chiang, C. Y., Tu, B. P., 
De Jesus, P. D., Lilley, C. E., Seidel, S., Opaluch, A. M., Caldwell, J. S., Weitzman, M. D., 
Kuhen, K. L., Bandyopadhyay, S., Ideker, T., Orth, A. P., Miraglia, L. J., Bushman, F. D., 
Young, J. A., & Chanda, S. K. 2008. Global analysis of host-pathogen interactions that 
regulate early-stage HIV-1 replication. Cell, 135(1): 49-60. 
Koo, H. M., Parthasarathi, S., Ron, Y., & Dougherty, J. P. 1994. Pseudotyped REV/SRV retroviruses 
reveal restrictions to infection and host range within members of the same receptor 
interference group. Virology, 205(1): 345-351. 
Kosakovsky Pond, S. L., Murrell, B., Fourment, M., Frost, S. D., Delport, W., & Scheffler, K. 2011. 
A random effects branch-site model for detecting episodic diversifying selection. Mol 
Biol Evol, 28(11): 3033-3043. 
Kozak, C. A. 2014. Origins of the endogenous and infectious laboratory mouse 
gammaretroviruses. Viruses, 7(1): 1-26. 
Kuwata, T., Kaori, T., Enomoto, I., Yoshimura, K., & Matsushita, S. 2013. Increased infectivity in 
human cells and resistance to antibody-mediated neutralization by truncation of the SIV 
gp41 cytoplasmic tail. Front Microbiol, 4: 117. 
Kypr, J., Mrazek, J., & Reich, J. 1989. Nucleotide composition bias and CpG dinucleotide content 
in the genomes of HIV and HTLV 1/2. Biochim Biophys Acta, 1009(3): 280-282. 
Laguette, N., Bregnard, C., Benichou, S., & Basmaciogullari, S. 2010. Human immunodeficiency 
virus (HIV) type-1, HIV-2 and simian immunodeficiency virus Nef proteins. Mol Aspects 
Med, 31(5): 418-433. 
LaPierre, L. A., Holzschu, D. L., Wooster, G. A., Bowser, P. R., & Casey, J. W. 1998. Two closely 
related but distinct retroviruses are associated with walleye discrete epidermal 
hyperplasia. J Virol, 72(4): 3484-3490. 
Lavillette, D., & Kabat, D. 2004. Porcine endogenous retroviruses infect cells lacking cognate 
receptors by an alternative pathway: implications for retrovirus evolution and 
xenotransplantation. J Virol, 78(16): 8868-8877. 
Le Bao, D. E., Raunaq Malhotra , Michael DeGiorgio, Theodora Maravegias, Lindsay Horvath, 
Laura Carrel, Colin Gillin, Tomáš Hron, Helena Fábryová, David R. Hunter, Mary Poss. 
2014. Computational and Statistical Analyzes of Insertional Polymorphic Endogenous 
Retroviruses in a Non-Model Organism. Computation, 2(4): 221-245. 
Lemos de Matos, A., de Sousa-Pereira, P., Lissovsky, A. A., van der Loo, W., Melo-Ferreira, J., Cui, 
J., & Esteves, P. J. 2015. Endogenization of mouse mammary tumor virus (MMTV)-like 
elements in genomes of pikas (Ochotona sp.). Virus Res, 210: 22-26. 
Lerner, D. L., Wagaman, P. C., Phillips, T. R., Prospero-Garcia, O., Henriksen, S. J., Fox, H. S., 
Bloom, F. E., & Elder, J. H. 1995. Increased mutation frequency of feline 
immunodeficiency virus lacking functional deoxyuridine-triphosphatase. Proc Natl Acad 
Sci U S A, 92(16): 7480-7484. 
Lewis, N. E., Liu, X., Li, Y., Nagarajan, H., Yerganian, G., O'Brien, E., Bordbar, A., Roth, A. M., 
Rosenbloom, J., Bian, C., Xie, M., Chen, W., Li, N., Baycin-Hizal, D., Latif, H., Forster, J., 
Betenbaugh, M. J., Famili, I., Xu, X., Wang, J., & Palsson, B. O. 2013. Genomic landscapes 
of Chinese hamster ovary cell lines as revealed by the Cricetulus griseus draft genome. 
Nat Biotechnol, 31(8): 759-765. 
Li, W., Yap, M. W., Voss, V., & Stoye, J. P. 2016. Expression levels of Fv1: effects on retroviral 
restriction specificities. Retrovirology, 13(1): 42. 
Liao, W., Hong, S. H., Chan, B. H., Rudolph, F. B., Clark, S. C., & Chan, L. 1999. APOBEC-2, a 
cardiac- and skeletal muscle-specific member of the cytidine deaminase supergene 
family. Biochem Biophys Res Commun, 260(2): 398-404. 
Lichtenstein, D. L., Rushlow, K. E., Cook, R. F., Raabe, M. L., Swardson, C. J., Kociba, G. J., Issel, C. 
J., & Montelaro, R. C. 1995. Replication in vitro and in vivo of an equine infectious 
anemia virus mutant deficient in dUTPase activity. J Virol, 69(5): 2881-2888. 
130 
 
Liu, Z., Pan, Q., Ding, S., Qian, J., Xu, F., Zhou, J., Cen, S., Guo, F., & Liang, C. 2013. The interferon-
inducible MxB protein inhibits HIV-1 infection. Cell Host Microbe, 14(4): 398-410. 
Lochelt, M., Romen, F., Bastone, P., Muckenfuss, H., Kirchner, N., Kim, Y. B., Truyen, U., Rosler, 
U., Battenberg, M., Saib, A., Flory, E., Cichutek, K., & Munk, C. 2005. The antiretroviral 
activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein. Proc Natl Acad 
Sci U S A, 102(22): 7982-7987. 
Lounkova, A., Draberova, E., Senigl, F., Trejbalova, K., Geryk, J., Hejnar, J., & Svoboda, J. 2014. 
Molecular events accompanying rous sarcoma virus rescue from rodent cells and the 
role of viral gene complementation. J Virol, 88(6): 3505-3515. 
Lovatt, A., Black, J., Galbraith, D., Doherty, I., Moran, M. W., Shepherd, A. J., Griffen, A., Bailey, 
A., Wilson, N., & Smith, K. T. 1999. High throughput detection of retrovirus-associated 
reverse transcriptase using an improved fluorescent product enhanced reverse 
transcriptase assay and its comparison to conventional detection methods. J Virol 
Methods, 82(2): 185-200. 
Macfarlan, T. S., Gifford, W. D., Driscoll, S., Lettieri, K., Rowe, H. M., Bonanomi, D., Firth, A., 
Singer, O., Trono, D., & Pfaff, S. L. 2012. Embryonic stem cell potency fluctuates with 
endogenous retrovirus activity. Nature, 487(7405): 57-63. 
Mackey, L., Jarrett, W., Jarrett, O., & Laird, H. 1975. Anemia associated with feline leukemia virus 
infection in cats. J Natl Cancer Inst, 54(1): 209-217. 
Maddon, P. J., Dalgleish, A. G., McDougal, J. S., Clapham, P. R., Weiss, R. A., & Axel, R. 1986. The 
T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the 
brain. Cell, 47(3): 333-348. 
Makowka, L., Wu, G. D., Hoffman, A., Podesta, L., Sher, L., Tuso, P. J., Breda, M., Chapman, F. A., 
Cosenza, C., Yasunaga, C., & et al. 1994. Immunohistopathologic lesions associated with 
the rejection of a pig-to-human liver xenograft. Transplant Proc, 26(3): 1074-1075. 
Malfavon-Borja, R., & Feschotte, C. 2015. Fighting fire with fire: endogenous retrovirus 
envelopes as restriction factors. J Virol, 89(8): 4047-4050. 
Malicorne, S., Vernochet, C., Cornelis, G., Mulot, B., Delsuc, F., Heidmann, O., Heidmann, T., & 
Dupressoir, A. 2016. Genome-Wide Screening of Retroviral Envelope Genes in the Nine-
Banded Armadillo (Dasypus novemcinctus, Xenarthra) Reveals an Unfixed Chimeric 
Endogenous Betaretrovirus Using the ASCT2 Receptor. J Virol, 90(18): 8132-8149. 
Marino, D., Perkovic, M., Hain, A., Jaguva Vasudevan, A. A., Hofmann, H., Hanschmann, K. M., 
Muhlebach, M. D., Schumann, G. G., Konig, R., Cichutek, K., Haussinger, D., & Munk, C. 
2016. APOBEC4 Enhances the Replication of HIV-1. PLoS One, 11(6): e0155422. 
Marker, L., Munson, L., Basson, P. A., & Quackenbush, S. 2003. Multicentric T-cell lymphoma 
associated with feline leukemia virus infection in a captive namibian cheetah (Acinonyx 
jubatus). J Wildl Dis, 39(3): 690-695. 
Martin, G. S. 2004. The road to Src. Oncogene, 23(48): 7910-7917. 
Mattiuzzo, G., Ivol, S., & Takeuchi, Y. 2010. Regulation of porcine endogenous retrovirus release 
by porcine and human tetherins. J Virol, 84(5): 2618-2622. 
Mattiuzzo, G., & Takeuchi, Y. 2010. Suboptimal porcine endogenous retrovirus infection in non-
human primate cells: implication for preclinical xenotransplantation. PLoS One, 5(10): 
e13203. 
Mattiuzzo, G., Takeuchi, Y., & Scobie, L. 2012. Potential zoonotic infection of porcine 
endogenous retrovirus in xenotransplantation. Methods Mol Biol, 885: 263-279. 
Mbisa, J. L., Barr, R., Thomas, J. A., Vandegraaff, N., Dorweiler, I. J., Svarovskaia, E. S., Brown, W. 
L., Mansky, L. M., Gorelick, R. J., Harris, R. S., Engelman, A., & Pathak, V. K. 2007. Human 
immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit 
defects in plus-strand DNA transfer and integration. J Virol, 81(13): 7099-7110. 
131 
 
McNally, M. M., Wahlin, K. J., & Canto-Soler, M. V. 2010. Endogenous expression of ASLV viral 
proteins in specific pathogen free chicken embryos: relevance for the developmental 
biology research field. BMC Dev Biol, 10: 106. 
Meli, M. L., Cattori, V., Martinez, F., Lopez, G., Vargas, A., Simon, M. A., Zorrilla, I., Munoz, A., 
Palomares, F., Lopez-Bao, J. V., Pastor, J., Tandon, R., Willi, B., Hofmann-Lehmann, R., & 
Lutz, H. 2009. Feline leukemia virus and other pathogens as important threats to the 
survival of the critically endangered Iberian lynx (Lynx pardinus). PLoS One, 4(3): e4744. 
Mertz, J. A., Simper, M. S., Lozano, M. M., Payne, S. M., & Dudley, J. P. 2005. Mouse mammary 
tumor virus encodes a self-regulatory RNA export protein and is a complex retrovirus. J 
Virol, 79(23): 14737-14747. 
Mi, S., Lee, X., Li, X., Veldman, G. M., Finnerty, H., Racie, L., LaVallie, E., Tang, X. Y., Edouard, P., 
Howes, S., Keith, J. C., Jr., & McCoy, J. M. 2000. Syncytin is a captive retroviral envelope 
protein involved in human placental morphogenesis. Nature, 403(6771): 785-789. 
Miller, A. D. 2008. Hyaluronidase 2 and its intriguing role as a cell-entry receptor for oncogenic 
sheep retroviruses. Semin Cancer Biol, 18(4): 296-301. 
Miller, D. G., Edwards, R. H., & Miller, A. D. 1994. Cloning of the cellular receptor for 
amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia 
virus. Proc Natl Acad Sci U S A, 91(1): 78-82. 
Miller, D. G., & Miller, A. D. 1992. Tunicamycin treatment of CHO cells abrogates multiple blocks 
to retrovirus infection, one of which is due to a secreted inhibitor. J Virol, 66(1): 78-84. 
Miller, D. G., & Miller, A. D. 1993. Inhibitors of retrovirus infection are secreted by several 
hamster cell lines and are also present in hamster sera. J Virol, 67(9): 5346-5352. 
Mitchell, R. S., Beitzel, B. F., Schroder, A. R., Shinn, P., Chen, H., Berry, C. C., Ecker, J. R., & 
Bushman, F. D. 2004. Retroviral DNA integration: ASLV, HIV, and MLV show distinct 
target site preferences. PLoS Biol, 2(8): E234. 
Miyazawa, T., Tomonaga, K., Kawaguchi, Y., & Mikami, T. 1994. The genome of feline 
immunodeficiency virus. Arch Virol, 134(3-4): 221-234. 
Mora, M., Napolitano, C., Ortega, R., Poulin, E., & Pizarro-Lucero, J. 2015. Feline 
immunodeficiency virus and feline leukemia virus infection in free-ranging guignas 
(Leopardus guigna) and sympatric domestic cats in human perturbed landscapes on 
Chiloe Island, Chile. J Wildl Dis, 51(1): 199-208. 
Mun, S., Lee, J., Kim, Y. J., Kim, H. S., & Han, K. 2014. Chimpanzee-specific endogenous retrovirus 
generates genomic variations in the chimpanzee genome. PloS One, 9(7): e101195. 
Munson, L., Marker, L., Dubovi, E., Spencer, J. A., Evermann, J. F., & O'Brien, S. J. 2004. 
Serosurvey of viral infections in free-ranging Namibian cheetahs (Acinonyx jubatus). J 
Wildl Dis, 40(1): 23-31. 
Mura, M., Murcia, P., Caporale, M., Spencer, T. E., Nagashima, K., Rein, A., & Palmarini, M. 2004. 
Late viral interference induced by transdominant Gag of an endogenous retrovirus. Proc 
Natl Acad Sci U S A, 101(30): 11117-11122. 
Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y., & Honjo, T. 2000. Class 
switch recombination and hypermutation require activation-induced cytidine deaminase 
(AID), a potential RNA editing enzyme. Cell, 102(5): 553-563. 
Naidenko, S. V., Pavlova, E. V., & Kirilyuk, V. E. 2014. Detection of seasonal weight loss and a 
serologic survey of potential pathogens in wild Pallas' cats (Felis [Otocolobus] manul) of 
the Daurian Steppe, Russia. J Wildl Dis, 50(2): 188-194. 
Narezkina, A., Taganov, K. D., Litwin, S., Stoyanova, R., Hayashi, J., Seeger, C., Skalka, A. M., & 
Katz, R. A. 2004. Genome-wide analyzes of avian sarcoma virus integration sites. J Virol, 
78(21): 11656-11663. 
Nisole, S., Stoye, J. P., & Saib, A. 2005. TRIM family proteins: retroviral restriction and antiviral 
defence. Nat Rev Microbiol, 3(10): 799-808. 
132 
 
Nolen, R. S. 2004. Feline leukemia virus threatens endangered panthers. J Am Vet Med Assoc, 
224(11): 1721-1722. 
O'Hara, B., Johann, S. V., Klinger, H. P., Blair, D. G., Rubinson, H., Dunn, K. J., Sass, P., Vitek, S. M., 
& Robins, T. 1990. Characterization of a human gene conferring sensitivity to infection 
by gibbon ape leukemia virus. Cell Growth Differ, 1(3): 119-127. 
OhAinle, M., Kerns, J. A., Malik, H. S., & Emerman, M. 2006. Adaptive evolution and antiviral 
activity of the conserved mammalian cytidine deaminase APOBEC3H. J Virol, 80(8): 
3853-3862. 
Oliveira, N. M., Farrell, K. B., & Eiden, M. V. 2006. In vitro characterization of a koala retrovirus. J 
Virol, 80(6): 3104-3107. 
Overbaugh, J., Miller, A. D., & Eiden, M. V. 2001. Receptors and entry cofactors for retroviruses 
include single and multiple transmembrane-spanning proteins as well as newly 
described glycophosphatidylinositol-anchored and secreted proteins. Microbiol Mol Biol 
Rev, 65(3): 371-389, table of contents. 
Perez-Caballero, D., Zang, T., Ebrahimi, A., McNatt, M. W., Gregory, D. A., Johnson, M. C., & 
Bieniasz, P. D. 2009. Tetherin inhibits HIV-1 release by directly tethering virions to cells. 
Cell, 139(3): 499-511. 
Pertel, T., Hausmann, S., Morger, D., Zuger, S., Guerra, J., Lascano, J., Reinhard, C., Santoni, F. A., 
Uchil, P. D., Chatel, L., Bisiaux, A., Albert, M. L., Strambio-De-Castillia, C., Mothes, W., 
Pizzato, M., Grutter, M. G., & Luban, J. 2011. TRIM5 is an innate immune sensor for the 
retrovirus capsid lattice. Nature, 472(7343): 361-365. 
Pizzato, M., Erlwein, O., Bonsall, D., Kaye, S., Muir, D., & McClure, M. O. 2009. A one-step SYBR 
Green I-based product-enhanced reverse transcriptase assay for the quantitation of 
retroviruses in cell culture supernatants. J Virol Methods, 156(1-2): 1-7. 
Planelles, V., & Barker, E. 2010. Roles of Vpr and Vpx in modulating the virus-host cell 
relationship. Mol Aspects Med, 31(5): 398-406. 
Poleshko, A., Einarson, M. B., Shalginskikh, N., Zhang, R., Adams, P. D., Skalka, A. M., & Katz, R. A. 
2010. Identification of a functional network of human epigenetic silencing factors. J Biol 
Chem, 285(1): 422-433. 
Powell, R. D., Holland, P. J., Hollis, T., & Perrino, F. W. 2011. Aicardi-Goutieres syndrome gene 
and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide 
triphosphohydrolase. J Biol Chem, 286(51): 43596-43600. 
Priester, W. A., & Mantel, N. 1971. Occurrence of tumors in domestic animals. Data from 12 
United States and Canadian colleges of veterinary medicine. J Natl Cancer Inst, 47(6): 
1333-1344. 
Quackenbush, S. L., Holzschu, D. L., Bowser, P. R., & Casey, J. W. 1997. Transcriptional analysis of 
walleye dermal sarcoma virus (WDSV). Virology, 237(1): 107-112. 
Quigley, J. G., Burns, C. C., Anderson, M. M., Lynch, E. D., Sabo, K. M., Overbaugh, J., & Abkowitz, 
J. L. 2000. Cloning of the cellular receptor for feline leukemia virus subgroup C (FeLV-C), 
a retrovirus that induces red cell aplasia. Blood, 95(3): 1093-1099. 
Rafatpanah, H., Farid, R., Golanbar, G., & Jabbari Azad, F. 2006. HTLV-I Infection: virus structure, 
immune response to the virus and genetic association studies in HTLV-I-infected 
individuals. Iran J Allergy Asthma Immunol, 5(4): 153-166. 
Rasheed, S., & Gardner, M. B. 1981. Isolation of feline leukemia virus from a leopard cat cell line 
and search for retrovirus in wild felidae. J Natl Cancer Inst, 67(4): 929-933. 
Rein, A. 2011. Murine leukemia viruses: objects and organisms. Adv Virol, 2011: 403419. 
Rice, G. I., Rodero, M. P., & Crow, Y. J. 2015. Human Disease Phenotypes Associated With 
Mutations in TREX1. Journal of Clinical Immunology, 35(3): 235-243. 
Richards, S. 2015. It's more than stamp collecting: how genome sequencing can unify biological 
research. Trends Genet, 31(7): 411-421. 
133 
 
Robinson, H. L., Astrin, S. M., Senior, A. M., & Salazar, F. H. 1981. Host Susceptibility to 
endogenous viruses: defective, glycoprotein-expressing proviruses interfere with 
infections. J Virol, 40(3): 745-751. 
Rosenberg, B. R., Hamilton, C. E., Mwangi, M. M., Dewell, S., & Papavasiliou, F. N. 2011. 
Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in 
transcript 3' UTRs. Nat Struct Mol Biol, 18(2): 230-236. 
Rous, P. 1910. A Transmissible Avian Neoplasm. (Sarcoma of the Common Fowl.). J Exp Med, 
12(5): 696-705. 
Rouzine, I. M., Rodrigo, A., & Coffin, J. M. 2001. Transition between stochastic evolution and 
deterministic evolution in the presence of selection: general theory and application to 
virology. Microbiol Mol Biol Rev, 65(1): 151-185. 
Ruboyianes, R., & Worobey, M. 2016. Foamy-like endogenous retroviruses are extensive and 
abundant in teleosts. Virus Evol, 2(2): vew032. 
Sakaguchi, S., Shojima, T., Fukui, D., & Miyazawa, T. 2015. A soluble envelope protein of 
endogenous retrovirus (FeLIX) present in serum of domestic cats mediates infection of a 
pathogenic variant of feline leukemia virus. J Gen Virol, 96(Pt 3): 681-687. 
Santoni, F. A., Guerra, J., & Luban, J. 2012. HERV-H RNA is abundant in human embryonic stem 
cells and a precise marker for pluripotency. Retrovirology, 9: 111. 
Sanz-Ramos, M., & Stoye, J. P. 2013. Capsid-binding retrovirus restriction factors: discovery, 
restriction specificity and implications for the development of novel therapeutics. J Gen 
Virol, 94(Pt 12): 2587-2598. 
Sasada, A., Takaori-Kondo, A., Shirakawa, K., Kobayashi, M., Abudu, A., Hishizawa, M., Imada, K., 
Tanaka, Y., & Uchiyama, T. 2005. APOBEC3G targets human T-cell leukemia virus type 1. 
Retrovirology, 2: 32. 
Sears, J. F., & Khan, A. S. 2003. Single-tube fluorescent product-enhanced reverse transcriptase 
assay with Ampliwax (STF-PERT) for retrovirus quantitation. J Virol Methods, 108(1): 
139-142. 
Shapiro, B., Ho, S. Y., Drummond, A. J., Suchard, M. A., Pybus, O. G., & Rambaut, A. 2011. A 
Bayesian phylogenetic method to estimate unknown sequence ages. Mol Biol Evol, 
28(2): 879-887. 
Sheets, R. L., Pandey, R., Jen, W. C., & Roy-Burman, P. 1993. Recombinant feline leukemia virus 
genes detected in naturally occurring feline lymphosarcomas. J Virol, 67(6): 3118-3125. 
Schneider, I. C., Eckhardt, M., Brynza, J., Collins, M. K., Cichutek, K., & Buchholz, C. J. 2011. 
Escape from R-peptide deletion in a gamma-retrovirus. Virology, 418(2): 85-92. 
Schroder, A. R., Shinn, P., Chen, H., Berry, C., Ecker, J. R., & Bushman, F. 2002. HIV-1 integration 
in the human genome favors active genes and local hotspots. Cell, 110(4): 521-529. 
Simmons, G., Clarke, D., McKee, J., Young, P., & Meers, J. 2014. Discovery of a novel retrovirus 
sequence in an Australian native rodent (Melomys burtoni): a putative link between 
gibbon ape leukemia virus and koala retrovirus. PLoS One, 9(9): e106954. 
SJ, O. B., Haussler, D., & Ryder, O. 2014. The birds of Genome10K. Gigascience, 3(1): 32. 
Skibba, R. 2016. Geneticists hope to unlock secrets of bats' complex sounds. Nature, 539(7630): 
481. 
Slater, G. J., Cui, P., Forasiepi, A. M., Lenz, D., Tsangaras, K., Voirin, B., de Moraes-Barros, N., 
MacPhee, R. D., & Greenwood, A. D. 2016. Evolutionary Relationships among Extinct and 
Extant Sloths: The Evidence of Mitogenomes and Retroviruses. Genome Biol Evol, 8(3): 
607-621. 
Sleeman, J. M., Keane, J. M., Johnson, J. S., Brown, R. J., & Woude, S. V. 2001. Feline leukemia 
virus in a captive bobcat. J Wildl Dis, 37(1): 194-200. 
Smart, J. E., Oppermann, H., Czernilofsky, A. P., Purchio, A. F., Erikson, R. L., & Bishop, J. M. 1981. 
Characterization of sites for tyrosine phosphorylation in the transforming protein of 
134 
 
Rous sarcoma virus (pp60v-src) and its normal cellular homologue (pp60c-src). Proc Natl 
Acad Sci U S A, 78(10): 6013-6017. 
Smith, E. J., Brojatsch, J., Naughton, J., & Young, J. A. 1998. The CAR1 gene encoding a cellular 
receptor specific for subgroup B and D avian leukosis viruses maps to the chicken tvb 
locus. J Virol, 72(4): 3501-3503. 
Smith, M. F., & Patton, J. L. 1991. Variation in mitochondrial cytochrome b sequence in natural 
populations of South American akodontine rodents (Muridae: Sigmodontinae). Mol Biol 
Evol, 8(1): 85-103. 
Soll, S. J., Neil, S. J., & Bieniasz, P. D. 2010. Identification of a receptor for an extinct virus. Proc 
Natl Acad Sci U S A, 107(45): 19496-19501. 
Steckbeck, J. D., Kuhlmann, A. S., & Montelaro, R. C. 2014. Structural and functional comparisons 
of retroviral envelope protein C-terminal domains: still much to learn. Viruses, 6(1): 284-
300. 
Stenglein, M. D., Burns, M. B., Li, M., Lengyel, J., & Harris, R. S. 2010. APOBEC3 proteins mediate 
the clearance of foreign DNA from human cells. Nat Struct Mol Biol, 17(2): 222-229. 
Stewart, A. F. 2002. Identification of human homologues of the mouse mammary tumor virus 
receptor. Arch Virol, 147(3): 577-581. 
Suzuki, Y., Kobayashi, Y., Horie, M., & Tomonaga, K. 2014. Origin of an endogenous bornavirus-
like nucleoprotein element in thirteen-lined ground squirrels. Genes Genet Syst, 89(3): 
143-148. 
Takeda, A., & Matano, T. 2007. Inhibition of infectious murine leukemia virus production by Fv-4 
env gene products exerting dominant negative effect on viral envelope glycoprotein. 
Microbes Infect, 9(14-15): 1590-1596. 
Takeda, E., Nakagawa, S., Nakaya, Y., Tanaka, A., Miyazawa, T., & Yasuda, J. 2012. Identification 
and functional analysis of three isoforms of bovine BST-2. PLoS One, 7(7): e41483. 
Takeuchi, Y., Vile, R. G., Simpson, G., O'Hara, B., Collins, M. K., & Weiss, R. A. 1992. Feline 
leukemia virus subgroup B uses the same cell surface receptor as gibbon ape leukemia 
virus. J Virol, 66(2): 1219-1222. 
Tamura, K., Peterson, D., Peterson, N., Stecher, G., Nei, M., & Kumar, S. 2011. MEGA5: molecular 
evolutionary genetics analysis using maximum likelihood, evolutionary distance, and 
maximum parsimony methods. Mol Biol Evol, 28(10): 2731-2739. 
Tamura, K., Stecher, G., Peterson, D., Filipski, A., & Kumar, S. 2013. MEGA6: Molecular 
Evolutionary Genetics Analysis version 6.0. Mol Biol Evol, 30(12): 2725-2729. 
Tarlinton, R., Meers, J., Hanger, J., & Young, P. 2005. Real-time reverse transcriptase PCR for the 
endogenous koala retrovirus reveals an association between plasma viral load and 
neoplastic disease in koalas. J Gen Virol, 86(Pt 3): 783-787. 
Tarlinton, R. E., Meers, J., & Young, P. R. 2006. Retroviral invasion of the koala genome. Nature, 
442(7098): 79-81. 
Tonjes, R. R., & Niebert, M. 2003. Relative age of proviral porcine endogenous retrovirus 
sequences in Sus scrofa based on the molecular clock hypothesis. J Virol, 77(22): 12363-
12368. 
Tronick, S. R., Golub, M. M., Stephenson, J. R., & Aaronson, S. A. 1977. Distribution and 
expression in mammals of genes ralated to an endogenous type C RNA virus of 
Odocoileus hemionus. J Virol, 23(1): 1-9. 
Tsangaras, K., Mayer, J., Alquezar-Planas, D. E., & Greenwood, A. D. 2015. An Evolutionarily 
Young Polar Bear (Ursus maritimus) Endogenous Retrovirus Identified from Next 
Generation Sequence Data. Viruses, 7(11): 6089-6107. 
Turelli, P., Guiguen, F., Mornex, J. F., Vigne, R., & Querat, G. 1997. dUTPase-minus caprine 
arthritis-encephalitis virus is attenuated for pathogenesis and accumulates G-to-A 
substitutions. J Virol, 71(6): 4522-4530. 
135 
 
van de Lagemaat, L. N., Medstrand, P., & Mager, D. L. 2006. Multiple effects govern endogenous 
retrovirus survival patterns in human gene introns. Genome Biol, 7(9): R86. 
van Zeijl, M., Johann, S. V., Closs, E., Cunningham, J., Eddy, R., Shows, T. B., & O'Hara, B. 1994. A 
human amphotropic retrovirus receptor is a second member of the gibbon ape leukemia 
virus receptor family. Proc Natl Acad Sci U S A, 91(3): 1168-1172. 
Varma, M., Rudolph, D. L., Knuchel, M., Switzer, W. M., Hadlock, K. G., Velligan, M., Chan, L., 
Foung, S. K., & Lal, R. B. 1995. Enhanced specificity of truncated transmembrane protein 
for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-
2 infections by western blot (immunoblot) assay containing recombinant envelope 
glycoproteins. J Clin Microbiol, 33(12): 3239-3244. 
Versteeg, G. A., Benke, S., Garcia-Sastre, A., & Rajsbaum, R. 2014. InTRIMsic immunity: Positive 
and negative regulation of immune signaling by tripartite motif proteins. Cytokine 
Growth Factor Rev, 25(5): 563-576. 
Weiss, R. A. 2006. The discovery of endogenous retroviruses. Retrovirology, 3: 67. 
Wittekindt, N. E., Padhi, A., Schuster, S. C., Qi, J., Zhao, F., Tomsho, L. P., Kasson, L. R., Packard, 
M., Cross, P., & Poss, M. 2010. Nodeomics: pathogen detection in vertebrate lymph 
nodes using meta-transcriptomics. PloS One, 5(10): e13432. 
Wu, T., Yan, Y., & Kozak, C. A. 2005. Rmcf2, a xenotropic provirus in the Asian mouse species 
Mus castaneus, blocks infection by polytropic mouse gammaretroviruses. J Virol, 79(15): 
9677-9684. 
Wu, X., Li, Y., Crise, B., & Burgess, S. M. 2003. Transcription start regions in the human genome 
are favored targets for MLV integration. Science, 300(5626): 1749-1751. 
Wu, Y., Koharudin, L. M., Mehrens, J., DeLucia, M., Byeon, C. H., Byeon, I. J., Calero, G., Ahn, J., & 
Gronenborn, A. M. 2015. Structural Basis of Clade-specific Engagement of SAMHD1 
(Sterile alpha Motif and Histidine/Aspartate-containing Protein 1) Restriction Factors by 
Lentiviral Viral Protein X (Vpx) Virulence Factors. J Biol Chem, 290(29): 17935-17945. 
Xu, W., Gorman, K., Santiago, J. C., Kluska, K., & Eiden, M. V. 2015. Genetic diversity of koala 
retroviral envelopes. Viruses, 7(3): 1258-1270. 
Yan, Y., Buckler-White, A., Wollenberg, K., & Kozak, C. A. 2009. Origin, antiviral function and 
evidence for positive selection of the gammaretrovirus restriction gene Fv1 in the genus 
Mus. Proc Natl Acad Sci U S A, 106(9): 3259-3263. 
Yang, L., Guell, M., Niu, D., George, H., Lesha, E., Grishin, D., Aach, J., Shrock, E., Xu, W., Poci, J., 
Cortazio, R., Wilkinson, R. A., Fishman, J. A., & Church, G. 2015. Genome-wide 
inactivation of porcine endogenous retroviruses (PERVs). Science, 350(6264): 1101-1104. 
Yap, M. W., Colbeck, E., Ellis, S. A., & Stoye, J. P. 2014. Evolution of the retroviral restriction gene 
Fv1: inhibition of non-MLV retroviruses. PLoS Pathog, 10(3): e1003968. 
Yap, M. W., & Stoye, J. P. 2013. Apparent effect of rabbit endogenous lentivirus type K 
acquisition on retrovirus restriction by lagomorph Trim5alphas. Philos Trans R Soc Lond 
B Biol Sci, 368(1626): 20120498. 
Ye, L., Bu, Z., Vzorov, A., Taylor, D., Compans, R. W., & Yang, C. 2004. Surface stability and 
immunogenicity of the human immunodeficiency virus envelope glycoprotein: role of 
the cytoplasmic domain. J Virol, 78(24): 13409-13419. 
Zeng, M., Hu, Z., Shi, X., Li, X., Zhan, X., Li, X. D., Wang, J., Choi, J. H., Wang, K. W., Purrington, T., 
Tang, M., Fina, M., DeBerardinis, R. J., Moresco, E. M., Pedersen, G., McInerney, G. M., 
Karlsson Hedestam, G. B., Chen, Z. J., & Beutler, B. 2014. MAVS, cGAS, and endogenous 
retroviruses in T-independent B cell responses. Science, 346(6216): 1486-1492. 
Zhang, G., Rahbek, C., Graves, G. R., Lei, F., Jarvis, E. D., & Gilbert, M. T. 2015. Genomics: Bird 
sequencing project takes off. Nature, 522(7554): 34. 
Zou, L., Peng, Q., Wang, P., & Zhou, B. 2016. Progress in Research and Application of HIV-1 TAT-




Publication 1: Endogenous Lentivirus in Malayan colugo (Galeopterus variegatus), a close 
relative of primates 
Publication 2: Life History of the Oldest Lentivirus: Characterization of ELVgv Integrations 
in the Dermopteran Genome 
Publication 3: Discovery of the first endogenous Deltaretrovirus, in the genome of long-
fingered bats (Miniopteridae) 
Publication 4: Induction and characterization of a replication competent cervid 
endogenous Gammaretrovirus (CrERV) from mule deer cells 
 
